Optogenetic dissection of septohippocampal neural circuitry for the treatment of epilepsy by Laxpati, Nealen G.
OPTOGENETIC DISSECTION OF SEPTOHIPPOCAMPAL 


























In Partial Fulfillment 
Of the Requirements for the Degree 
















COPYRIGHT © 2015 BY NEALEN G. LAXPATI
OPTOGENETIC DISSECTION OF SEPTOHIPPOCAMPAL 

























Approved by:   
   
Dr. Robert E. Gross, Advisor 
Department of Neurosurgery 
Emory University School of Medicine 
Department of Biomedical Engineering 
Georgia Institute of Technology 
 Professor Joseph R. Manns 
Department of Psychology 
Emory University 
   
Dr. Kerry J. Ressler 
Department of Psychiatry and Behavioral 
Sciences 
Emory University School of Medicine 
Department of Neuroscience 
Emory University 
 Professor Dieter Jaeger 
Department of Biomedical Engineering 
Georgia Institute of Technology 
Department of Biology 
Emory University 
 
   
Professor Garrett B. Stanley 
Department of Biomedical Engineering 
Georgia Institute of Technology 
  
 
Date Approved:  July 16, 2014 
   
































I am forever indebted to my mentor, Dr. Robert Gross, for everything. For 
welcoming me into the lab; for giving me the freedom and independence to make many, 
many mistakes; for supporting my ideas and project; for providing the opportunities for 
which I could never have dreamed; for the advice that has made me a better person; and 
for supporting me through all of the trials and tribulations, I thank you.  
I also must express my great appreciation for my committee members, Dr. Dieter 
Jaeger, Dr. Garrett Stanley, Dr. Kerry Ressler, and Dr. Joe Manns, who have watched 
over and guided me from the beginning, and whose advice, collaborations, and support 
have greatly improved the quality of this work. 
I am immensely grateful to my wonderful lab mates. First and foremost is Claire-
Anne Gutekunst, who has taught me everything I know about viral vectors, histology, and 
raising a young swimmer. Also Jack Tung, Babak Mahmoudi, Sharanya Desai, Otis 
Smart, Maggie McDougal, Alex Wang, Lissa Jackson, and Leigh Nadel,  who all in some 
way (and often in big ways) taught me something and contributed to this work. I am 
beholden to my undergraduate volunteers – Megha Chiruvella, Iordan Potchileev, 
Jonathan Decker, Christopher Hrvoj, Bahar Rehsepar, Neeha Kaja, Drew Cutshaw, and 
Melissa Klein – without whom this project would have never been completed, and who 
taught me much about mentorship.  
I owe a great debt and am immensely thankful for the mentorship, training, and 
friendship of John Rolston, who started me on this wonderful path. 
I would also like to thank my collaborators, in particular those at Georgia Tech in 
the Potter Lab, such as Steve Potter, Jon Newman, Riley Zeller-Townson, and Ming-fai 
v 
 
Fong, who were formative in this projects origin whose advice, insight, and support has 
proven invaluable. I would like to acknowledge Karl Deisseroth and the Deisseroth Lab, 
who made this work possible by providing the channels and transgenic animals. I would 
also like to thank Dr. Michael Kaplitt, who made our first AAV virus.  
I would like to thank the students, faculty, and administrators of the Emory 
MD/PhD Program and the Georgia Tech BME program who have been wonderfully 
supportive in both the best and worst times. My classmates have been extraordinary, and 
I’d especially like to thank David Bass, for his scientific insights and immeasurable 
friendship. 
I am forever grateful to the Emory Women’s Water Polo Team, the Georgia Tech 
Water Polo Team, and the Dynamo Water Polo Team. They have kept me healthy and 
sane, taught me immeasurably about leadership, teamwork, strength, and love. 
Finally, to my Mom (Maureen), Papa (Sharad), and Sister (Leela): Thank you for 
always being there for me, for your insight and perspective, and for your steadfast belief. 
I love you all very, very much. 
I am better than I was, and in large part that is because of all of you. 
This work was supported by funding from an Emory Neuroscience Initiative Seed 
Grant, an American Epilepsy Society Investigator Award, U.S. National Institutes of 
Health grants R01-NS079268-01, 5T32-NS007480-12, and an Epilepsy Research 





TABLE OF CONTENTS 
 
ACKNOWLEDGEMENTS ........................................................................................ IV 
LIST OF TABLES ........................................................................................................ X 
LIST OF FIGURES ..................................................................................................... XI 
SUMMARY ............................................................................................................... XIII 
CHAPTER I INTRODUCTION ......................................................................................1 
1.1 AN UNMET NEED ....................................................................................................... 1 
1.1.1 The current state of epilepsy therapy..............................................................1 
1.1.2 Empirically-derived clinical targets and stimulation parameters ................1 
1.1.3 The hippocampus is a large and complex structure ......................................2 
1.1.4 Cell-type non-specificity of electrical stimulation. .........................................2 
1.2. THETA REPRESENTS A SEIZURE-RESISTANT FUNCTIONAL STATE .......................... 3 
1.3. THE MEDIAL SEPTUM IS AN ATTRACTIVE FOCAL TARGET FOR DISTRIBUTED 
HIPPOCAMPAL OSCILLATORY CONTROL ................................................................... 4 
1.4. OPTOGENETIC NEUROMODULATION ....................................................................... 6 
1.5. OPTOGENETIC MODULATION OF EPILEPTIC ACTIVITY ......................................... 9 
1.6. THESIS ORGANIZATION ......................................................................................... 12 
CHAPTER II THE CURRENT STATE OF DEEP BRAIN STIMULATION 
FOR THE TREATMENT OF EPILEPSY: CIRCUITS, 
TARGETS, AND TRIALS ...................................................................15 
2.1. INTRODUCTION ...................................................................................................... 16 
2.1.1 The Burden of Epilepsy ..................................................................................16 
2.1.2 Rationale: Cortical-Subcortical Networks in Epilepsy ...............................17 
2.1.3 Mechanism: Neuromodulation via Electrical Stimulation ..........................19 
2.2. TARGETS FOR ELECTRICAL STIMULATION IN EPILEPSY ....................................... 27 
2.2.1 Cerebellum.......................................................................................................28 
2.2.2 Hippocampal formation .................................................................................30 
2.2.3 Subthalamic Nucleus/Substantia Nigra ........................................................40 
2.2.4 Caudate Nucleus..............................................................................................43 
2.2.5 Centromedian Nucleus of the Thalamus ......................................................44 
2.2.6 Anterior Nucleus of the Thalamus ................................................................47 
2.3. FUTURE DIRECTIONS ............................................................................................. 53 
2.4. CONCLUDING REMARKS ........................................................................................ 56 
CHAPTER III REAL-TIME IN VIVO OPTOGENETIC 
NEUROMODULATION AND MULTIELECTRODE 
ELECTROPHYSIOLOGIC RECORDING WITH 
NEURORIGHTER ...............................................................................58 
3.1. INTRODUCTION ...................................................................................................... 59 
3.2. NEURORIGHTER PLATFORM ................................................................................. 61 
3.2.1 Design ...............................................................................................................63 
vii 
 
3.2.1.1 Design criteria ........................................................................................... 63 
3.2.1.2 Optical stimulation .................................................................................... 63 
3.2.1.3 Electrode Arrays ....................................................................................... 66 
3.2.2 Methods ............................................................................................................68 
3.2.2.1 Surgeries ................................................................................................... 68 
3.2.2.2 Optical stimulation and electrophysiologic recordings ............................. 70 
3.2.2.3 Histology ................................................................................................... 72 
3.3. RESULTS ................................................................................................................. 72 
3.3.1 Histologic validation of channel expression and electrode 
placement ..................................................................................................................72 
3.3.2 Validation of hippocampal response to pulsatile stimulation 
patterns in the medial septum .................................................................................74 
3.3.3 Alternative, customizable stimulation patterns ...........................................80 
3.3.3.1 5 Hz jitter .................................................................................................. 80 
3.3.3.2 Poisson distribution ................................................................................... 82 
3.3.3.3 Cross-frequency stimulation ..................................................................... 82 
3.3.3.4 Continuous sinusoidal ............................................................................... 83 
3.3.4 Validation of hippocampal response to pulsatile stimulation 
patterns in the hippocampus ...................................................................................84 
3.3.5 Closed-loop stimulation ..................................................................................88 
3.4. DISCUSSION ............................................................................................................ 90 
3.5. CONCLUDING REMARKS ........................................................................................ 93 
CHAPTER IV OPTOGENETIC NEUROMODULATION OF MEDIAL 
SEPTAL GABAERGIC NEURONS AND THE IMPACT 
ON HIPPOCAMPAL OSCILLATORY ACTIVITY IN 
AWAKE AND BEHAVING RATS .....................................................94 
4.1. INTRODUCTION ...................................................................................................... 94 
4.2. METHODS ............................................................................................................. 100 
4.2.1 Surgeries ........................................................................................................100 
4.2.2 Optical stimulation and electrophysiologic recordings .............................103 
4.2.3 Data analysis ..................................................................................................104 
4.2.4 Histology ........................................................................................................104 
4.3. RESULTS ............................................................................................................... 105 
4.3.1 Histologic verification of channel expression .............................................105 
4.3.2 Rhythmic excitation of GABAergic MSDB neurons .................................107 
4.3.2.1 Evoked LFP response waveforms to excitation are highly influenced by 
stimulation parameters. ............................................................................ 107 
3.2.2 Frequency-specific responses to optical excitation in both layers ............. 108 
4.3.2.3 Phase-locking to the theta stimulus pattern ............................................ 113 
4.3.3 Inhibition of MSDB GABAergic neurons ...................................................115 
4.3.3.1 Rhythmic 35 Hz inhibition of MSDB GABAergic neurons produces a 
concurrent increase in power at the stimulus frequency. ......................... 115 
4.3.3.2 Constant 90 mW/mm
2
 inhibition of MSDB GABAergic neurons does not 
alter hippocampal LFP. ............................................................................ 117 
4.4. DISCUSSION .......................................................................................................... 118 
4.5. CONCLUSIONS ...................................................................................................... 121 
viii 
 
CHAPTER V OPTOGENETIC MODULATION OF MEDIAL SEPTAL 
GLUTAMATERGIC NEURONS AND THE IMPACT ON 
HIPPOCAMPAL OSCILLATORY ACTIVITY IN AWAKE 
AND BEHAVING RATS ...................................................................123 
5.1. INTRODUCTION .................................................................................................... 123 
5.2. METHODS ............................................................................................................. 127 
5.2.1 Surgeries ........................................................................................................127 
5.2.2 Optical stimulation and electrophysiologic recordings .............................129 
5.2.3 Data analysis ..................................................................................................130 
5.2.4 Histology and Immunohistochemistry ........................................................131 
5.3. RESULTS ............................................................................................................... 132 
5.3.1 Histologic verification of channel expression .............................................132 
5.3.2 Rhythmic excitation of glutamatergic MSDB neurons ..............................135 
5.3.2.1 Evoked LFP response waveforms ........................................................... 135 
5.3.2.2 Frequency-specific responses to excitation in both layers ...................... 137 
5.3.2.3 Phase-locking to the theta stimulus pattern ............................................ 141 
5.3.3 Inhibition of MSDB glutamatergic neurons ...............................................143 
5.3.3.1 Rhythmic 35 Hz inhibition of MSDB glutamatergic neurons did not alter 
hippocampal LFP ..................................................................................... 143 
5.3.3.2 Constant 90 mW/mm
2
 inhibition of MSDB glutamatergic neurons does 
not alter hippocampal LFP power, but may impact theta-phase 
maintenance. ............................................................................................. 144 
5.4. DISCUSSION .......................................................................................................... 148 
5.5. CONCLUSIONS ...................................................................................................... 149 
CHAPTER VI OPTOGENETIC MODULATION OF MEDIAL SEPTAL 
CHOLINERGIC NEURONS AND THE IMPACT ON 
HIPPOCAMPAL ACTIVITY IN AWAKE AND 
BEHAVING RATS .............................................................................151 
6.1. INTRODUCTION .................................................................................................... 151 
6.2. METHODS ............................................................................................................. 154 
6.2.1 Surgeries ........................................................................................................154 
6.2.2 Optical stimulation and electrophysiologic recordings .............................157 
6.2.3 Data analysis ..................................................................................................158 
6.2.4 Histology and immunohistochemistry.........................................................159 
6.3. RESULTS ............................................................................................................... 160 
6.3.1 Histologic verification of channel expression .............................................160 
6.3.2 Rhythmic excitation of cholinergic MSDB neurons ..................................162 
6.3.2.1 Rhythmic cholinergic MSDB stimulation fails to alter hippocampal LFP 
dynamics at any stimulation frequency .................................................... 162 
6.3.2.2 CA3 Single-unit firing rate changes observed during implantation under 
anesthesia .................................................................................................. 166 
6.3.2.3 Three isolated CA3 and CA1 single units reduced their firing rate in 
response to 50 mW/mm
2
, 35 Hz, 10 ms stimulation of cholinergic neurons 
of the medial septum ................................................................................ 167 
6.3.3 Inhibition of MSDB cholinergic neurons ....................................................170 
ix 
 
6.3.3.1 Rhythmic 35 Hz inhibition of MSDB cholinergic neurons did not alter 
hippocampal LFP power or coherence ..................................................... 171 
6.3.3.2 No hippocampal single units altered their firing rate in response to 
optogenetic inhibition ............................................................................... 172 
6.4. DISCUSSION .......................................................................................................... 173 
6.5. CONCLUSIONS ...................................................................................................... 175 
CHAPTER VII CONCLUSIONS .................................................................................176 
7.1. FUTURE EXPERIMENTAL THOUGHTS FOR ELUCIDATING MSDB-HIPPOCAMPAL 
INTERACTIONS ....................................................................................................... 177 
7.2. APPLYING OUR FINDINGS TO AN OPTOGENETIC THERAPY FOR EPILEPSY ......... 178 
 







LIST OF TABLES 
 





LIST OF FIGURES 
 
Figure 1: The septohippocampal network and targets for optogenetic 
neuromodulation ................................................................................................5 
Figure 2: Neural Circuits and Anatomical Targets for Stimulation ...................................18 
Figure 3: Median percentage change in seizure frequency from baseline during the 
SANTE and RNS® Trials. ...............................................................................49 
Figure 4: NeuroRighter software and hardware for calibration, optical stimulation, 
and recording. ..................................................................................................60 
Figure 5: Robust expression of ChR2 on transverse section histology and 
verification of electrode placement. .................................................................73 
Figure 6: Peristimulus average hippocampal LFP responses to medial septal 
stimulation reveal the influence of stimulation parameters on waveform 
shape. ...............................................................................................................75 
Figure 7: Spectral and correlational response of the CA3 hippocampal LFP to 
medial septal pulse stimulation demonstrate time-locked and frequency 
specific responses.............................................................................................76 
Figure 8: Harmonic deconstruction demonstrates their participation in non-
oscillatory dynamics of the hippocampal pulse response. ...............................78 
Figure 9: Hippocampal single unit firing rates increase in response to optical 
stimulation of the medial septum. ....................................................................79 
Figure 10: Hippocampal LFP response to alternative, customizable optical 
stimulation patterns in the medial septum. ......................................................81 
Figure 11: Stimulation and recording within the hippocampus. ........................................85 
Figure 12: Closed-loop stimulation of the medial septum in response to decreased 
theta power. ......................................................................................................90 
Figure 13: Robust expression of ChR2-EYFP in the medial septum. .............................106 
Figure 14: CA3 LFP response as a function of stimulus intensity, frequency, and 
pulse width. ....................................................................................................108 
Figure 15: CA1 and CA3 demonstrate stimulation theta frequency-specific 
increases in power with 7 Hz stimulation. .....................................................109 
Figure 16: Stimulus-frequency specific increases in spectral power with 35 Hz 
stimulation......................................................................................................110 
Figure 17: Temporal specificity of the spectrographic and coherence response to 7 
Hz stimulation. ...............................................................................................112 
Figure 18: Temporal specificity of the spectrographic and coherence response to 35 
Hz stimulation. ...............................................................................................113 
Figure 19: Auto and cross-correlation properties indicate phase-locking to stimulus 
pulses..............................................................................................................114 
Figure 20: Rhythmic inhibition significantly increases power at the inhibition 
frequency........................................................................................................116 
Figure 21: Constant inhibition of MSDB GABAergic neurons does not alter 
hippocampal oscillatory power. .....................................................................117 
Figure 22: Constant inhibition of MSDB GABAergic neurons does not significantly 
alter hippocampal phase. ................................................................................118 
xii 
 
Figure 23: Robust expression of ChR2-mCherrry in the medial septum. ........................133 
Figure 24: CaMKIIα-ChR2 selectively expressed in glutamatergic neurons of the 
medial septum. ...............................................................................................134 
Figure 25: CA3 LFP response as a function of stimulus intensity, frequency, and 
pulse width. ....................................................................................................136 
Figure 26: CA1 and CA3 demonstrate stimulation theta frequency-specific 
increases in power with theta stimulation. .....................................................138 
Figure 27: Stimulus-frequency specific increases in spectral power with 35 Hz 
stimulation......................................................................................................139 
Figure 28: Temporal specificity of the spectrographic and coherence response to 7 
Hz stimulation. ...............................................................................................140 
Figure 29: Temporal specificity of the spectrographic and coherence response to 35 
Hz stimulation. ...............................................................................................141 
Figure 30: Auto and cross-correlation properties indicate phase-locking to stimulus 
pulses..............................................................................................................142 
Figure 31: Rhythmic inhibition at 35 Hz does not alter hippocampal spectral power. ...144 
Figure 32: Constant inhibition of MSDB glutamatergic neurons does not alter 
hippocampal oscillatory power. .....................................................................145 
Figure 33: Constant inhibition may alter consistency of hippocampal phase and 
phase synchrony between CA1 and CA3.......................................................147 
Figure 34: Robust and selective expression of ChR2-mCherry in transgenic Chat-
CRE medial septal cholinergic neurons. ........................................................161 
Figure 35: Rhythmic 7 Hz cholinergic stimulation fails to alter hippocampal LFP 
power..............................................................................................................162 
Figure 36: Rhythmic 7 Hz cholinergic stimulation fails to alter hippocampal LFP 
power and coherence......................................................................................163 
Figure 37: Rhythmic 35 Hz cholinergic stimulation fails to alter hippocampal LFP 
power..............................................................................................................164 
Figure 38: 35 Hz stimulation of MSDB cholinergic neurons fails to alter 
hippocampal power or coherence ..................................................................165 
Figure 39: 7 Hz stimulation does not alter theta phase in CA1 or CA3 ..........................166 
Figure 40: Single-unit response to stimulation during surgical implantation ..................167 
Figure 41: Three CA1 and CA3 single units reduced their firing rate in response to 
50 mW/mm
2
, 35 Hz, 10 ms stimulation of cholinergic MSDB neurons .......169 
Figure 42: Rhythmic inhibition at 35 Hz does not alter hippocampal spectral power. ...170 
Figure 43: Constant inhibition of MSDB cholinergic neurons does not alter 
hippocampal oscillatory power ......................................................................171 







Over 50 million people worldwide suffer from epilepsy. Of these, nearly a third will be 
refractory to medical therapy, and many will be poor candidates for surgical resection. 
Thus there is a need for novel targets and therapies, the former of which will require a 
greater understanding of neural networks involved in epilepsy, and the latter of which 
demands the development of novel therapeutic techniques. Seizures are less frequent 
during periods where theta – a 3-12Hz oscillatory rhythm in the hippocampal local field 
potential – is present. Theta is thought to originate in the medial septum, a basal forebrain 
structure that projects to the site of origin for the most common form of intractable 
epilepsy, the hippocampus. As has been demonstrated with pharmacologic and electrical 
stimulation, theta generation via the medial septum is consequently an ideal target for 
intervention. However, of the three neuron populations within the medial septum – 
cholinergic, GABAergic, and glutamatergic – it is unclear which is responsible for theta, 
or indeed if a single population is driving the oscillation. Optogenetics, a novel technique 
that enables activation and inhibition of genetically-defined neurons on a millisecond 
time-scale, provides the means to functionally dissect this septohippocampal axis and 
leverage the results for seizure therapy. In this thesis, I detail the current state of deep 
brain stimulation for epilepsy, and describe our motivation for targeting the medial 
septum and the importance of the hippocampal theta rhythm. I describe new technologies, 
software, and adaptations to our electrophysiology platform, NeuroRighter, to enable 
concurrent optogenetic neuromodulation and electrophysiology in awake and behaving 
animals, and demonstrate how these technologies and techniques can be used in several 
experimental approaches. I next use this system to show that both the GABAergic and 
xiv 
 
glutamatergic neurons of the medial septum can drive and pace hippocampal oscillatory 
rhythms, but only the glutamatergic neurons are necessary to maintain phase relationships 
between successive theta cycles. I also demonstrate that activating and inhibiting the 
cholinergic neurons of the medial septum does not alter hippocampal local field potential 
activity, but does alter single-unit firing rates. These results shed light on the function of 
the medial septum in generating and modulating theta, and provide clear targets for 











1.1 AN UNMET NEED 
1.1.1 The current state of epilepsy therapy 
A large proportion of patients with temporal lobe epilepsy are unable to achieve seizure 
freedom with pharmacologic medical therapy (Kwan and Sperling 2009; Kwan et al. 
2011). Those who fail to respond to two antiepileptic drugs only possess a 5-10% chance 
of responding to a new drug therapy (Kwan and Sperling 2009). Surgery, only sometimes 
an option, is not always effective (Wiebe et al. 2001) and can generate new morbidities 
such as memory deficits (Helmstaedter et al. 2008; Helmstaedter et al. 2011). Thus, there 
is a defined need for novel, function-preserving therapeutic strategies. Electrical 
stimulation of the brain has been shown to reduce seizure frequency, but only a small 
proportion of patients become seizure free (Boon et al. 2009; Fisher et al. 2010), 
regardless of anatomical target. These results are potentially the result of several factors. 
 
1.1.2 Empirically-derived clinical targets and stimulation parameters  
The targets and parameters used in deep brain stimulation (DBS) of a variety of 
neurologic disorders have largely been determined observationally and empirically 
(Hunka et al. 2005). Indeed, parameters used at a particular anatomical target have often 
gone unchanged for decades, despite their lack of success (CHAPTER II, Table 1). In 
large part, the clinical targets and stimulation parameters chosen for a new trial are based 
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on limited case-control studies, and are not necessarily grounded in mechanistic concepts. 
Thus, it is unclear to what extent the poor results of clinical trials of deep brain 
stimulation for epilepsy therapy are in part due to the chosen stimuli (McIntyre and Grill 
2002). A more rational approach is to leverage our existing knowledge of hippocampal 
neural activity and epilepsy to guide targeting, stimulation choices, and therapeutic 
approaches. 
 
1.1.3 The hippocampus is a large and complex structure 
Successful amygdalohippocampectomy involves resecting a large hippocampal volume to 
remove epileptic foci (Helmstaedter et al. 2008). However, the volume of neural tissue 
directly modulated by electrical stimulation is much smaller than this (McIntyre et al. 
2006). Direct hippocampal single-electrode electrical stimulation may fail to alleviate 
seizures because it is unable to sufficiently impact the entire epileptic foci. Stimulation of 
an upstream target that projects to a large hippocampal volume is a rational alternative 
approach which has some demonstrated success (Fisher et al. 2010). 
 
1.1.4 Cell-type non-specificity of electrical stimulation.  
Electrical stimulation affects all neural tissue within the voltage gradient established 
around an electrode, including both excitatory and inhibitory neurons, axons, and 
dendrites (Ranck 1975; Histed et al. 2009), not to mention glial cells and even blood 
vessels. The impact of electrical stimulation on a laminar structure like the hippocampus, 
and the neuron subpopulations that will be recruited by electrical stimulation, is highly 
dependent on the electrode location relative to these structures. This is problematic, as the 
physiologic rhythms of the hippocampus – such as theta, gamma, and ripple oscillations – 
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are thought to be generated from complex interactions between interneurons and 
pyramidal cells (Freund and Buzsáki 1996; Buzsáki 2002; Klausberger et al. 2003; 
Gloveli et al. 2005). Interactions between inhibitory and excitatory neurons could thus 
play a prominent role in generating the pathologic oscillations of epileptic activity 
(Ziburkus et al. 2006). Altering these dynamics through excitation/inhibition of specific 
neuronal subpopulations in the network would prove useful not only in deciphering their 
role in producing normal oscillatory activity, but furthermore in understanding and 
preventing the generation and propagation of seizures. 
 
1.2. THETA REPRESENTS A SEIZURE-RESISTANT FUNCTIONAL STATE 
The theta rhythm is a 3-12 Hz oscillation of hippocampal local field potential (LFP) – 
observed during active awake behavior and random-eye-movement (REM) sleep – that 
plays a role in several behaviors, such as memory and navigation (Bland and Colom 
1993; Buzsáki 2002; Patel et al. 2012; Buzsaki and Moser 2013). A large body of 
evidence indicates that in epileptic models, however, theta activity is disturbed 
(Arabadzisz et al. 2005; Colom 2006; Dugladze et al. 2007; García-Hernández et al. 
2010; Kitchigina et al. 2013). In the tetanus toxin model of epilepsy used by our group 
(Rolston et al. 2010) we have observed significant reductions in theta power as compared 
to normal controls. 
 However, during periods of prominent theta power epileptic seizures are less 
frequent (Colom 2006). Seizures in epileptic patients occurred less frequently during 
REM sleep (Montplaisir et al. 1987). Furthermore, induction of hippocampal theta 
activity demonstrably reduces and arrests epileptic activity in several animal and seizure 
models (Miller et al. 1994; Colom et al. 2006; Kitchigina and Butuzova 2009). Miller et 
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al. showed that microinjections of the muscarinic agonist carbachol into the medial 
septum – a procedure known to generate hippocampal theta oscillations (Monmaur and 
Breton 1991) – arrested pentylenetetrazol (PTZ) induced behavioral seizures and EEG 
spiking (Miller et al. 1994). Carbachol-injected animals demonstrated a significant 
reduction in seizure duration (6.8 s) as compared to controls (26.8 s). In an additional 
four rats, the authors successfully electrically stimulated the medial septum with 100 µA 
4-8 Hz electrical stimulation to produce a similar antiseizure effect (Miller et al. 1994). 
 This work supporting theta as an antiepileptic intervention was further 
substantiated by Colom et al. in the pilocarpine model of chronic epilepsy (Colom et al. 
2006). The authors showed that the hippocampal theta rhythm was also reduced in this 
model of epilepsy, and that its restoration – either observed spontaneously, induced by 
sensory stimulation (tail pinch), or by carbachol administration – reduced the frequency 
of hippocampal epileptic discharges to 7-14% of their peak in all cases. The authors thus 
proposed that due to these disparate methods of induction, the primary modulator of this 
antiepileptic effect was the theta oscillatory functional state, and not the method used to 
induce it. 
 
1.3. THE MEDIAL SEPTUM IS AN ATTRACTIVE FOCAL TARGET FOR 
DISTRIBUTED HIPPOCAMPAL OSCILLATORY CONTROL 
The medial septum, the fimbria/fornix, and the hippocampus comprise one continuous 
anatomical structure – the septohippocampal axis (Colom 2006). Substantial evidence 
implicates the medial septum-diagonal band complex (MSDB) in the generation and 
maintenance of the theta rhythm in the hippocampus, and indeed the medial septum is the 
hypothesized pacemaker for this 3-12 Hz oscillatory rhythm (Stewart and Fox 1990; Tóth 
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et al. 1997; Buzsáki 2002; Colom et al. 2006; Kitchigina et al. 2013). Colom et al. 
hypothesized that this septohippocampal network plays an important role in maintaining 
hippocampal activity and oscillations within non-pathologic regimes, preventing the 
occurrence of abnormally excited states (Colom 2006; Colom et al. 2006; Colom and 
Garrido-Sanabria 2007; García-Hernández et al. 2010). Induction of theta via 
pharmacologic and electrical methods has often acted through the medial septum (Miller 
et al. 1994; Kitchigina and Butuzova 2009), and it is also an attractive target for epilepsy 
neuromodulation due to its distributed projections to the hippocampus. It provides a 
single target location that projects bilaterally to both hippocampi, potentially impacting 
seizure foci regardless of location or distribution (Figure 1).  
 
 
Figure 1: The septohippocampal network and targets for optogenetic neuromodulation 
Schematic representation of the major cholinergic (gray), GABAergic (black), and glutamatergic 
(white) connections in the septohippocampal network between the hippocampus (H), medial 
septum (MS), and lateral septum (LS). Also represented are targets for optogenetic excitation 
(blue arrows) and inhibition (yellow arrows). Note that this schematic does not fully represent 




Three genetically-distinct neuron subpopulations have been identified within the 
MSDB – GABAergic, glutamatergic, and cholinergic neurons – all of which project to 
the hippocampus and may play a role in modulating hippocampal activity and theta 
oscillations (Figure 1) (Freund and Antal 1988; Sotty et al. 2003; Yoder and Pang 2005; 
Huh et al. 2010; Bell et al. 2013). In order to evaluate the role of each of these 
populations in modulating hippocampal theta – and in turn determining an optimum 
target for arresting seizure activity – we need to employ a spatially, temporally, and 
genetically selective method for excitation and inhibition in awake and behaving animals. 
 
1.4. OPTOGENETIC NEUROMODULATION 
Optogenetics is a powerful approach for neuromodulation that enables selective 
activation or inhibition of genetically-defined neuron subpopulations in vivo at the 
millisecond time scale (Yizhar et al. 2011). Optogenetics thus provides a powerful means 
to elucidate the specific cellular mechanisms underlying MSDB regulation of 
hippocampal theta oscillations. Optogenetics provides the cell-type specificity of 
pharmacologic techniques while retaining the temporal specificity of electrical 
stimulation. This enables time-sensitive manipulation of the neural code (Stanley 2013) 
in genetically-defined neuron subpopulations to an impressive and heretofore 
unprecedented degree, enabling exquisite insight into neural network function (Gradinaru 
et al. 2009; Liu et al. 2012; Bell et al. 2013). 
 Optogenetics involves a set of techniques to introduce and manipulate microbial 
light-sensitive ion channels and pumps (LSICs) in genetically-specified cell populations. 
LSICs enable the passage of ions across a cell membrane – either down the 
electrochemical gradient or pumped against it – altering the membrane potential of the 
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cell. In neurons, excitation (channelrhodopsin-2 and its peers) can be used to bring the 
cell to threshold, while hyperpolarization (halorhodopsin, archaerhodopsin) can inhibit 
cell firing. As many LSICs have been designed to respond to light on a millisecond 
timescale (Yizhar et al. 2011; Tchumatchenko et al. 2013), complex and temporally-
sensitive stimulation patterns can be provided to particular subpopulations within a 
complex neural circuit.  
One of the most successful channels is channelrhodopsin-2 (ChR2), which 
enables cation entry in response to light stimulation (Boyden et al. 2005). Continued 
manipulation and discovery have rapidly expanded the available repertoire of optogenetic 
channels (Gradinaru et al. 2010; Gunaydin et al. 2010; Diester et al. 2011; Witten et al. 
2011; Yizhar et al. 2011), including inhibitory pumps for effective neural silencing 
(Gradinaru et al. 2010). Indeed, a vast repertoire of optogenetic tools are being designed 
to fit numerous experimental needs (Diester et al. 2011; Yizhar et al. 2011; Lin et al. 
2013). 
 Optogenetics takes advantage of gene therapy-based selectivity for targeted 
channel expression in particular genetically-defined neuron subpopulations within a 
heterogeneous network (Davidson and Breakefield 2003). The genetic code for a LSIC is 
coupled to a particular sequence known as a promoter. Different promoters are active in 
different cell types – such as the choline acetyltransferase (ChAT) promoter in 
cholinergic neurons. Promoters are regions of DNA which initiate transcription and 
translation of particular genes specific to a cell’s function (Klein et al. 1998; Paterna et al. 
2000). By driving expression of our channel with these promoters, we can selectively 
express the LSIC in specific cell subtypes. Cells whose transcriptional pathways do not 
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target the promoter will ignore the gene, and thus not express the channel, enabling cell-
type specific expression and manipulation. 
 Viral vectors have consequently become a favored means of introducing genetic 
constructs into the nervous system in vivo for targeted expression (Davidson and 
Breakefield 2003; Burger et al. 2004; Cockrell and Kafri 2007; Howard et al. 2008; 
Nathanson et al. 2009; Blits et al. 2010). Different viruses possess different tropisms 
(Davidson and Breakefield 2003; Burger et al. 2004), that when coupled with promoter-
type specificity can more effectively limit gene expression to particularly desired 
subpopulations. Lentivirus (Cockrell and Kafri 2007) and adeno-associated virus (AAV) 
(Tenenbaum et al. 2004) have been most commonly used in optogenetic experiments, but 
a diverse repertoire of viral methods can enable complex and targeted experimentation to 
be performed (Yizhar et al. 2011).  
Increasingly, Cre-Lox recombination systems are being employed to target 
optogenetic LSICs (Witten et al. 2011; Madisen et al. 2012). Transgenic animals are 
produced that constitutively express the Cre bacterial enzyme in particular cell-types 
based on promoter sequence (e.g. ChAT-Cre). This enzyme can selectively excise 
sequences flanked by LoxP sites, reverse the sequence, and then reintegrate it. As a 
result, it can take a reversed non-expressing sequence and change it to an expressing one. 
As the selectivity of this system is determined by transgenic Cre expression, strong 
ubiquitous promoters with short sequences can be coupled to our introduced gene to 
produce robust expression selectively in our desired cell population.  
 Finally, as the name implies, control of light-sensitive ion channels is mediated 
optically. Activation and inhibition with light possesses a number of advantages over 
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electrical stimulation. Different LSICs are uniquely sensitive to particular wavelengths of 
light, enabling simultaneous and independent excitation and inhibition within the same 
neural network, or even the same neuron (Zhang et al. 2007; Yizhar et al. 2011). 
Substantial efforts have been made to produce LSICs with unique wavelength 
responsiveness (Lin et al. 2013), expanding the repertoire of experiments that can be 
performed, particularly with combinatorial approaches. 
 Light is also advantageous in that it distributes predictably through nervous 
system tissue, providing for greater prediction of the volume of tissue manipulated 
(Aravanis et al. 2007). In addition, optically-induced artifacts are often negligible, 
particularly when compared to those experienced during electrical stimulation. Electrical 
stimulation necessitates the use of stimulating voltages many orders of magnitude greater 
than those being recorded, resulting in large, amplifier-saturating artifacts. Optogenetics, 
on the other hand, enables simultaneous stimulation and recording to be performed. 
 
1.5. OPTOGENETIC MODULATION OF EPILEPTIC ACTIVITY 
The advantages optogenetics holds over electrical and pharmacologic stimulation have 
provided great insight into nervous system function in normal and pathologic states 
(Gradinaru et al. 2009; Liu et al. 2012), including epilepsy. The earliest work was 
performed with optogenetic inhibition in hippocampal slice models of epileptiform 
activity (Tønnesen et al. 2009). Lentiviral vectors introduced a halorhodopsin chloride 
pump (NpHR) under the calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) 
promoter, selectively expressing in principal cells of the hippocampus and cortex. 
Optogenetic hyperpolarization of these neurons was sufficient to arrest induced 
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epileptiform activity, providing proof of concept that optogenetic neuromodulation could 
be an effective therapeutic tool for seizures.  
 This finding was recapitulated by Wykes et al. in the tetanus toxin motor cortex 
model of epilepsy (Wykes et al. 2012). Focal injection of tetanus toxin into the motor 
cortex generates bursts of epileptiform EEG activity and associated clonic movements of 
the face and forelimbs. The authors tested whether acute inhibition of principal neurons 
(targeted by a lentivirus encoding CaMKIIα-NpHR2.0) in the induced epileptic focus 
could attenuate or arrest network excitability. They used a 20-s on/20-s off protocol to 
provide for NpHR recovery and prevent desensitization and chloride shifting. Inhibition 
did not visibly affect rat behavior, but did significantly reduce high-frequency power. 
Furthermore it decreased the frequency of epileptic events. 
 Krook-Magnuson et al. used a closed-loop approach to directly inhibit pyramidal 
neurons in the kainate-induced epileptic hippocampus (Krook-Magnuson et al. 2013).  
Selective expression of halorhodopsin in pyramidal neurons was achieved by crossing 
CaMKIIα-Cre with Cre-halorhodopsin mouse lines. The authors then designed a novel, 
tunable closed-loop seizure detection program to randomly inhibit 50% of detected 
events, thus letting each animal serve as its own control. Inhibition of the pyramidal 
neurons in this fashion significantly reduced seizure duration (70%), with 57% of 
seizures arresting with one second of light delivery.  
In a second set of experiments, the authors sought to excite the inhibitory 
interneurons of the hippocampus using the same closed-loop stimulation approach 
(Krook-Magnuson et al. 2013). Optogenetic stimulation of this population (achieved by 
crossing PV-Cre mice with mice expressing Cre-dependent ChR2) also significantly 
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reduced seizure duration (43%). Intriguingly, stimulation of inhibitory neurons 
contralateral to the kainic acid injection was also able to significantly reduce seizure 
duration, indicating distributed effects on epileptiform foci were a feasible epilepsy 
control strategy in the hippocampus. Arresting behavioral seizures proved more difficult, 
however, with a 29.6% reduction observed. In order to accomplish this level of success, 
bilateral excitation of inhibitory neurons was necessary, presumably to impact a larger 
volume of tissue. As the authors discuss, seizures originate outside the focal site, or have 
diffuse onset. This makes seizure control difficult with focal interventions, particularly in 
larger nervous systems. There is consequently an advantage to targeting focal regions 
with large distributions (i.e. bottlenecks), particularly as efforts scale to non-human 
primates and human patients.  
 Further support for the effectiveness of indirect neuromodulation of epileptic foci 
through a distributed network was provided by Paz et al. (Paz et al. 2013). The cortex is 
intimately connected to the thalamus, and also appears to play a role in the network 
oscillations underlying epilepsy (Paz et al. 2013). The authors sought to selectively 
inhibit thalamocortical neurons using eNpHR3.0, and consequently arrest focal cortical 
seizures in their photothrombotic stroke model. Selective illumination of this population 
interrupted epileptic activity in the thalamus and cortex, as well as the associated 
behavioral seizure. This suggests that targeting a central location in a distributed network, 
such as the medial septum in the septohippocampal axis, may prove more effective in 
modulating the electrographic and behavioral elements of epilepsy. 
 My thesis work involves the development of tools for in vivo optogenetic 
neuromodulation of the septohippocampal axis with concurrent electrophysiologic 
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recording, and the application of these tools to the different subpopulations of the medial 
septum to examine their role in producing hippocampal theta. The goal of this work is to 
develop open-source and low cost tools for optogenetic experiments, gain insight into the 
role of the medial septum in hippocampal theta oscillations, and identify cellular targets 
for optogenetic neuromodulation of the medial septum for the treatment of epilepsy. 
 
1.6. THESIS ORGANIZATION  
The rest of the thesis is as follows: 
CHAPTER II: The Current State of Deep Brain Stimulation for the Treatment of 
Epilepsy: Circuits, Targets, and Trials, Dr. Willard Kasoff and I elaborate on the current 
state of clinical trials and techniques available for deep brain stimulation in the treatment 
of medically-refractory epilepsy. We discuss the results of clinical trials for several 
anatomical targets, including the empirical nature by which the targets and stimulation 
patterns have been run.  
 
CHAPTER III: Real-time in vivo Optogenetic Neuromodulation and Multielectrode 
Electrophysiologic Recording with NeuroRighter discusses the development and 
performance characteristics of adaptations that my collaborators, Jon P. Newman, Riley 
Zeller-Townson, and the Potter Lab, and I made to the open-source NeuroRighter 
electrophysiology platform for in vivo behavioral experimentation with optogenetics. I 
detail two kinds of experiments – proximal stimulation and recording in the hippocampus 
and distal stimulation of the medial septum and recording in the hippocampus, and 




CHAPTER IV: Optogenetic Neuromodulation of Medial Septal GABAergic Neurons and 
the Impact on Hippocampal Oscillatory Activity in Awake and Behaving Rats applies our 
adapted NeuroRighter system to test the hypothesis that GABAergic neurons of the 
medial septum are responsible for pacing the hippocampal theta rhythm. I demonstrate 
that rhythmic excitation of the GABAergic population transmits a stimulus-frequency-
specific oscillatory rhythm to the hippocampus that drives and controls hippocampal 
local field potential activity. In contrast, I show that sustained inhibition of this same 
population does not alter hippocampal oscillatory activity or theta power. This 
demonstrates that while the MSDB GABAergic neurons can modulate hippocampal 
oscillations and theta, they are not necessary for theta function in awake and behaving 
animals, and suggesting that they are not the pacemaker of this oscillatory rhythm.  
 
CHAPTER V: Optogenetic Modulation of Medial Septal Glutamatergic Neurons and the 
Impact on Hippocampal Oscillatory Activity in Awake and Behaving Rats tests the 
hypothesis that the glutamatergic neurons of the medial septum are responsible for pacing 
the hippocampal theta rhythm. I demonstrate that rhythmic excitation of this population – 
much as was demonstrated in the GABAergic population in CHAPTER IV – generates a 
stimulus-frequency-specific increase in power in the hippocampal local field potential, 
although not as robustly as was observed in the GABAergic population. I also 
demonstrate that optogenetic inhibition of this population does not alter hippocampal 
theta power, but does impact the ability of theta to maintain the phase relationship 





CHAPTER VI: Optogenetic Modulation of Medial Septal Cholinergic Neurons and the 
Impact on Hippocampal Activity in Awake and Behaving Rats tests the hypothesis that 
the cholinergic neurons of the medial septum are responsible for pacing and modulating 
the hippocampal theta rhythm. I demonstrate that neither rhythmic excitation nor constant 
inhibition of cholinergic neurons modulates hippocampal local field potential in awake 
animals. I show that rhythmic 35 Hz stimulation, however, can modulate single unit 
firing rates under anesthesia and in the awake animal. These results suggest that the either 
the cholinergic hypothesis of hippocampal theta may be incorrect, that this population 
may act primarily upon single unit firing rates, or that response to cholinergic input is 
dependent upon specific network states. 
 
CHAPTER VII: Conclusion. I conclude the thesis by discussing the implications of this 
work and its results, and future experimental directions, particularly in the realms of 
understanding theta and applying our results to epilepsy. 
 
Hardware and software that I have developed during the course of this work will be made 
publicly available through open access on our website. Portions of this thesis have been 
published previously or submitted for publication. Chapters based upon published and 
submitted work are presented here with permission from the relevant publisher (where 
applicable) and include a citation at the start of the chapter. These chapters are largely 






THE CURRENT STATE OF DEEP BRAIN STIMULATION 






Deep brain stimulation (DBS) has proven remarkably safe and effective in the treatment 
of movement disorders. As a result, it is being increasingly applied to a range of 
neurologic and psychiatric disorders, including medically-refractory epilepsy. This 
review will examine the use of DBS in epilepsy, including known targets, mechanisms of 
neuromodulation and seizure control, published clinical evidence, and novel 
technologies. Cortical and deep neuromodulation for epilepsy has a long experimental 
history, but only recently have better understanding of epileptogenic networks, precise 
stereotactic techniques, and rigorous trial design combined to improve the quality of 
available evidence and make DBS a viable treatment option. Nonetheless, underlying 
mechanisms, anatomical targets and stimulation parameters remain areas of active 
investigation.  
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2.1.1 The Burden of Epilepsy 
Epilepsy afflicts 1% of the world’s population, and is medically refractory in 30-40% of 
cases. (WHO ; Wiebe et al. 2001; Sander 2003; Kwan and Sperling 2009). A substantial 
portion (10-50%) of medically-refractory patients are candidates for resective surgery 
(Engel 2013), with postoperative seizure freedom rates of 40-90% depending, in part, on 
underlying pathology. Nonetheless, there remain millions of patients who either cannot 
undergo resective surgery or who have recurrent seizures despite surgery (Wiebe et al. 
2001; Helmstaedter et al. 2008; Helmstaedter et al. 2011; Engel et al. 2012; Engel 2013). 
Very few of these will respond to additional medication trials (Beleza 2009), and less 
than 10% will achieve seizure freedom with vagal nerve stimulation after failed resection 
(Amar et al. 2004). Thus, there is a pressing need for alternative therapies in medically 
refractory epilepsy. 
Deep brain stimulation (DBS) has proven remarkably effective, safe, and practical 
in the treatment of movement disorders – primarily Parkinson’s disease, dystonia and 
essential tremor (Hariz et al. 2010; Sironi 2011). These successes have inspired the 
application of DBS to an ever-broadening range of neurologic and psychiatric disorders, 
including depression (Holtzheimer et al.), obsessive-compulsive disorder (Blomstedt et 
al. 2013), and Gilles de la Tourette’s syndrome (Kim and Pouratian 2014), as well as 
epilepsy. This review will examine the use of DBS in epilepsy, including potential 
targets, mechanisms of neuromodulation and seizure control, clinical evidence and recent 




2.1.2 Rationale: Cortical-Subcortical Networks in Epilepsy 
Although partial-onset seizures – the most common seizure type in medically refractory 
epilepsy – are heterogeneous in onset zone and clinical manifestations, they often 
propagate along well-defined neural pathways. The networks incorporating these 
pathways – such as the cortical-striatal-thalamic network (Detre et al. 1996; Guye et al. 
2006; Mueller et al. 2010) and the limbic circuit of Papez (Papez 1937; Oikawa et al. 
2001) (Figure 2) – provide nodes at which neuromodulatory tools such as electrical 
stimulation have the potential to regulate the flow of neural information, including 
pathological signals mediating seizure propagation.  
One of the most well-studied of these networks is the circuit of Papez (Papez 
1937). Originally characterized for its role in mediating emotions, more recently this 
circuit has been associated with memory as well as the generation and propagation of 
limbic (e.g. mesial temporal lobe) seizures (Oikawa et al. 2001; Lega et al. 2010). The 
circuit originates from the hippocampus and subiculum, projects via the fornix to the 
mammillary body, then via the mammilothalamic tract to the anterior nucleus of the 
thalamus (ANT) (Figure 2). The ANT projects to the cingulate gyrus, then to the 
parahippocampal gyrus, followed by the entorhinal cortex, which finally projects via the 
perforant pathway back to the hippocampus (Papez 1937; Oikawa et al. 2001). 
Supporting the notion that neural networks provide multiple points for potential 
therapeutic interactions, lesions and high-frequency electrical stimulation at several 
locations along this pathway – including the hippocampus, mammillary bodies, 
subiculum and ANT – have demonstrated effective modulation of seizure propagation 
(Velasco et al. 2000; Duprez et al. 2005; Van Rijckevorsel et al. 2005; Fisher et al. 2010; 




Figure 2: Neural Circuits and Anatomical Targets for Stimulation 
Several major neural circuits have been identified and targeted for neuromodulation of epileptic 
seizures, including the Circuit of Papez (red), the Cerebello-cortico circuit (green), and the basal 
ganglia (yellow). GPe = external globus pallidus; GPi = internal globus pallidus; SC = superior 
colliculus; SNr = substantia nigra pars reticulata. 
 
Cortico-thalamo-cortical excitatory loops appear to be involved in absence 
epilepsy (Lüttjohann and van Luijtelaar 2012) and motor cortex seizures (Detre et al. 
1996). In a non-human primate model of chronic focal motor seizures, thalamotomy 
restricted to the anterior part of the ventro-postero-lateral nucleus was able to produce 
long-lasting benefit and in most cases led to nearly complete seizure suppression 
(Mondragon and Lamarche 1990). Thalamic relays are also thought to mediate the 
benefits from lesions and electrical stimulation of the cerebellum for epilepsy, but this 
circuit and its influence is less clearly defined (Gale 1992; Fountas et al. 2010; Haneef et 
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al. 2013). More precise work identifying and manipulating neural signaling within the 
thalamocortical network is currently being performed (Paz et al. 2013). 
These networks, in conjunction with lesional studies and investigations in animal 
models, have implicated several potential neuromodulatory targets for the treatment of 
epileptic seizures. To achieve the greatest therapeutic effects and identify the optimum 
targets and parameters for deep brain stimulation, however, requires a greater 
understanding of the mechanisms underlying the effects of electrical stimulation. 
 
2.1.3 Mechanism: Neuromodulation via Electrical Stimulation 
The stimulation parameters utilized in clinical trials have remained largely empirical in 
nature – oftentimes unchanged from the arbitrary patterns that were initially explored for 
each particular anatomical target (Table 1). Only recently have more complex deep brain 
stimulation parameters begun to be entertained in experiments with human patients 
(Brocker et al. 2013). A more reasoned approach would be to understand the underlying 
mechanisms guiding the effects of electrical stimulation on the nervous system, and to 
implement the most efficacious parameters in clinical trials and practice.  
Despite the extensive use of DBS in neuromodulation, its mechanism of action 
remains poorly understood. The initial observation that high-frequency (>50 Hz) 
stimulation mimicked the effects of ablative procedures (Benabid et al. 2002) suggested 
that DBS was inhibitory in nature (Boon et al. 2009), inducing a reversible, functional 




Table 1: Published reports of deep brain stimulation for epilepsy 














(Most 10Hz, 10V; 
1-min epochs alternating 
hemispheres) 
11-38 mo 4 of 15 SF at ≥ 
30 mo (2 CPSz, 
1 GTC, 1 myo) 
6 of 15 improved 
(2CPSz, 2 GTC, 
2 myo) 
5 of 15 no 
change 









5 Variable 10Hz, 10-14V; 
8 min ON R/OFF L, 8 min 
ON L/OFF R 
24-29 mo 0 of 5 SF 
0 of 5 improved 
3 cerebrospinal fluid 
(CSF) leaks 
1 increased CSF 
pressure 






6 Variable 10Hz, 2-4V;  
8 min ON R/OFF L, 8 min 
ON L/OFF R 
7-20 mo 0 of 6 SF 
2 of 6 improved 
1 infection resulting in 
explantation 








12 Variable 10Hz, 5-7 mA; 
1 min ON R/OFF L, 1 min 
ON L/OFF R 
6 mo 0 of 11 SF 
0 of 11 improved 
6 patients more than 
one operation 
2 post-op wound 
infections, 1 resulting 
in explantation 
4 reoperations 
1 lead repositioning 












4 min ON B/l, 4 min OFF 
B/l 
24 mo 3 mo: mean 
seizure reduction 
33% 
6 mo: mean 
seizure reduction 
41% 
3 reoperations for 
migration 
1 wound infection 
resulting in removal 
1 ataxia and dysmetria 











16 TLE 130 Hz, 0.2-0.4mA, PW 
450μs 
2 weeks 7 of 10 SF after 
6 d 












4 MTLE 190Hz, 1.8-4.5V, PW 90µs 6 mo 0 of 4 SF 








9 MTLE 130Hz, 0.3mA, PW 450µs 
1 min ON B/l, 4 min OFF 
B/l 
18 mo 4 of 9 SF 
5 of 9 improved 
3 skin erosion and local 







12 TLE 130Hz, 2-3V, PW 450µs 15-52 mo 1 patient exited 
trial before 
stimulation 
1 of 11 SF 
9 of 11 improved 
(6 of 11 > 50%) 










2 MTLE 185Hz, “subthreshold”, PW 
90µs 
9 mo 0 of 2 SF 
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Study Target Design N Seizure type Stimulation parameters Followup Results Adverse Events 
 
Boëx et al. 
2011; 
Bondallaz 





130Hz, 0.5-2V, PW 450µs 10-74 mo 2 of 8 SF 





1 electrode fracture 







12 TLE (6 HS) 130Hz 1V peak-to-peak, 


















et al. 2002 
STN Open-
label 
5 Variable 130Hz, 0.8-5.2V, PW 90µs 30 mo 0 of 5 SF 






et al. 2006 
STN Open-
label 
2 CPSz 185Hz, <3.5V, PW 90µs 27 mo 2 of 2 improved 
(33-50%) 
1 repeated surgery 







5 Myoclonic 130 Hz, 3.0V, PW 90µs 12-42 mo 1 of 5 SF 







2 Variable 130Hz, 2-3V, PW 60µs 12-48 mo 1 of 2 improved 
(65%) 
1 patient demonstrated 
mild balance 
impairment, dysarthria, 
severe aboulia, apathy, 
and mood changes 
under chronic 
stimulation 




Study Target Design N Seizure type Stimulation 
parameters 





li et al. 
1997; 
Chkhenke




57 Variable Variable Variable Unclear N/A 









18 Variable 60Hz, 0.5-0.6mA 
1 min ON R/OFF L, 4 
min OFF B/l, 1 min ON 
L/OFF R, 4 min OFF 
18 mo Lennox-Gastaut: 2 
of 13 SF, 8 of 13 
improved (50-80%) 
Partial seizures: 2 of 
5 improved (>80%) 
2 patients explanted due 







6 Variable 65Hz, 0.5-10V, PW 
90µs 
1 min ON, 4 min OFF x 
2 hr/day 
9 mo 30% mean seizure 
reduction 
With stim 24 hr/day, 
3 of 6 improved 
(>50%) 
1 connection repair 
1 minor hemorrhage 
with no symptoms or 
complications 
Andrade 
et al. 2006 
CMT Open-
label 
2 Variable 100-185Hz, 1-10V, PW 
90-120µs, 














(6 PGE, 5 
FLE) 
130Hz, < 5V, PW 90µs 6-72 mo PGE: 5 of 6 
improved (>50%) 
FLE: 1 of 5 
improved (>50%) 
1 infection resulting in 
explantation 
1 transient agraphia 
  
Table 4: continued 
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Study Target Design N Seizure type Stimulation 
parameters 




et al. 2006 
ANT Single 
blind 
6 Variable 100-185Hz, 1-10V, PW 
90-120µs 
50-70 mo Difficult to 
interpret; 6 of 6 
improved (>50%) 
by implantation; no 
further improvement 
with stim 
1 skin erosion requiring 
wound revision 
1 lethargy with 
continuous stimulation 
Kerrigan 
et al. 2004 
ANT Open-
label 
5 Variable 100Hz, 1-10V, PW 90-
330µs 
6-36 mo Difficult to 
interpret; non-
significant 
improvement in 4 of 
5 
1 reimplantation for 
incorrect positioning 




4 Variable 90-110Hz, 4-5V, PW 
60-90µs 
33-48 mo 4 of 4 improved (37-
75%) 












4 Variable 145Hz, 4.1V, PW 90µs,  
1 min ON b/l, 5 min 
OFF b/l 












Partial-onset 145Hz, 5V, PW 90µs 4 mo 
(blinded) 
13 -37 mo 
(open) 
4 mo: Median 
seizure reduction 




13 mo: 2 of 110 SF; 
43% with >50% 
response 
25 mo: 6 of 81 SF; 
54% with >50% 
response 
808 reported in 109 
participants, 55 in 40 
categorized as serious, 





during blinded phase 
13.0% memory 
impairment during 
blinded phase  
Table 5: continued 
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12.7% implant site 
infection 
10.9% implant site pain 





5 status epilepticus 
 
SANTE = Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy; HC = hippocampus; STN = subthalamic nucleus; CMT = 
centromedian nucleus of the thalamus; ANT = anterior nucleus of the thalamus; CPSz = complex partial seizure; GTC = generalized tonic-
clonic seizure; TLE = temporal lobe epilepsy; MTLE = mesial temporal lobe epilepsy; HS = hippocampal sclerosis; FLE = frontal lobe 
epilepsy; R = right; L = left; PW = pulse width; b/l = bilateral; SF = seizure-free; myo = myoclonic; PGE = primary generalized epilepsy; 
CSF = cerebrospinal fluid; N/A = not available 
*Follow-up in months unless otherwise specified 
 





neural circuits has been recognized as complex and multifaceted. Stimulation amplitude, 
frequency and pulse-width play a major role in determining the effects of stimulation, and 
manipulating other parameters such as waveform and polarity can have significant effects 
as well (Rolston et al. 2011; Bari et al. 2013).  
Early work by Ranck (Ranck 1975) indicated that electrical fields have 
differential effects on different neuronal structures. Activation thresholds were lowest in 
myelinated axons, increasing in unmyelinated axons, dendrites, and cell bodies, 
respectively. Further work by Histed and colleagues, utilizing low-current 250 Hz 
electrical microstimulation with concurrent 2-photon calcium imaging to identify the 
location of electrically-activated neurons (Histed et al. 2009), has supported these 
hypotheses.  
Using multi-compartment cable models of neurons coupled to a finite element 
model of extracellular electric fields, McIntyre et al. (McIntyre et al. 2004) suggest that 
the majority of cells within ~2 mm of the electrode will generate efferent (axonal) output 
at the stimulus frequency, whereas those stimulated at sub-threshold levels will be 
suppressed (McIntyre et al. 2004). Electrical stimulation may consequently be 
“hijacking” the neural circuit (Cheney et al. 2012) – blocking the extant neural activity 
and replacing the efferent output with its own. Our own work demonstrates ‘entrainment’ 
of downstream (both orthodromic and antidromic) neuronal firing by deep brain 
stimulation in a Parkinson’s patient (R. Gross, K. Mewes, M. DeLong, unpublished data). 
The consequences of this new efferent output on downstream circuits will depend on 
their neural connections.  
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Other mechanisms may be important as well, including neurochemical 
mechanisms, gene, and protein expression. The anticonvulsant effects of low frequency 
stimulation have been correlated with changes in adenosine receptor expression 
(Jahanshahi et al. 2009), and vagal nerve stimulation has been associated with alterations 
in a variety of neurotransmitters and hormones in cerebrospinal fluid (Hammond et al. 
1992). Furthermore, the progressive improvement in outcome associated with electrical 
stimulation for movement disorders (Krack et al. 2002) and epilepsy (see below) (Fisher 
et al. 2010; Morrell 2011), suggest that synaptic, neurochemical, and/or expression 
changes are occurring in response to electrical stimulation of the pathologic neural 
network.   
 
2.2. TARGETS FOR ELECTRICAL STIMULATION IN EPILEPSY 
The history of electrical stimulation for epilepsy has been one of extreme heterogeneity 
(Table 1), with a great variety of anatomical targets, stimulation parameters, and outcome 
measures being evaluated. These have primarily been investigated in small case series, 
and the varying nature of these studies has often made synthesizing conclusions – 
particularly statistical conclusions – quite difficult. To this end, we attempt here to 
highlight and summarize the results of these investigations – where possible using the 
original authors own phrasing with regards to outcome – categorized by anatomical 
target. In general, the results are described in terms of complete freedom from seizures 
(seizure-free), a clinically significant reduction in seizure frequency (reduction, response, 
improvement), or no response (unresponsive, no benefit).     




The earliest subcortical target of stimulation for epilepsy was the cerebellum, which was 
found as early as the 1950s to modify or halt seizures in animal models of both cortically-
induced (Moruzzi 1950; Cooke and Snider 1955) and hippocampal (Iwata and Snider 
1959) seizures. The mechanism of action was originally thought to be thalamic inhibition 
via stimulation-induced Purkinje cell output, but this remains somewhat unclear (Fountas 
et al. 2010). In the 1970s, Cooper and colleagues were the first to report human cerebellar 
stimulation for epilepsy. A heterogeneous patient population underwent subdural 
stimulation of the superior surface of the cerebellar cortex via an inductively-driven 
system using variable stimulation parameters (Cooper et al. 1973). Of 15 patients, 10 
showed significant seizure improvement for up to three years (Cooper Is 1976). However, 
when Van Buren et al. used a similar technique to perform a double-blind crossover study 
of 5 patients with intractable epilepsy, no significant differences in seizure frequency 
were detected (Van Buren et al. 1978). Contemporary results were also published by 
Levy and Auchterlonie, showing a modest response rate of 33% (2 of 6 patients) (Levy 
and Auchterlonie 1979). Following these results, Wright et al (Wright et al. 1984) 
published a prospective, double-blind, crossover study of 12 patients with stable, long-
term epilepsy (10 to 32 years) using bilateral 8-contact electrodes inserted over the 
superior cerebellar surface via occipital burr holes. Patients received 2 months of 
continuous 5-7 mA 10 Hz stimulation of alternating polarity that alternated hemispheres 
every other minute (some patient parameters were uniquely adjusted based on their 
individual responses), 2 months of self-controlled stimulation, and 2 months of no 
stimulation. There was no observed decrease in the frequency of seizures in the 11 
patients available for follow-up. There was a 25% rate of lead migration, a 16.6% rate of 
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wound infection, and an 8.3% rate of mechanical failure. Interestingly, although there 
was no objective effect on either seizures or neuropsychological testing, a majority of 
patients reported that stimulation was beneficial (Wright et al. 1984). 
The failure of these two trials, despite the previous apparent clinical successes, led 
to the cerebellum falling out of favor as a target for epilepsy until revisited by Velasco et 
al. in 2005 (Velasco et al. 2005). In this double-blind crossover study of 5 patients with 
medically intractable epilepsy, subjects were implanted bilaterally with 4-contact 
electrodes on the superomedial surface of the cerebellum. Stimulation parameters were 
adjusted to deliver a charge density of 2.0 µC/cm
2
/phase, with a fixed pulse width of 0.45 
ms and current amplitude of 3.8 mA. Stimulation frequency was set at 10 Hz, akin to that 
explored by Cooper et al. (Cooper Is 1976; Van Buren et al. 1978; Wright et al. 1984). At 
the end of the three-month blinded evaluation, seizure frequency had decreased by 33% 
in the group receiving stimulation vs. no reduction in the unstimulated group. At the end 
of the six-month unblinded stimulation period, the mean seizure reduction rate was 41% 
(range, 14-75%). Statistical analysis demonstrated a significant reduction in tonic-clonic 
seizures (p < 0.001) and tonic seizures (p < 0.05). As with previous trials, there was a 
high incidence of lead migration (60%). 
The small sample sizes, conflicting results and high complication rate of 
cerebellar stimulation (Van Buren et al. 1978; Wright et al. 1984; Velasco et al. 2005) 
make its role in the treatment of epilepsy unclear without further investigation. A pooled 
analysis of prior small series has recently been published by Krauss and Koubeissi 
(Krauss and Koubeissi 2007), demonstrating a seizure freedom rate of 27% (31 of 115 
patients) and at minimum a reduction of seizures in 76% (87 of 115 patients) in the prior, 
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heterogeneous case series. More rigorously controlled studies across 17 patients found 
none seizure free, and 5 of 17 with reduced seizures. A detailed review on the subject has 
also recently been published (Fountas et al. 2010). 
 
2.2.2 Hippocampal formation 
Mesial temporal lobe epilepsy (MTLE) is the most common form of medically refractory 
epilepsy and enjoys a high rate of seizure freedom following amygdalohippocampal 
resection (Wiebe et al. 2001; Kwan et al. 2011; Engel et al. 2012; Engel 2013). However, 
hippocampal resection or ablation may be contraindicated in cases of dominant-onset 
MTLE with preserved verbal memory, cases with bilateral mesial temporal onsets, or 
recurrent MTLE contralateral to a prior resection. Thus, the ability to prevent or abort 
seizures arising from the mesial temporal structures without resection or ablation — 
potentially preserving interictal function — would represent a major advance in the 
surgical treatment of epilepsy. 
The hippocampus is an appealing target for neuromodulation. Although larger 
than most other DBS targets, and therefore potentially more prone to targeting error and 
variability, the hippocampus is often stereotactically accessed with recording electrodes 
and consequently is a relatively familiar target for epilepsy surgeons. Several studies of 
hippocampal slices and rodent models provided preclinical support for hippocampal DBS 
(Lian et al. 2003; Ellis and Stevens 2008; Boon et al. 2009; Zhong et al. 2012). The first 
systematic human studies of hippocampal stimulation came from the Mexico City group 
of Velasco et al., initially in a pilot study of stimulation prior to temporal lobectomy in 10 
patients (Velasco et al. 2000). More recently, the same group reported 18-month follow-
up of 9 patients with MTLE, 4 with classic radiological signs of hippocampal sclerosis 
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(HS) and 5 with normal MRIs, who experienced 15-70 seizures per month (average of 28 
seizures) (Velasco et al. 2007). All patients initially underwent invasive monitoring with 
bilateral 8-contact hippocampal depth electrodes in preparation for 
amygdalohippocampectomy, but did not undergo resection due to bilateral independent 
onsets (4 patients) or onsets on the dominant side associated with preserved verbal 
memory (3 patients). One patient with right-sided onset did not undergo resection due to 
occasional left-sided epileptiform discharges and another because of bilateral MRI 
evidence for hippocampal sclerosis. After the completion of the diagnostic phase, the 
depth electrodes were removed and quadripolar DBS leads (1.5 mm contacts, 0.5 mm 
spacing) were placed within the long axis of the hippocampus, targeted so that at least 2 
contacts were within the identified area (or bilateral areas) of maximal seizure onset. As 
per their diagnostic findings, 4 patients were implanted bilaterally, 3 unilaterally on the 
left and 2 unilaterally on the right. Bipolar stimulation within the seizure focus (usually 
the pes hippocampus or amygdala-pes junction) was performed with 1-minute trains of 
square wave pulses at 130 Hz, 450 µs duration, and 300 µA amplitude, followed by 4-
minute stimulation-free intervals (alternating side-to-side in bilateral cases). Five patients 
were randomized to an initial one-month, double-blinded period without stimulation in 
order to investigate possible implantation effects. 
Of the 9 patients, 4 (44%) were seizure-free at 18-month followup. Interestingly, 
these 4 were all in the MRI-normal group, and all showed early and dramatic responses 
within the first 2 months of stimulation. The fifth patient with a normal MRI also had an 
immediate, sharp decrease in seizure frequency and, although not seizure-free, continued 
with only brief, occasional complex partial seizures throughout the study. In contrast, the 
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4 patients with evidence of hippocampal sclerosis on MRI showed more delayed and 
partial responses to stimulation, with seizure reduction becoming statistically significant 
by 8 months and leveling off (with between 50 and 70% reduction) by 10 months. 
Seizure freedom and levels of seizure reduction were maintained through 18 months of 
follow-up in all patients.  
Important features of the Mexico City series include the use of eight-contact 
diagnostic depth electrodes followed, in a separate procedure, by DBS placement targeted 
to the ictal onset zone, which in one case resulted in more posterior DBS placement than 
would have occurred with standardized placement in the pes hippocampus. As the 
authors state, a substantial minority (20% in some studies (King et al. 1997)) of MTLE 
patients demonstrate onset in the posterior hippocampus, and standardized anterior 
placement of quadripolar electrodes might leave these patients’ ictal onset zone outside 
the area of stimulation. Second, the stimulation paradigm used a constant-current design, 
which may be more physiologically appropriate in compensating for changes in electrode 
and/or tissue impedance. Third, in contrast to the study of Boon et al. (Boon et al. 2007) 
discussed below, better responses were seen in MRI-normal patients than in those with 
MRI evidence for hippocampal sclerosis. The authors suggest the decreased cell counts 
and, presumably, lesser network connectivity of a sclerotic hippocampus as an 
explanation for the delayed effectiveness in these patients. The authors also considered 
the possibility that tissue impedances may be substantially different in sclerotic vs. 
normal tissue, but felt this was unlikely, since stimulation artifacts were seen on scalp 
electrodes at similar threshold voltages in all patients. Finally, a few pieces of evidence 
support a true effect of stimulation in this trial. The 5 patients who experienced one 
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double-blind month absent stimulation onset did not show a change in seizure frequency 
compared to baseline during the first postoperative month, whereas the 4 patients who 
underwent stimulation during that month showed immediate decreases in seizure 
frequency. In addition, three patients in whom stimulation was later interrupted (one from 
battery depletion, two from skin erosion and device removal) showed a partial return to 
baseline seizure frequency. 
The Belgian group of Boon et al. published their experience with acute and long-
term hippocampal DBS in patients with refractory TLE (Boon et al. 2007). In twelve 
patients, two quadripolar DBS electrodes were implanted bilaterally through parieto-
occipital burr holes, with one electrode terminating in the amygdala and one terminating 
in the anterior hippocampus. During the same surgery, recording grid and/or strip 
electrodes were implanted and monitoring was performed to ascertain seizure onset 
zone(s). One patient with unilateral mesial temporal onsets exited the trial in favor of 
resective surgery prior to the stimulation phase. Of the patients that went on to 
stimulation, 10 had unilateral and 1 had bilateral onsets. All eight contacts across the 
amygdala and hippocampal quadripolar electrodes on the side of onset were used for 
stimulation in each unilateral patient; the bilateral patient was stimulated through the 
bilateral hippocampal electrodes only. Bipolar stimulation was delivered through two 
pairs of contacts on each electrode, with mean output voltage of 2.3V (range 2-3V), 
frequency of 130 Hz (1 patient at 200Hz), and pulse width of 450µs. Initial acute 
stimulation was performed using a temporary external pulse generator, followed by long-
term stimulation with an implanted pulse generator if >50% reduction of interictal spike 
frequency was achieved with temporary stimulation, which occurred in 10 of 11 patients.  
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Outcome was assessed by comparing each patient’s mean monthly seizure frequency 
during the last six months of follow-up (mean total follow-up 33 months; range 15-52 
months) to the pre-intervention baseline. One patient (10%) became seizure free, one had 
>90% seizure frequency reduction, 5 had seizure reduction >50%, 2 had 30-49% seizure 
reduction, and one had <30% reduction. Long-term follow-up of the same group plus one 
additional patient was recently reported, with stimulation adjustments including 
implementation of bilateral stimulation in 6 patients with <90% response to unilateral 
stimulation (Vonck et al. 2013). Going from unilateral to bilateral stimulation improved 3 
of 5 patients, with one becoming seizure-free, despite onset regions being unilateral. The 
previous one patient who was seizure-free continued as such, despite stimulation being 
discontinued at battery end-of-life, and one other patient became seizure-free when 
stimulation was stopped. Thus, while a total of 6 (55%) patients achieved >90% seizure 
reduction, the overall 27% rate of seizure freedom (3 of 11) in this long-term follow-up 
group must be cautiously interpreted. In contrast to the results of Velasco et al. (Velasco 
et al. 2007), discussed previously, 2 of 3 patients in this study with hippocampal sclerosis 
became seizure-free (vs. 1 of 11 without), although one of them was the patient that 
became seizure-free when stimulation was turned off, and the other maintained seizure 
freedom despite stimulation discontinuation. 
The low rate of seizure freedom in this study may have been attributable in part to 
the proportion of patients (50%) with regional onset in the temporal lobe, rather than a 
well-defined mesial temporal onset. Another issue may be that stimulation was delivered 
to only a small region of the hippocampus: the electrodes spanned at most 21 mm (10.5 
mm x 2 electrodes) and since the anterior one was in the amygdala, the posterior 
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electrode did not extend much beyond the hippocampal head. Moreover, bipolar 
stimulation only delivers cathodic pulses to one of the pair due to the Lilly pulse 
waveform (charge-balanced biphasic pulses designed to prevent charge deposition and 
resultant tissue damage (Hauptmann et al. 2009)). It would be interesting to know the 
effects of using all 8 contacts as cathodes with the case as the anode (“monopolar” 
stimulation), to affect a larger volume of hippocampal tissue. 
Two small series of hippocampal stimulation have been reported by the 
University of Western Ontario group (Tellez-Zenteno et al. 2006; Boëx et al. 2011). In 
the first, 4 patients with left mesial temporal seizure onset who were unable to undergo 
resection (1 due to prior right temporal resection, 3 due to failed intracarotid amobarbital 
testing) underwent placement of unilateral quadripolar electrodes (3 mm contacts, 6 mm 
spacing; total span 30 mm) with the first contact in the pes hippocampus and three 
contacts in the hippocampal body. All four had imaging evidence of hippocampal 
sclerosis (2 left, 2 bilateral, including the patient with prior right-sided resection). 
Monopolar stimulation using all four contacts (190 Hz, pulse wide 90µs, voltage adjusted 
below the patients’ conscious thresholds, ranging from 1.8 to 4.5V) was delivered in a 
double-blinded, randomized, crossover design for 6 months (3 consecutive 2-month 
periods randomized to ON-OFF vs. OFF-ON). Median seizure frequency reduction 
between the 3 ON months and 3 OFF months was 15%, although results did not reach 
statistical significance. No patient was rendered seizure-free, and results were somewhat 
variable among the 4 patients. This investigation went so far as to explore multiple 
neuropsychological measures, which importantly did not show any difference between 
the stimulation-on and stimulation-off states. In their second series, the same group 
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reported their results in 2 patients with independent, bilateral mesial temporal seizure 
onset, 1 of whom had a normal MRI and 1 of whom had bilateral MRI evidence for 
hippocampal sclerosis. Electrode placement and stimulation parameters were similar 
(with the only difference being stimulation at 185Hz instead of 190Hz). The 2 patients 
were randomized to undergo 3 months ON and 3 months OFF (in this series, as 3-month 
blocks) in random order, with a 3-month washout period. Results with bilateral 
stimulation were slightly more robust than in the earlier, unilateral series, with a mean 
seizure frequency reduction of 33% in ON periods compared to OFF. Again, no patient 
was rendered seizure-free. One patient showed declines in verbal and visuospatial 
learning scores during stimulation. Of note, the volume of tissue modulated in these 6 
patients is likely larger than in the Belgian group, since electrodes spanning 3 cm of 
hippocampal length were used in a “monopolar” configuration.  
More recently, the Swiss group of Boëx et al. (Boëx et al. 2011) presented a series 
of 8 TLE patients (2 with hippocampal sclerosis, 6 non-lesional) who were unable to 
undergo amygdalohippocampectomy due to bilateral onset (5 patients) or onset ipsilateral 
to preserved verbal memory (3 patients). All patients received unilateral DBS placement 
on the side of more frequent seizure onset as determined noninvasively (3 patients) or 
with intracranial recording (5 patients). A single DBS lead was placed along the long axis 
of the hippocampus at its junction with the parahippocampal gyrus, with the anterior-
most contact at the amygdalo-hippocampal junction. The first 5 patients received 
quadripolar electrodes (3mm contacts with 6mm spacing; total length 30mm) and the last 
3 received octrodes (3mm contacts with 1.5mm spacing; total length 34.5mm). 
Stimulation was tested in both monopolar configuration, with 4 contacts as the cathode 
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(130Hz, pulse width 450µs, 1-2V), and in bipolar configuration (130Hz, pulse width 
450µs, 0.5-1.5V), using the two contacts with the highest frequency of interictal 
discharges as cathode and anode.  
Of the 8 patients reported, 2 (25%) became seizure-free (one without stimulation, 
as with Vonck et al. (Vonck et al. 2013), discussed above). Four patients, including the 2 
with HS, had 50-90% reduction in seizure frequency, and 2 patients did not show 
statistically significant seizure reduction. In the 2 patients with presumed hippocampal 
sclerosis, monopolar stimulation appeared to be more effective than bipolar, but there did 
not appear to be significant differences between monopolar and bipolar stimulation in 
non-lesional patients. Interestingly, a subsequent re-analysis of this cohort (Bondallaz et 
al. 2013) demonstrated that all 6 patients with >50% seizure frequency reduction had 
active contacts located within 3 mm of the subiculum, whereas the 2 non-responders had 
electrodes more than 3 mm from the subiculum. Proximity to the presumed seizure onset 
zone, in contrast, was not associated with outcome, with responders’ and non-responders’ 
active contacts located 11 ± 4.3 mm (mean ± SD) and 9.1 ± 2.3 mm from the ictal onset 
zone, respectively. 
Although this study demonstrated significant overall seizure reduction, several 
inconsistencies make it difficult to interpret. First, the lack of intracranial evaluation in 3 
of 8 patients introduces some degree of diagnostic uncertainty, although 2 of these 3 had 
MRI evidence for hippocampal sclerosis concordant with the side of seizure onset and 
would have thus proceeded directly to resection were it not for the results of their 
intracarotid amobarbital testing. Second, the use of two different types of DBS leads and 
multiple stimulation parameters introduces additional variables; however, this may more 
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accurately reflect real practice, which will likely require patient-by-patient stimulation 
adjustments. Third, by the authors’ own admission, the use of unilateral stimulation even 
in cases with documented bilateral seizure onset may have limited the effectiveness of 
DBS therapy in comparison to the series of Velasco et al. (Velasco et al. 2007) Fourth, 
stimulation voltages were generally low in comparison to other studies, with maximum 
amplitude of 2V, potentially limiting the volume of tissue stimulated. Finally, the use of 
battery depletion as a method of “OFF” testing raises an additional degree of 
heterogeneity, since the exact timing of “OFF” periods may not be precisely known and 
will not be consistent, and since variable degrees of neuromodulation may have occurred 
prior to battery depletion in individual patients.  
This group recently published a comparison of biphasic and pseudomonophasic 
stimulation using hippocampal depth electrodes in 12 patients undergoing intracranial 
monitoring (Tyrand et al. 2012). Stimulation (1V peak-to-peak, 130 Hz, pulse width 210 
and 450 µs) via perpendicular depth electrodes (and, in 3 cases, also via longitudinal 
DBS leads prior to internalization) was performed in 4-hour epochs during an acute 
hospital stay. The effect on the interictal epileptiform discharge rate (IEDR) was 
measured using an automated detection algorithm. In patients with MRI evidence for 
hippocampal sclerosis, there was a reduction in IEDR of 51.8% +/- 10.3 (mean +/- SD) 
using biphasic stimulation, but no significant reduction using pseudomonophasic 
stimulation. In non-lesional patients, neither waveform produced a decrease in IEDR. 
Thus waveform characteristics, which may select differently-oriented fibers for activation 
by more heavily weighting cathodic or anodic pulses at each electrode, may play a role 
along with other DBS parameters in determining the effectiveness of stimulation. 
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Cukiert et al. (Cukiert et al. 2011) recently reported suppression of interictal 
spiking with intraoperative test stimulation (130 Hz, 300μs, 4V) in 4 of 6 patients 
undergoing bilateral hippocampal DBS placement, but associated clinical outcomes have 
not yet been reported for this cohort. 
The above open label studies laid the groundwork for two clinical trials to further 
evaluate the effectiveness of hippocampal stimulation in epilepsy therapy: the Controlled 
Randomized Stimulation Versus Resection (CoRaStiR) trial, based in Belgium and 
Germany (NCT00431457) (University Hospital and Medtronic), and the Medical vs. 
Electrical Therapy for Temporal Lobe Epilepsy (METTLE) study, based at the University 
of Calgary (NCT00717431) (Calgary et al.), the latter of which has been terminated due 
to insufficient enrollment. The CoRaStiR trial will randomize patients with TLE into 
three arms: immediate amygdalohippocampectomy, immediate hippocampal stimulation, 
and implantation of hippocampal electrodes with delayed initiation of stimulation by 6 
months. Treatment will be unblinded and results compared at 12 months post-surgery 
using measures of seizure frequency, neuropsychological outcome, mood and quality of 
life. Also at this period, patients undergoing neurostimulation will have the option to 
either continue neurostimulation or undergo resective surgery. 
Despite promising small series and open label data, the value of hippocampal 
DBS remains difficult to assess in the absence of larger, prospective data sets. The 
procedure appears to be safe and does not appear to carry significant neuropsychological 
risks (Velasco et al. 2007; McLachlan et al. 2010; Miatton et al. 2011). However, as 
seizure freedom rates have been low in open label trials thus far performed, the prospect 
for hippocampal DBS achieving a high rate of seizure freedom in blinded controlled trials 
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is similarly low. This is substantiated by the randomized, double-blind, sham-stimulation 
controlled trial of responsive neurostimulation (RNS
®
; Neuropace, Mountainview, CA), 
in which 50% of the 191 patients with medically refractory seizures had mesial temporal 
onsets and were implanted with 4-contact leads in the amygdala/hippocampus (Morrell 
2011). Overall, 7.1% of patients were seizure-free over the last 3 months of follow-up 
available (≥ 1 year). In the long-term continuation trial, combining all implanted RNS 
patients (feasibility plus pivotal trials), this number increased to 13% (31/247); 20.3% 
had at least one seizure-free period of 6+ months during the trial, albeit not necessarily at 
last follow-up (Bergey et al., submitted). It should be noted that in this combined group, 
only 43.4% had seizures arising solely from the mesial temporal lobe. While detailed 
outcome analysis of the mesial temporal patients was not provided in either report of this 
trial, seizure localization to the mesial temporal lobe (vs. other locations) was not a 
significant factor in determining the treatment response, suggesting that there was not a 
high rate of seizure freedom in MTLE patients in this trial (see Morrell et al., in this 
issue). Thus, neurocognitive factors notwithstanding, it is likely that hippocampal DBS 
will emerge as a tool to reduce the frequency of – but not eliminate – seizures in patients 
who are not candidates for surgical resection or ablation, which remains the gold standard 
for achieving seizure freedom in MTLE. 
 
2.2.3 Subthalamic Nucleus/Substantia Nigra 
Control of limbic seizures in rats by bilateral pharmacological inhibition of the substantia 
nigra (SNr) was first demonstrated in the early 1980s (Iadarola and Gale 1982; Garant 
and Gale 1983; Vercueil et al. 1998). Although the mechanisms of such control in animal 
models is unclear (Vercueil et al. 1998; Dinner et al. 2002; Gross 2008; Zhang et al. 
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2008), it has been suggested that the release of nigral inhibition of a dorsal midbrain (i.e. 
superior colliculus) anticonvulsant zone is involved (Loddenkemper et al. 2001) (Figure 
2). Thus far, rather than directly modulating SNr with DBS, animal studies have 
attempted to achieve SNr inhibition via modulation of the subthalamic nucleus (STN) 
(Vercueil et al. 1998), with the idea that high-frequency stimulation of the STN would 
reduce excitatory input from the STN to SNr. Although STN DBS was found to be 
effective in rodent models of epilepsy, more recent evidence that high-frequency 
stimulation actually drives STN activity rather than inhibits it, in addition to supportive 
neurotransmitter evidence (Zhang et al. 2008), suggests the possibility that inhibitory 
effects of STN stimulation on SNr were mediated indirectly via activation of GPe (Gross 
2008). Resulting elevated GABA levels in SNr from overdriving its GPe afferents would 
be predicted to dominate any increased glutamate release in SNr from STN driving, due 
to more proximal location of GABA vs. glutamate receptors on SNr cell bodies (Gross 
2008).  Additional mechanistic explanations for the use of STN DBS include antidromic 
neuromodulation of the motor cortex (Dinner et al. 2002; Gross 2008), or other frontal 
neocortex (Urrestarazu et al. 2009), from STN (Gradinaru et al. 2009). 
Several small case series of STN stimulation have been reported (Benabid et al. 
2002; Chabardès et al. 2002; Handforth et al. 2006; Lee et al. 2006; Vesper et al. 2007; 
Franzini et al. 2008; Capecci et al. 2012). In 2002, the Grenoble group reported 5 patients 
who underwent bilateral STN DBS (some with multiple leads) for inoperable seizures of 
various types (Benabid et al. 2002; Chabardès et al. 2002). Three patients (all with 
paracentral neocortical seizures) experienced 67-80% seizure reduction, while 2 patients 
(one with Dravet syndrome and one with fronto-insular seizures) did not show significant 
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improvement. In 2006, Handforth et al. (Handforth et al. 2006) reported two patients with 
refractory partial-onset seizures in whom bilateral STN stimulation (<3.5V, 90µs ,185 Hz 
pulses) was performed. The first, with partial complex seizures and bitemporal EEG 
onset, had a 50% reduction in seizure frequency. The second, with post-encephalitic 
hemiatrophy and left-sided seizure onset, experienced a 33% reduction in seizure 
frequency and a reduction in seizure severity, including arrest of generalized convulsions, 
fewer seizure-related injuries, and an improved quality of life. In 2007, Vesper et al. 
(Vesper et al. 2007) described a single patient with myoclonic epilepsy, who received 
monopolar stimulation (3.0V, 90µs, 130Hz) via two contacts spanning the inferior STN 
and SNr bilaterally. At 1-year follow-up, 50% reduction in the severity and frequency of 
myoclonic seizures was achieved, and the patient’s vagal nerve stimulator (VNS) was 
turned off without recurrence of generalized seizures, which previously had been 
controlled only with VNS. In 2012, Capecci et al. (Capecci et al. 2012) presented two 
cases of bilateral STN DBS after failed disconnective surgery. The first case, a patient 
with widespread cortical atrophy, multiple seizure types, and prior anterior callosotomy, 
demonstrated a 70% reduction of partial seizures and 85% reduction of secondarily 
generalized seizures at 1 year with STN stimulation (2.0V, 60µs, 130Hz; stimulator off at 
night). The second case, a patient with bilateral temporal and occipital cortical and white 
matter abnormalities, had previously undergone anterior commissurotomy. Continuous 
stimulation (3.0V, 130Hz, 60µs) was associated with a decrease in tonic-clonic seizures, 
but a sharp rise in absence seizure frequency, leading to discontinuation of stimulation. 
Following their successful 2007 case report (Vesper et al. 2007), Wille and 
Vesper (Wille et al. 2011) reported a series of five adults with progressive myoclonic 
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epilepsy who were implanted with STN DBS and followed in an unblinded fashion for 
12-42 months. All five experienced improvement, with reduction of myoclonic seizure 
frequency between 30 and 100% and accompanying improvement in quality of life. Of 
note, 4 patients were implanted with bilateral Vim thalamus leads in addition to STN, but 
no benefit was seen with Vim stimulation. 
Based on the above case series, STN DBS may be a palliative option, particularly 
in cases of myoclonic epilepsy. Unfortunately, with the termination of the Grenoble-
based STIMEP trial (NCT00228371) due to insufficient enrollment, no larger-scale or 
randomized trials of STN stimulation appear to be forthcoming. 
 
2.2.4 Caudate Nucleus 
With the rationale of modulating the cortico-striato-thalamic network and inducing 
cortical hyperpolarization, Chkhenkeli et al. (Sramka and Chkhenkeli 1990; Chkhenkeli 
and Chkhenkeli 1997; Chkhenkeli et al. 2004) tested DBS of the ventral caudate in a 
large number of patients undergoing stereo-electroencephalography for seizure disorders. 
Low-frequency (4-8Hz) stimulation decreased cortical and hippocampal interictal spiking 
and epileptiform activity in a subset of these patients, several dozen of whom 
subsequently underwent placement of internalized DBS systems. 12 of 21 patients 
undergoing chronic stimulation of the head of the caudate nucleus (HCN) after resection 
of the epileptic focus did not provide benefit received a Class IC (Engel et al. 1993) 
(seizure free) outcome, with the remaining nine achieving worthwhile improvement 
(class IIIA) (Chkhenkeli et al. 2004). Amongst unlesioned patients, 9 of 17 experienced a 
IC with chronic therapeutic HCN stimulation, with five experiencing worthwhile 
reduction and three no improvement. The authors speculated on a suppressive effect due 
44 
 
to inhibitory processes from head of the caudate nucleus activation, although they noted 
variability in the excitatory and inhibitory effects of stimulation. However, a 
heterogeneous patient population, varying targets and stimulation paradigms, 
uncontrolled observations, and insufficient follow-up render this large, single institution 
series difficult to interpret. 
 
2.2.5 Centromedian Nucleus of the Thalamus 
The centromedian nucleus of the thalamus (CMT) has widespread projections to the 
cortex and plays a central role in wakefulness and cortical excitability (Figure 2) (Al-
Otaibi et al. 2011). As these circuits seem to play a role in seizure generation and 
propagation (Mondragon and Lamarche 1990; Detre et al. 1996; Miller 1996; Lüttjohann 
and van Luijtelaar 2012), CMT has been explored as a potential target for DBS therapy. 
It is important to note, however, that CMT also has strong projections to the striatum, and 
some of its effects, at least in part, may be mediated via the cortico-striato-thalamic 
circuit (Smith et al. 2014).  
Velasco et al. reported their first five cases of CMT DBS in 1987 (Velasco et al. 
1987), and larger series in 2000 (Velasco et al. 2000) and 2006 (Velasco et al. 2006), 
using an alternating left-right stimulation paradigm (60Hz, 500-600µA, 1 minute on/4 
minutes off, 24 hours/day). Seizure frequency was measured during a one-month baseline 
period and monthly for 18 months postoperatively during open label stimulation. Of the 
18 patients reported, the most clearly positive results were seen in the 13 patients with 
Lennox-Gastaut syndrome, 2 of whom became seizure-free, 8 demonstrating 50-80% 
seizure reduction, and 3 having no response to therapy. Consistent with other 
observations of progressively decreasing seizure frequency during DBS (Fisher et al. 
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2010), VNS and RNS (Morrell 2011), seizure frequency decreased immediately after 
implantation and continued to decline thereafter, reaching its minimum after 6 months of 
stimulation. Double-blinded 3-month periods of stimulation cessation (between 6 and 12 
months after surgery) did not show a return to baseline frequency, whereas open label 
interruption of stimulation and explantation in two patients with skin erosion and battery 
depletion after 20 and 39 months on-stimulation, respectively, was associated with 
increases in seizure frequency to reach or surpass the baseline period. These results a 
residual antiepileptic effect, possibly due to neural plasticity, however patient bias cannot 
be excluded. In contrast to the patients with generalized tonic-clonic seizures and 
consistent with previous results (Velasco et al. 1993; Velasco et al. 1993), 5 patients with 
partial epilepsy syndromes fared less well, with only 2 of 5 achieving >80% seizure 
reduction.  
Fisher et al. attempted to subject CMT DBS to objective evaluation using a 
randomized, double-blind, sham-stimulation controlled design. Six patients were enrolled 
in a cross-over design with 3-month blinded periods; 3-month washout periods were 
interposed between stimulation periods (Fisher et al. 1992). Although there was a 30% 
decrease in seizures during stimulation, as compared to an 8% decrease during sham 
periods, the results were not statistically significant. Several critical factors mitigate 
interpretation of these findings to support ineffectiveness of CMT DBS. First, the 
amplitude for active stimulation was set at 50% of the sensory threshold in order to 
maintain effective blinding. Although details of the actual stimulation amplitude (range 
0.5 – 10 V) were not provided, it was likely somewhat below that used in the Mexico 
City studies where amplitudes 90% of sensory threshold were used. Thresholds were 
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allowed to increase to this level during the open label extension in the Fisher et al. study; 
3 of 6 patients experienced a >50% reduction of generalized tonic-clonic seizures during 
this phase (Fisher et al. 1992). Moreover, since sensory threshold arises from current 
spread to the ventrobasal sensory nucleus, it is subject to proximity of the electrode to 
that structure; low thresholds would lead to correspondingly low stimulation dosages 
with respect to CMT and would undermine effectiveness. Second, the small number of 
patients studied place findings at risk of being non-representative (this is true of both 
studies). Third, the controlled study design may well have affected outcomes. On one 
hand, the presence of a sham-stimulation period may have limited biasing ‘placebo’ 
responses (actually contributed to by both subject and experimenter bias), making the 
Fisher study more accurate by controlling Type 1 error. Conversely, one patient who was 
initially randomized to active stimulation had a marked reduction in seizures and refused 
to undergo sham stimulation, eliminating one of the responders from the data analysis. In 
the latter context, the controlled study design may have introduced Type 2 error. This 
early controlled trial of DBS was - if nothing else - highly illustrative that even the ability 
to perform sham (or “placebo”) stimulation does not render DBS trials free of 
methodological challenges. A cross-over design with a washout period is 
methodologically rigorous, but is still fraught with difficulties and assumptions, and has 
rarely been used since publication of this trial.  
Additional studies of CMT DBS have been reported. Andrade et al. (Andrade et 
al. 2006) reported 2 patients in an uncontrolled design, one of whom had >50% seizure 
reduction. Most recently, Valentín et al. (Valentín et al. 2013) reported 11 patients (5 
with frontal lobe epilepsy, 6 with primary generalized epilepsy) treated with CMT DBS 
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at two centers in London and Madrid. After bilateral implantation, patients underwent 
single-blinded treatment with 3 months of sham stimulation followed by 3 months of 
therapeutic stimulation (up to 5 V at 130 Hz with a pulse width of 90 µs), followed by 6 
months of open label therapeutic stimulation. Open label stimulation was maintained 
after 12 months for patients in whom stimulation was thought to be effective. Two 
patients with generalized epilepsy became seizure-free immediately after implantation, 
one of whom was maintained off stimulation throughout 50 months of follow-up, and 
another was seizure free for 12 months, followed by recurrence of seizures that was 
eliminated with 60 Hz stimulation. All six patients with generalized epilepsy had >50% 
seizure reduction during the blinded phase, and five of six maintained >50% seizure 
reduction during the long-term extension phase. The five frontal lobe epilepsy patients 
did not fare as well, with only one patient with >50% improvement in seizure frequency 
during the blinded phase. During the open label long-term extension, the frontal lobe 
patients had a heterogeneous response, with three demonstrating 50-90% reductions in 
seizure frequency and two showing no clear signs of improvement.  
Taken together, these data suggest that CMT DBS may be effective for a subset of 
patients with generalized epilepsy, namely those with Lennox-Gastaut syndrome or with 
predominance of tonic-clonic or other generalized seizures. CMT DBS appears to show 
strong implantation and carry-over neuromodulatory effects even without active 
stimulation. 
 
2.2.6 Anterior Nucleus of the Thalamus 
The anterior nucleus of the thalamus (ANT) in fact consists of several distinct sub-nuclei, 
some of which have extensive frontal and temporal cortical projections, and others of 
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which are key stations in the limbic circuit of Papez (Papez 1937). Thus the ANT is an 
attractive target for both modulation of overall thalamocortical excitability as well as 
modulation of the limbic seizure network (Lega et al. 2010). Early lesion studies of the 
ANT in cats and non-human primates demonstrated effective reduction in seizure 
frequency and duration (Kusske et al. 1972), and human studies began as early as the 
1960’s (Mullan Ss 1967; Cooper et al. 1980). Several small open label studies throughout 
the 2000’s showed promising decreases in seizure frequency – between ~30-90% – with 
prominent implantation effects as well as carryover effects with 2-3 months of 
stimulation cessation (Hodaie et al. 2002; Kerrigan et al. 2004; Andrade et al. 2006; Lim 
et al. 2007; Osorio et al. 2007). 
The promising results of these initial open label studies were the foundation for 
the Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy trial (SANTE, 
NCT00101933, Medtronic, Minneapolis, MN), a multicenter, randomized, double-blind 
trial of bilateral stimulation of ANT for localization-related epilepsy (Fisher et al. 2010). 
Participants (N=110) with medically-refractory partial seizures – including secondarily 
generalized seizures – were implanted with bilateral ANT DBS leads and randomized at 
one month post-surgery to receive either 3 months of stimulation at 5V (90µs pulse 
duration, 145Hz frequency, 1 minute on alternating with 5 minutes off) or 3 months of 
sham stimulation. Following the 3-month double-blind period, all patients received open 
label stimulation for 9 months, with two interspersed office visits at which stimulation 
parameters could be adjusted in a limited fashion. Following the first year, AEDs and 
stimulation parameters could be freely adjusted. Of the 110 implanted patients, 108 
patients completed the blinded evaluation period, 105 patients were evaluated at the one-
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year outcome point and 102 evaluated at 2 years. Two of the implanted patients were 
excluded from the analysis due to explant of an infected device, one of whom was 
explanted prior to randomization, and one of whom was randomized to sham-stimulation 
and – importantly – had only 66 of the pre-specified 70 days of required post-
randomization seizure diaries prior to explanation. 
 
 
Figure 3: Median percentage change in seizure frequency from baseline during the SANTE 
and RNS® Trials. 
In both trials, stimulation was begun one month after implantation (vertical dashed line). (left) 
Despite an appreciable reduction in seizure frequency with implantation, Control patients (red, 
dashed line) in the SANTE trial did not improve in seizure reduction during the blinded phase of 
the trial (gray). This is in contrast to Stimulated patients (green, solid line), who underwent a 
median 40.4% reduction in seizure frequency in the final blinded month, as compared to a 14.5% 
reduction in controls. (right) Stimulated patients in the RNS® trial demonstrated an appreciable 
reduction in seizure frequency with implantation as well. Stimulation was optimized for a month 
before the blinded evaluation phase (gray). During this phase, Stimulated patients underwent a 
mean 37.9% reduction in seizure frequency, as opposed to a 17.3% reduction in Controls 
(p=0.012). [Adapted from (Fisher et al. 2010) and (Morrell 2011)] 
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There were some important statistical issues that warrant discussion. First, as in 
previous studies, an appreciable implantation effect was noted (although placebo and/or 
regression to the mean effects could also have been factors): one month following 
implantation and prior to initiation of the treatment phase patients assigned to both the 
stimulation and sham-stimulation groups experienced a median 21-22% seizure 
reduction. As shown in Figure 3, the two groups began to separate beginning with the 
first month after active- or sham-stimulation and continuing to the end of the blinded 
period. However, only in the 3
rd
 (and final) month of blinded stimulation was there an 
unequivocal statistical difference in seizure frequency between the two groups (Figure 3, 
median 40.4% reduction in seizures in active stimulation as compared to 14.5% reduction 
with sham-stimulation, p=0.0017), evidently due to continued reduction in the active 
group and regression towards baseline in the sham group. This finding was in the group 
of 108 randomized patients who had at least 70 diary days, as pre-specified in the 
statistical analysis plan. This was not, however, the actual pre-specified primary outcome 
measure, which was a generalized estimating equation (GEE) model encompassing the 
entire 3 month blinded evaluation period. The GEE is a useful tool in evaluating 
biological count data that has a very high variance, as in seizure counts. However, the 
GEE could not generate a result for this group of 108 patients, due to a treatment-by-visit 
(i.e. months follow-up) interaction, resulting from the lack of a significant difference 
between the groups prior to the 3
rd
 month of treatment. This presented a critical challenge 
in determining whether the study was a success. 
To address this issue, two post-hoc analyses were additionally performed. First, 
one patient in the stimulated group was statistically determined to be an “outlier”: when 
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first activated at the protocol-determined 5 V this patient had 210 brief partial seizures 
during the one-minute on-stimulation phases over 3 days. Although the stimulator was 
inactivated (and later restored at 4 V with good clinical effect), these seizures 
disproportionately decreased the difference between the active and sham-stimulation 
groups. However, when this outlier was excluded from the analysis, the difference 
between the groups was increased during the first month but was still not statistically 
significant until the 3
rd
 month (P=0.0023), and the GEE model still indicated a treatment-
by-visit effect and again failed to generate a result. The second post-hoc analysis 
excluded the outlier subject, but additionally included the patient in the sham-stimulation 
group who had only had 66 of the 70 required days of seizure diaries prior to 
explantation, in an ‘intent-to-treat’ analysis. With this group of 108 patients, the 
treatment-by-visit interaction was no longer in the GEE model, and a statistically 
significant treatment effect became evident over the entire blinded evaluation phase 
(P=0.039).  
This use of a post-hoc analysis has raised a good degree of debate as to whether 
this was a successful trial. The primary outcome measure, rather than generating a 
negative result, simply could not generate a result owing to the time course over which 
the treatment and placebo groups diverged. In the absence of a result from the pre-
specified primary outcome measure, should we discard the important post-hoc secondary 
outcome measure (statistically significant group difference at 3 months) and the non-pre-
specified intent-to-treat GEE result? Although “post-hoc,” does this truly increase the 
chance that this finding (P=0.039) represents a Type I error? Or is it more likely that 
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adopting the stance that the primary outcome measure was not met and the trial was a 
failure represents a Type II error?  
Arguably more relevant than this unresolvable question is the implication that the 
results are not sufficiently robust to support the usefulness of this treatment. Since there 
clearly was a statistically significant difference between the groups in the 3
rd
 month of 
treatment but not the first two, it was not the robustness per se that impaired the GEE 
analysis, but rather the progressive improvement in the treated group and decline of effect 
in the non-stimulated group. In fact, seizure frequency continued to decline during the 
open label stimulation phase: median seizure frequency decreased by 41% at one year, 
56% at 2 years (Fisher et al. 2010), and 69% at 5 years (N=74), whereas and the 50% 
responder rate increased from 43% at one year to 54% at 2 years (Fisher et al. 2010) and 
68% at 5 years (N=59) (Salanova et al., in preparation). Nevertheless, seizure freedom 
was relatively low, with 16% becoming seizure-free for at least 6 months during the first 
5 years of the trial. Six subjects (5.5%) were seizure free for over two continuous years 
and 11 (10%) were seizure free over the last 6 months at the 5 year follow-up. 
Complaints of memory impairment occurred in 27% of subjects over the course of 
the trial (Salanova et al., in preparation). Impairment, which could be confirmed in 50% 
of the cases, was never serious and occurred in the context of baseline memory 
impairment in 50%. Conversely, overall group statistics did not show decline in memory 
measures, but did show improvement in various measures including attention, executive 
function, and mood. 
The complicated statistical issues discussed above may have obfuscated the 
analysis of the clinical significance of the trial by the U.S. FDA advisory panel. Although 
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the panel ultimately recommended approval by a 7:5 margin, pre-market approval was 
not granted and the status of ANT DBS remains in limbo in the United States. 
Nevertheless, approval was granted by the regulatory agencies in Canada, Europe, 
Australia and elsewhere. In the wake of the recent approval of the RNS therapy on 
improbably similar data (Figure 3), it may be worthwhile for the FDA to revisit its 
decision with respect to ANT DBS. 
 
2.3. FUTURE DIRECTIONS 
Despite these significant clinical successes, DBS therapy for epilepsy remains in its 
infancy. Our limited understanding of the mechanisms of DBS action (McIntyre et al. 
2006; Butson et al. 2007; Maks et al. 2009), the epileptogenic networks themselves, and 
their interaction, as well as the nonselective effects of DBS on heterogeneous populations 
of neurons, combine to make this promising therapy still relatively unrefined and 
dependent on careful empiric progress.  
Further incremental advances may be gained through technological innovations, 
such as constant-current and novel devices that may enable more predictable and directed 
stimulation volumes and better avoidance of stimulation side effects (Chaturvedi et al. 
2012; Okun et al. 2012; Gross and McDougal 2013). Additional benefits in device 
longevity, and perhaps effectiveness and tolerability, may be gained through the use of 
closed-loop (feedback-controlled) neurostimulation devices and alternative stimulation 
parameters. One form of closed-loop therapy is the Responsive Neurostimulation System 
(RNS
®
) (Morrell 2011), which activates electrical stimulation of the previously defined 
seizure onset zone upon detection of electrophysiological signature of a seizure. Presently 
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applied directly to the epileptic focus or foci, similar technology could conceivably be 
applied to modulatory nodes, such as ANT, in response to seizure detection.  
An alternate approach, however, is to characterize states that are associated with 
seizures and mitigate those states with, amongst other approaches, DBS. For example, 
theta band activity within the septo-hippocampal circuit has been associated with 
decreased seizures (Colom 2006; Colom et al. 2006), and continuous multimicroelectrode 
electrical stimulation using theta frequencies in a rat model of temporal lobe epilepsy 
decreases seizures (Desai, S. A., Gross, R.E. et al., in preparation). Conceivably, the 
RNS
®
 system could be adapted to accomplish this. Alternatively, using a novel 
bidirectional stimulation and recording pulse generator unit approved for research in 
human subjects (Activa PC+S
®
, Medtronic, Minneapolis, MN), a closed loop state 
control algorithm was recently tested in a large animal (sheep) model (Stypulkowski et al. 
2011). One DBS electrode was implanted in the ANT and a second one in the 
hippocampus. Spectral power was examined in the latter, which was decreased by 
stimulation in ANT (Stypulkowski et al. 2013). The sensitivity for evoking seizure 
activity by stimulation in the hippocampus was decreased in the low power state 
associated with ANT stimulation as well. Moreover, the power could be continuously 
kept low in the hippocampus by a closed-loop algorithm that titrated ANT stimulation to 
hippocampal power, thereby keeping the hippocampus in the less sensitive state for 
seizure evocation. This paradigm may easily be tested in animal models of epilepsy, or 
indeed in human subjects with epilepsy, as the safety of both ANT and hippocampal 
electrode implantation has been thoroughly established. A similar approach is under 
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study and found to be promising in a non-human primate model of seizures (S. 
Chabardes, personal communication).    
The success to date in ANT DBS for refractory epilepsy likely results in part from 
the stereotyped pathways for seizure propagation through the ANT in MTLE (60% of 
patients in the SANTÉ trial had onsets in the temporal lobe (Fisher et al. 2010)) and 
perhaps forms of frontal lobe epilepsy that may share those pathways. Many foci outside 
the mesial temporal lobe likely have different propagation networks; in vivo studies of 
epileptogenic networks may therefore allow more rational and patient-specific (Butson et 
al. 2007) targeting for DBS placement in this heterogeneous and more difficult to treat 
group of patients. Thus, a true leap forward in neuromodulation therapy will require both 
a more detailed understanding of epileptogenic networks and the ability to selectively 
modulate different cell populations within those networks.  
Optogenetics, a novel molecular technology utilizing cell-type specific expression 
of light-sensitive ion channels, is not only capable of millisecond-level precision control, 
but can also selectively activate and inhibit particular genetically defined subpopulations 
of neurons within a larger circuit (Yizhar et al. 2011). Activated by particular 
wavelengths of light, these channels selectively conduct cations or anions across the cell 
membrane, producing defined depolarization or hyperpolarization in the expressing cells.  
The resulting technique combines the specificity of pharmacologic therapies with the 
temporal control of electrical stimulation. Several early studies of optogenetics in vitro 
and in animal models of epilepsy have shown promising results. The earliest application 
of optogenetics to epilepsy was by Tønneson et al. (Tønnesen et al. 2009), who 
demonstrated that halorhodopsin – an inhibitory chloride pump – was capable of 
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suppressing epileptiform activity in hippocampal organotypic slice cultures. More 
recently, three groups have demonstrated that inhibition of particular targets can interrupt 
seizures in vivo in rat models of epilepsy. Paz et al. (Paz et al. 2012) took advantage of 
the thalamocortical circuit, inhibiting hyperexcitable thalamocortical neurons in response 
to epileptic activity in the cortex, arresting the seizure. Wykes et al. (Wykes et al. 2012), 
on the other hand, targeted the seizure foci directly, again successfully inhibiting 
seizures. Similarly, Krook-Magnuson et al. (Krook-Magnuson et al. 2013) used a closed-
loop approach to directly target the subpopulations of the hippocampus to detect and 
arrest spontaneous temporal lobe seizures. These early results suggest that optogenetics 
could play a greater role in future therapeutics. However, there are a number of 
challenges that currently limit its implementation, such as issues with gene therapy 
(Henderson et al. 2009), miniaturization of light sources, and channel and light 
distribution in primate brains. While not insurmountable, these limitations necessitate 
greater research – particularly with non-human primates, which will better reflect the 
limitations on human optogenetic therapies. 
 
2.4. CONCLUDING REMARKS 
The use of electrical stimulation for epilepsy has been explored for a half-century, and 
only recently have two therapies successfully obtained regulatory approval for more 
widespread use in patients: ANT DBS outside of the U.S. (but not within) and RNS 
within the U.S. (but not outside). Given the complementarity of these two approaches, it 
would be ideal if all patients in all geographical locations had access to either. For 
patients with identified foci within functional regions, RNS may be preferable, but is not 
indicated for multiple (> 2) foci, whereas ANT DBS may be effective in the latter. This 
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is, however, conjecture, and will remain so for a long period to come. Most proximately, 
we hope that ANT DBS attains approval in the U.S., either on the basis of a more rational 
evaluation of the results of the controlled multicenter trial, or as a result of a new trial 
(which we do not anticipate). While ANT DBS has been approved in Europe and 
elsewhere, post-approval surveillance data will not likely contribute to U.S. approval, 
since it is open label and uncontrolled. RNS, on the other hand, is approved only in the 
U.S. and has not been studied in Europe. The regulatory hurdles for CE Mark approval 
require safety but not effectiveness data, so it is anticipated that the pathway forward will 
be less burdensome for RNS approval outside the U.S. Finally, prospects for targets other 
than the cortex (RNS) and ANT (DBS) are dim, given the difficulty with ANT approval 
to date and the limited pilot data for alternative targets. CMT DBS would hold the most 
promise as an adjunct in the treatment of generalized epilepsy, in particular Lennox-
Gaustaut Syndrome. Generalized epilepsy remains amongst the most challenging of 
epileptic syndromes, for which neither RNS nor ANT DBS are likely to be effective, and 







REAL-TIME IN VIVO OPTOGENETIC 
NEUROMODULATION AND MULTIELECTRODE 





Optogenetic channels have greatly expanded neuroscience’s experimental capabilities, 
enabling precise genetic targeting and manipulation of neuron subpopulations in awake 
and behaving animals. However, many barriers to entry remain for this technology – 
including low-cost and effective hardware for combined optical stimulation and 
electrophysiologic recording. To address this, we adapted the open-source NeuroRighter 
multichannel electrophysiology platform for use in awake and behaving rodents in both 
open and closed-loop stimulation experiments. Here, we present these cost-effective 
adaptations, including commercially available LED light sources; custom-made optical 
ferrules; 3-D printed ferrule hardware and software to calibrate and standardize output 
intensity; and modifications to commercially available electrode arrays enabling 
stimulation proximally and distally to the recording target. We then demonstrate the 
capabilities and versatility of these adaptations in several open and closed-loop 
experiments, as well as demonstrate spectrographic methods of analyzing the results, as 
well as discuss artifacts of stimulation. 
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 Optogenetic techniques provide powerful tools for precise manipulation of 
complex nervous system circuitry. Selective excitation and inhibition with light of a 
genetically-targeted neuron population – without directly perturbing the neighboring 
untargeted cells – has provided the means to elegantly explore a number of important 
neuroscience questions (Aravanis et al. 2007; Carter et al. 2009; Gradinaru et al. 2009; 
Kravitz et al. 2010; Yizhar et al. 2011; Packer et al. 2012; Wykes et al. 2012; Paz et al. 
2013). When combined with electrophysiological recording techniques, optogenetic 
control can provide unprecedented insight into neural connectivity and function (Bell et 
al. 2013), as well as suggest potential therapeutic strategies (Gradinaru et al. 2009; Paz et 
al. 2012; Wykes et al. 2012; Krook-Magnuson et al. 2013).  
Optogenetics combines a number of techniques in molecular biology, 
electrophysiology, optics, and neuroscience, the mastery of which can prove a barrier to 
easy adoption. Significant efforts have been made to expand the toolbox of optogenetic 
channels, constructs, and viral techniques (Chow et al. 2010; Gunaydin et al. 2010; 
Diester et al. 2011), as well as to develop complex custom-designed optoelectric neural 
interfaces (Fan et al. 2013; Voigts et al. 2013). However, commercial electrophysiology 
hardware and software has lagged behind these developments, and often fails to 
incorporate support for complex stimuli, real-time multielectrode closed-loop control 
(Newman et al. 2013), and customized experimental configurations in awake and 
behaving animals. In addition, the cost of these systems is often prohibitive, particularly 
for investigators looking to initiate a new line of research with limited funding. There is 
consequently a need for a customizable, adaptive, and low-cost optoelectrophysiology 




Figure 4: NeuroRighter software and hardware for calibration, optical stimulation, and 
recording. 
NeuroRighter’s main application window enables real-time isolation of single units (A) and local 
field potentials (B) from multielectrode arrays. A number of settings and customizations are 
available, and have been described in detail elsewhere (Rolston et al. 2009; Rolston et al. 2009; 
Newman et al. 2013). Note that, in the example view in (B), optical stimulation of the medial 
septum began half-way through the recording, generating readily visible evoked potentials.(C) A 
comparison between the intensity generated by 473 nm Blue DPSS Laser (Shanghai Dream 
Laser) output (red) and 465 nm Blue LED (Plexon, Inc.) output (black). 100 samples of power 
output were measured at each input step using our calibration setup, and the mean (dot) and 
standard deviation (error bars) plotted. Note the high variance associated with the laser output as 
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compared to the LED (present for the LED but smaller than the data point marker) despite the 
similar inputs, and the non-linear nature of the laser output. This variation is an inherent property 
of the laser. The maximum intensity output generated by the LED was 80 mW/mm
2
, and for the 
laser was 30 mW/mm
2
. (D) Plexon LED Driver, 465 nm Blue LED module, and 200µm 0.67NA 
armored patch fiber cable. (E) Custom-made optical ferrules utilizing 200 µm diameter 0.37NA 
fiber optic. (F) Thorlabs PM100USB Power and Intensity Meter (top), with accompanying 
S120C Intensity Meter and 3D-printed Intensity Chamber. Custom-designed ferrules (E) plug 
into the chamber (F, bottom right) which overlays the S120C detector (F, bottom left). (G) Our 
Labview-based program for Automated Ferrule Intensity Calibration. Light wavelength, the range 
of voltages over which to calibrate, and the number of samples taken at each point can be 
customized with this graphical user interface to generate output vs. input plots (C). (H) A 3D-
printed implantation post has multiple modules to enable ferrule implantation alone (H, bottom 
right) or coupled to an array (H, top right, J). (I) TDT 16-channel MEA, which was implanted 
in the dorsal hippocampus. (J) A H-style NeuroNexus 16 channel shank array was manually 
coupled to a calibrated ferrule (J, inset), enabling simultaneous stimulation and recording from 
the same target site. 
 
3.2. NEURORIGHTER PLATFORM 
We developed our optoelectrophysiology platform based on the existing hardware 
and software for electrical stimulation and electrophysiology system, NeuroRighter. 
NeuroRighter is a low-cost open-source electrophysiology system written in C-Sharp  
and intended for open and closed-loop neural interfacing in vivo and in vitro (Rolston et 
al. 2009; Rolston et al. 2009; Rolston et al. 2010). The software, compatible with 32- and 
64-bit Windows operating systems (Microsoft Corp., Redmond, WA) is free and the 
source code is available on a publicly accessible repository
‡
. The hardware is also open-
source, utilizing printed circuit boards (PCBs) and commercially-available components, 
National Instruments (NI; National Instruments Corp, Austin, TX, USA) data acquisition 
hardware (NI PCI-6259, PCIe-6259, PCIe-6353, and PCIe-6363) and driven with NI’s 
hardware control library, DAQmx. The design, construction, and performance of this 







electrophysiology platform – which meets or exceeds the performance of many 
commercial alternatives – is well documented (Rolston et al. 2009; Newman et al. 2013). 
Recently, the NeuroRighter platform has been enhanced for improved usage with 
closed-loop multichannel interfacing experiments for electrical stimulation (Newman et 
al. 2013), as well as in vitro optogenetic stimulation (Newman et. al, under review). 
NeuroRighter is capable of recording single-unit (Figure 4A) and local field potential 
(Figure 4B) activity from multielectrode extracellular arrays, as well as delivering 
complex and customizable patterns of electrical stimulation through analog and digital 
outputs (Rolston et al. 2009; Rolston et al. 2010; Newman et al. 2013). NeuroRighter is 
consequently well-positioned to incorporate customized optogenetic hardware and 
provide a low-cost solution to the problems facing optoelectrophysiology. Here, we 
summarize the adaptations we have made to NeuroRighter to produce a system that 
enables real-time optogenetic neuromodulation and multielectrode electrophysiology in 
vivo in awake and behaving rodents using low-cost components. We describe two 
example experiments, one in which the site of optical stimulation is distant from the 
electrode recordings (medial septum and dorsal hippocampus, respectively), and the other 
in which optical stimulation and electrophysiologic recording is performed in the same 
location (dorsal hippocampus). In the former, we provide examples of the complex 
stimuli that can be performed with NeuroRighter, and present descriptive results. In the 






3.2.1.1 Design criteria 
We designed our optoelectrophysiology system to adapt the capabilities of NeuroRighter 
into the optogenetic purview in vivo. In so doing, we wished to maintain the standards 
established in its original design – that the system be 1) inexpensive, interfacing with 
commercially-available hardware as well as custom-designed solutions; 2) maintain the 
high spatial and temporal resolution required in electrophysiology; 3) function robustly in 
a number of different experimental environments; and 4) be open-source. 
 
3.2.1.2 Optical stimulation 
While many of the initial efforts with optogenetics relied on the use of lasers (Yizhar et 
al. 2011), high-intensity Light-Emitting Diodes (LEDs) have increasingly proven an 
attractive alternative, particularly for in vivo experiments. Lasers tend to be large and 
cumbersome, and many setups require careful collimation and alignment for proper 
function and maintenance of consistent output within and between experiments. These 
designs are sensitive to the slight perturbations generated from connections to awake and 
behaving animals. Commercially-available collimated LEDs, however, are compact, 
robust, and readily portable, making them easy to integrate into behavioral experiments. 
In addition, LEDs have a more precise input/output relationship than lasers. LED 
luminance output can be well approximated by a logarithmic or linear function with 
respect to input current. In contrast, similarly-priced DPSS lasers have a nonlinear 
sigmoidal relationship with input voltage (Figure 4C) (Cardin 2012). Furthermore, the 
light intensity generated by lasers can be unstable and demonstrate transient peaks and 
fluctuations (Cardin 2012). The output intensity of LEDs, in contrast, is much more 
stable and better approximates a square wave, with much less variation over time. Indeed, 
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we have determined that the variability in 465 nm Blue LED output intensity is less than 
that of a comparable-cost laser 475 nm DPSS Laser (Shanghai Dream Lasers, China; 
Figure 4C). While the standard deviation of the laser intensity output could be over 10% 
of the maximum output, the standard deviation of the LED intensity output was small 
enough to be obscured by the datapoint marker. It should be noted that the outputs of 
lasers and LEDs are influenced by temperature as well. Without proper heat dissipation, 
output efficiency will decrease and consistency will no longer be maintained (Newman 
2013). Controller properties also largely influence these input dynamics: more advanced 
and more expensive controllers can linearize outputs, in particular when coupled with 
optical feedback. Indeed, for experiments in which long-term stimulation may prevent 
heat dissipation, it is recommended that an optical feedback controller be used to 
maintain consistency in optical stimulation output. High-intensity LEDs thus enable 
precise experimental standardization and repeatability while also retaining the high-
intensity output and dynamic range that make lasers desirable for optogenetic 
experiments. Consequently, we designed our platform to make use of low-cost high 
intensity LEDs in optogenetic in vivo experiments in awake and behaving animals. 
 To this end, we made use of the Plexon PlexBright™ Optogenetic Stimulation 
System (Plexon Inc., Dallas, Texas; Figure 4D). Similar LEDs are available from other 
suppliers (Thorlabs, Newton, New Jersey). The PlexBright™ system consists of an LED 
Voltage to Current Controller, a 465nm Blue LED Module, and a patch fiber cable 
connected via FC/PC connection to the LED Module and protected by steel jacketing. 
The LED controller received input from one channel of the analog output from a National 
Instruments (NI) SCB-68 screw-terminal connector box. This output ranged from 0-5 V, 
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which was converted by the controller to 0-300 mA of current. This system was capable 
of driving 465 nm Blue LED light output at intensities of up to 80 mW/mm
2
 in custom-
made implantable optical ferrules (Figure 1C,E) – well within the acceptable window for 
non-damaging optical stimulation (Cardin et al. 2010). As each analog output of 
NeuroRighter can be accessed independently, four LEDs can be simultaneously 
controlled with NeuroRighter configuration on a single supported NI data acquisition 
card (NI PCI-6259, PCIe-6259, PCIe-6353, PCIe-6363 16-bit 1M sample/sec). The 
modular nature of the system enables the addition of additional NI data acquisition cards 
to increase the number of LED outputs, in addition to recording inputs. 
 Custom-made implantable optical ferrules (Figure 4E) were constructed from 1.25 
mm long 230 µm inner diameter ceramic stick ferrules (Precision Fiber Products, 
Milpitas, CA) in a fashion based on a previously-described design (Sparta et al. 2012). 
200 µm diameter 0.37 Numerical Aperture optical fiber (Thorlabs) was carefully stripped 
of its protective coating and cleaved. Heat-cure epoxy (Precision-Fiber Products) was 
mixed and applied to the concave end of the ferrule, through which the cleaved fiber 
segment was subsequently threaded. After wiping off the excess, a heat gun was applied 
to quickly cure the epoxy, and the ferrules were then allowed to finish curing overnight at 
room temperature. The ferrule connector was polished using a polishing disk and 
increasingly fine grades of polishing paper (Thorlabs), with frequent inspection to ensure 
transmission quality. Once polished, the free end of the fiber was scored and cleaved to 
10-12 mm in length. 
 Custom hardware and software was designed in order to standardize the variations 
in output intensity and calibrate each ferrule. An Intensity Calibration Device (ICD; 
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Figure 4F, bottom) was designed in Solidworks 2011, 3D-printed on an Objet Eden 250 
from FullCure 720 model resin, and painted black. A S121C Silicone Diode (Thorlabs) 
was placed within the central cavity of the ICD and connected to a PM100USB intensity 
meter (Figure 4F, top). Custom-written LabVIEW 2009 software (National Instruments, 
Austin, Texas; Figure 4G) steps the LED through user-defined output voltages and 
measures the power on the S121C Silicone Diode. LED output power passing through the 
ferrule is thus correlated to the analog input voltage signal to the LED controller. The 
program then calculated intensity from power based on the diameter of the fiber optic and 
linearly correlated to the voltage input. This standardized the output of each ferrule based 
on intensity rather than voltage input, enabling precise stimulation at accurate intensities 
across all experimental subjects. Custom-written Matlab scripts then converted standard 
output intensities to the appropriate signal voltages for each test subject. 
 Ferrules were attached to the patch fiber cable by means of 1.25 mm inner 
diameter Ceramic Split Sleeves (Precision Fiber Products). These were reinforced by 
threading them through trimmed heat shrink tubing (Digi-Key, Thief River Falls, MN), 
and subsequently heating them. These reinforced sleeves were superior to the bare split-
sleeves in resisting breakage due to vigorous movement of some subjects. This ceramic 
split sleeve was the most common breaking point in the connection, conveniently leaving 
the implanted ferrule and patch fiber cables intact.  
 
3.2.1.3 Electrode Arrays 
Two electrode array configurations were used in these experiments. For recording of the 
dorsal hippocampus while simultaneously stimulating the medial septum, 16-channel 
microwire multielectrode arrays (Tucker Davis Technologies (TDT), Alachua, FL., USA; 
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MEA) were constructed from sixteen 33 µm diameter tungsten electrodes with polyimide 
insulation (Figure 4I). The electrodes were arranged in two rows of eight electrodes with 
1 mm between rows and 175 µm of space between the electrodes within a row. Ground 
and reference wires were separated on the array and routed through two stainless steel 
wires, which were affixed to separate skull screws during the implantation surgery. The 
two rows were cut to different lengths, 4.0 mm and 3.0 mm, to target and record 
simultaneously from the hippocampal CA3 and CA1 regions, respectively, enabling 
multiunit and local field potential recording from the hippocampus distantly from the 
optical stimulation site in the medial septum. 
 NeuroNexus (Ann Arbor, Michigan, USA) 16-channel shank arrays were coupled 
with optical ferrules to record and stimulate simultaneously in the hippocampus. A 
single-shank H-style arrays was used, with 16 177 µm
2
 contacts spaced 100 µm apart 
along a 5 mm shaft. This length was sufficient to record simultaneously from the CA1 
and CA3 layers. The shaft was connected to an Omnetics connector via a 21 mm flexible 
cable. Ground and reference wires were again separated from the contact sites and routed 
through stainless steel wires. NeuroNexus “activated” the electrode contacts via iridium 
oxide - a process that reduced impedance and they suggested would reduce optical 
stimulation artifacts (personal communication). Both the NeuroNexus and TDT arrays 
made use of a magnet-based coupling technique to the 16-channel 100 gain tethered 
recording headstage (Triangle Biosystems, Durham, NC, USA) to reduce movement 
artifacts, a technique we have described previously (Rolston et al. 2009; Rolston et al. 
2010).  Once the magnet was attached with superglue, the array could be situated onto 
our custom-designed and 3D-printed implantation holder (Figure 4H, J). This enabled the 
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array shank and contacts to be positioned in parallel to the optical fiber, and cemented in 
place with quick-drying super glue. 
 The implantation device consists of a single post compatible with a Kopf 
Universal Holder (David Kopf Instruments, Tujunga, California, USA) with a single-
prong plug that enabled easy swapping and customization depending on the implant 
configuration (Figure 4H). This allowed us to use the device to implant an optical ferrule 
in isolation – as in the medial septum – or in conjunction with a NeuroNexus array 




2 month old adult male Sprague-Dawley rats (250-300g) were purchased from Charles 
River Laboratories (Wilmington, MA, USA). All animals were maintained within a 12/12 
light/dark cycle vivarium with unlimited access to food and water. This work was 
conducted in accordance with Emory University’s Institute for Animal Care and Use 
Committee. 
 Each subject underwent two surgical procedures. The first survival surgery 
introduced the optogenetic viral vector to the stimulation target – either the medial 
septum or the dorsal hippocampus. For medial septal stimulation, rats were anesthetized 
with 1.5-4% inhaled isoflurane, and a craniectomy was made 0.40 mm anterior and 2.00 
mm lateral to bregma on the right side of the skull. A pulled-glass pipette attached to a 
stereotactically mounted injector (Nanoject; Drummond Scientific Co., Broomall, PA, 
USA) was used to inject 1.8 µL of 10
12
 particles/mL AAV5-hSynapsin-hChR2(H134R)-
EYFP (UNC Vector Core Services, Chapel Hill, NC, USA). The injection was made at a 
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20° angle to the dorsal-ventral axis (0.40 mm anterior, 2.12 mm lateral at the 20° angle, 
5.80 mm ventral to pia along the rotated axis) in order to target the medial septum 
without damaging the medially-located central sinus. After 5 minutes of equilibration the 
injection was made over 7 minutes with the pipette remaining in place an additional 10 
minutes post-injection to prevent reflux. Once withdrawn, the scalp was stapled closed, 
ketofen was administered as an analgesic (3-5 mg/kg) to minimize pain, and the rats were 
quarantined for 72 hours before returning to normal housing. Hippocampal injections 
were similarly performed, but the craniectomy was made 3.30 mm posterior and 3.20 mm 
lateral over the right dorsal hippocampus. An injection of 1.8 µL of 10
12
 particles/mL 
AAV2-CaMKIIα-hChR2(H134R)-mCherry was made along the dorsal-ventral axis at 
3.10 mm depth to pia to target the hippocampal pyramidal neurons. Identical closure and 
quarantine procedures were performed.  
 The second survival surgery was performed two weeks later, which we have 
found to provide ample time for robust channel expression. For the medial septal 
stimulation experiments, a second craniectomy was made over the right dorsal 
hippocampus centered at 3.50 mm posterior and 2.80 mm lateral to bregma. The dura was 
incised with a sterile curved scalpel blade. The TDT array was positioned at a 50° angle 
to midline, with the posterior end swung laterally, to match the positioning of the 
hippocampal pyramidal cell layers (Rolston et al. 2010). The MEA was lowered while 
simultaneously recording single unit and local field potential (LFP) activity to attain the 
ideal positioning (Rolston et al. 2009). When the electrophysiologic recordings stabilized, 
the original injection craniectomy was reopened, and a calibrated optical fiber ferrule was 
implanted at a 20° angle to the dorsal-ventral axis (0.40 mm anterior, 2.12 mm lateral in 
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the rotated axis). Stimulation was performed as the ferrule was implanted, with the 
resulting recordings immediately analyzed spectrographically. Descent was halted when a 
strong stimulus-response signal was observed in the spectrogram, or when the optical 
ferrule reached a depth of 5.50 mm from pia along the rotated axis.  
For the hippocampal stimulation experiment, the previous craniectomy was 
reopened and expanded, and the combined optical fiber and NeuroNexus electrode array 
(Figure 4J) was inserted while similarly stimulating. Stimulation artifacts were noted in 
the upper cortical layers where there was no viral expression, and were recorded for later 
artifact analysis. A local field potential response was visible in the hippocampus in 
addition to the artifact and so the implantation was halted at 2.80 mm at the shank tip. In 
both experiments, once the electrodes and ferrules were in place, the craniectomy was 
sealed with dental acrylic (OrthoJet; Lang Dental; Wheeling IL), securing the 
array/electrode and ferrule in place. The rats were administered ketofen (3-5 mg/kg) to 
minimize pain and returned to normal housing to recover for 3-5 days. 
 
3.2.2.2 Optical stimulation and electrophysiologic recordings 
Using our adapted NeuroRighter system, electrophysiologic recordings were sampled at 
25 kHz with a 1-9,000 Hz bandwidth. LFPs were isolated online with a 1-500 Hz 1-pole 
Butterworth band-pass filter and downsampled to 2000 Hz. Action potentials were 
isolated both online (Newman et al. 2013) and offline, with the offline results presented 
here. Action potentials were detected offline using custom-written adaptations to the 
automated spike-sorting Wave_clus scripts (Quiroga et al. 2004). The raw data was band-
pass filtered offline from 500-5000 Hz. For the TDT electrodes, the median signal was 
removed across the CA3 and CA1 electrodes, respectively. For the NeuroNexus Array, 
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the median signal was removed across all electrodes. Positive and negative thresholds 
were applied at 5x the standard deviation of the signal, and the resulting waveforms were 
matched, sorted, and isolated using superparamagnetic clustering. Power spectra and 
spectrograms were computed using the Chronux suite of analysis tools and multitaper 
analysis (Bokil et al. 2010), with a moving window size of 4s stepping in 0.5s 
increments, T=1, W=4 and 3 tapers. Data were recorded intraoperatively and for up to 
four weeks postoperatively. 
 To stimulate awake and behaving animals, calibrated ferrules were connected via 
armored patch fiber cables (200 µm diameter, 0.67 NA, Plexon). Square-wave 
stimulation pulses varied between 10, 30, and 50 mW/mm
2
; 7, 11 (theta), 17, 23, 35 
(beta), and 42 (gamma) Hz; and 2, 5, and 10 ms pulse widths. NeuroRighter enables 
custom-designed stimulation times and amplitudes to be defined via Matlab script 
(Newman et al. 2013). We leveraged this customizability to develop several other 
stimulation patterns, including varying frequency, Poisson distributions, and continuous 
sinusoids, which are described in more detail as they are presented. In all cases, the 
experimental protocol consisted of repeated one minute recordings of 20 seconds of 
background, 20 seconds of stimulation with a particular pattern, and a subsequent 20 
seconds of additional background. Stimulation protocols were performed in random order 
and repeated numerous times over several recording sessions. This setup was able to 
stimulate and record LFP and single-unit responses from awake and behaving animals 





Histology was performed after experimentation to verify microelectrode recording 
locations and light-sensitive ion channel expression. Rats were deeply anesthetized with 
an overdose of Euthasol (5ml/kg, Virbac, Fort Worth, TX, U.S.A.) injected 
intraperitoneally. They were then transcardially perfused with 0.9% saline followed by 
4% paraformaldehyde in 0.1M phosphate buffer at pH 7.2. The heads, still containing the 
electrodes and ferrules, were then separated and post-fixed at 4°C overnight. The next 
day, the brains were dissected out, removed, and cryoprotected with 30% sucrose at 4°C. 
Frozen transverse (horizontal) sections were made of 50 µm thickness on a sliding 
microtome and collected in 0.1M PBS. Sections were mounted on glass slides and 
mounted with Vectashield mounting medium with DAPI (Burlingame, CA, U.S.A.) for 
visualization of nuclei. Sections were imaged in the NIS-Elements software (Nikon 
Instruments, Inc., Melville, NY, USA) using a Nikon DS-Fil color digital camera on a 
Nikon E400 microscope equipped with TRITC, FITC, and DAPI fluorescence cubes. 
 
3.3. RESULTS 
3.3.1 Histologic validation of channel expression and electrode placement 
Channelrhodopsin-2 expression in the medial septum (Figure 5A, green) and 
hippocampus (Figure 5B, red) was robust upon histologic evaluation. From the medial 
septum, axonal projections to the hippocampus (Figure 5A, C) were readily apparent, 
coinciding with the passage of the electrodes (Figure 5C, red and white arrows) and the 
hippocampal pyramidal cell layer (Figure 5, yellow arrow). The NeuroNexus array also 
passed alongside the expressing pyramidal cell layer of the hippocampus (Figure 5B). 
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Consequently, we would expect our recordings to appropriately reflect the influence of 




Figure 5: Robust expression of ChR2 on transverse section histology and verification of 
electrode placement.  
(A) AAV5-hSyn-ChR2-EYFP injection into the medial septum (MS) produced robust ChR2-
EYFP expression (green) in the MS. Axons from the MS could be tracked along the 
septohippocampal pathway (S-H) and into the hippocampus (H). Scale 1 mm. (B) Similarly, 
injection of AAV2-CaMKIIα-ChR2-mCherry into the dorsal hippocampus (red) selectively 
expressed in the pyramidal cell layer and their projecting axons/dendrites. The NeuroNexus array 
implantation site was localized alongside the expressing pyramidal cell layer by the damage it 
generated. Scale 0.5 mm (C) TDT arrays in the dorsal hippocampus were localized similarly by 
tracking their passage (white arrows) and endpoints (red arrows). Note the axons from the MS 
(green) expressing surrounding the pyramidal cell layer (yellow arrow) and the electrode array. 
Scale 200 mm.  
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3.3.2 Validation of hippocampal response to pulsatile stimulation patterns in the 
medial septum 
To validate the effectiveness of the platform, we first explored the LFP response in the 
dorsal hippocampus to square-wave pulsatile stimulation of the medial septum (Figure 6). 
At 50 mW/mm
2
, stimulation of the medial septum produced readily visible delayed 
pulsatile responses in the hippocampal LFP in both the CA1 and CA3 layers during the 
stimulation epoch (Figure 4B, Figure 6A). This delay is likely the result of synaptic 
conduction. These responses did not persist into the post-stimulation epoch, but instead 
were highly time-locked to the stimulus onset and offset. In order to examine the 
waveform of the LFP response, a peristimulus average was constructed by determining 
the mean LFP signal between 5 ms preceding and 40 ms following onset of each stimulus 
pulse. These were calculated across every stimulation parameter to produce the mean 
(solid line) and standard deviation (filled area) (Figure 6B). As expected, the stimulation 
parameter specifications had a large impact on response waveform amplitude, shape, and 
timing. Increasing the amplitude of the stimulus pulse tended to generate a more rapid 
time to peak response. Intriguingly, while increasing the pulse width at lower frequencies 
increased the amplitude of the response, at higher frequencies (23+ Hz) this was not the 
case. Indeed, the response to a 35 or 42 Hz, 10ms stimulus looked remarkably similar 
regardless of stimulation intensities, with the primary differences manifesting in phase. 
Biphasic responses were also noted at higher intensities, whereas unipolar depolarization 
was most common at 10 mW/mm
2
. 
To further characterize the hippocampal LFP response to pulsatile stimulation, we 
examined the spectral properties of the mean signal from six trials of 50 mW/mm
2
, 10ms 




Figure 6: Peristimulus average hippocampal LFP responses to medial septal stimulation 
reveal the influence of stimulation parameters on waveform shape.  
(A) Hippocampal LFP response to 50 mW/mm
2
, 7 Hz, 10ms square-wave optical stimulation of 
the medial septum (magenta bar). (B) Responses to stimuli at different frequency (rows), pulse 
width (columns), and intensities (blue, green, yellow, respectively). Lines indicate the mean 
response and the shaded areas indicate the standard deviation. Note the decrease in amplitude of 
the response waveform with increasing stimulation frequency, as well as the increasingly 
sinusoidal response at higher frequencies. The time-to-peak response was influenced not only by 
the stimulation intensity, but also by the pulse width. At 10 ms pulse widths at higher frequencies, 
a notable delay in the time-to-peak was observed that was not present at 2 ms pulse widths. Pulse 
widths at low frequencies also had an influence on response amplitude, with longer pulse widths 
associated with a larger amplitude response waveform.  
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multitaper spectrograms were generated using seven tapers (T=4 W=1) and a four second 
long moving window iterating at 0.5 second. This wide temporal window resulted in 
some temporal blurring of the stimulation onset and offset into the non-stimulation 
epochs, but allowed us to more precisely resolve the frequency domain. A clear increase 
in power in the spectrum corresponding to the stimulation frequency was apparent during 




Figure 7: Spectral and correlational response of the CA3 hippocampal LFP to medial septal 
pulse stimulation demonstrate time-locked and frequency specific responses.  
Stimulation at 50 mW/mm
2
, 10ms pulse width, and 7 Hz (A-C), 17 Hz (D-F), and 35 Hz (G-I) 
each produced unique and frequency-specific responses in the spectrum (A, D, G), spectrogram 
(B, E, H), and autocorrelation (C, F, I) of the LFP signal. The spectral analysis demonstrates a 
time-locked and frequency-specific response to stimulation onset. Blurred edges near stimulus 
onset and offset are a result of a wide (4s) moving window that better resolved the frequency-
specificity of the response. Note the presence of increased power at harmonics of the stimulation 
frequency; these are further analyzed in Figure 5. The autocorrelation demonstrates a highly 




(Figure 7A, D, G). A spectrogram of each case revealed the temporal precision of this 
response (Figure 7B, E, H), as well as some of the interactions with power at other 
frequencies. In all cases low-frequency (1-10Hz) power was reduced as compared to the 
pre- and post-stimulus epochs, presumably via stimulation-controlled hijacking of the 
LFP signal. Examining the mean autocorrelation lends further support to this idea: during 
stimulation in all cases, the signal became highly correlated at stimulation frequencies 
(Figure 7C, F, I). At higher frequencies the oscillatory nature of the LFP response 
dominated (Figure 6B), resulting in a highly correlated and almost sinusoidal signal that 
indicated the LFP rhythm was largely dominated and locked to the stimulus frequency 
and phase. 
Aside from increases in power at the stimulation frequency, there were 
concomitant increases of power at harmonics of that frequency. In the case of 7 Hz 
stimulation, power was also increased at 14 Hz, 21 Hz, and so forth (Figure 7A-B). We 
suspected that these were a result of the Fourier decomposition of the response 
waveform, and not evidence of other neurologic oscillatory responses, as neurologic 
oscillations are not typically so rigidly locked in frequency bandwidth. In order to 
distinguish the roles these harmonics play in the signal compared to the primary signal at 
the stimulation frequency, we systematically removed the harmonics from the LFP 
(rmlinesc.m, Chronux) (Bokil et al. 2010). The time-series signal is converted to 
frequency space, and then the spectrum is interpolated across at the defined frequencies, 
removing significant sine waves from continuously recorded data without altering phase 
properties as would happen with a notch filter. This has been used to remove the line 
noise resulting from nearby electronics and power sources (Viswanathan and Freeman 
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2007). As we progressively removed harmonics from the LFP response to 50 mW/mm
2
, 7 
Hz, 10ms stimulation, the peristimulus average became increasingly sinusoidal, centered 
on the stimulus frequency (Figure 8). The harmonics therefore play an integral role in 
generating the waveform of the LFP pulse response, particularly as the waveform 
deviates from the pure sinusoid of the stimulation frequency, but likely should not be 




Figure 8: Harmonic deconstruction demonstrates their participation in non-oscillatory 
dynamics of the hippocampal pulse response.  
The original LFP response to 50 mW/mm
2
, 7 Hz, 10 ms stimulation pulses demonstrates a 
stereotyped biphasic waveform, with several harmonics present in the spectrum during the 
stimulation epoch. Successively removing each of these harmonics (14, 21, 28, 35, and 42 Hz) 
results in alterations to the waveform shape – as demonstrated in the peristimulus average – that 







Figure 9: Hippocampal single unit firing rates increase in response to optical stimulation of 
the medial septum.  
Mean firing rates for two single units (A, C) identified from 50 mW/mm
2
, 23 Hz, 10 ms 
stimulation trials. Mean firing rate (B, D) tended to increase during the stimulation period. In the 




We next examined the hippocampal single-unit responses to medial septal 
optogenetic stimulation (Figure 9). NeuroRighter is capable of identifying and sorting 
units online (Newman et al. 2013). In a demonstration of its flexibility, however, we 
isolated units offline from 25kHz sampled data using Matlab scripts combining wavelet 
transformation and superparamagnetic clustering (wave_clus) (Quiroga et al. 2004). Two 
example units were analyzed for waveform (Figure 9A, C) and mean firing rate (Figure 
9B, D) properties before, during, and after a 50 mW/mm
2
, 23 Hz, 10ms stimulus train. In 
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both cases the mean firing rate increased during the stimulation epoch, as calculated 
across several trials. The firing rate returned to baseline for the first unit (Figure 9A-B), 
whereas the second unit maintained the new average firing rate during the post-stimulus 
epoch (Figure 9C-D). As these are only examples of the capabilities of NeuroRighter to 
explore single-unit activity, this study was not powered to statistically compare these 
results, but it was noted that several units demonstrated a trend towards increased firing 
rate during the stimulation epoch. 
 
3.3.3 Alternative, customizable stimulation patterns 
NeuroRighter is capable of generating complex and customizable stimulation patterns 
using scripted protocols (Newman et al. 2013). In order to demonstrate examples of this 
capability, we demonstrate how alternative optical stimulation patterns in the medial 
septum could alter hippocampal neural activity in our in vivo septohippocampal axis 
experiments. The results are presented from the combined analysis of several trials. 
 
3.3.3.1 5 Hz jitter 
In Figure 4 and 5, each stimulus pulse occurred at the same frequency during the 
stimulation epoch, producing a very frequency-specific increase in power in the 
hippocampal LFP. In the first experiment in alternative stimulation patterns, we 
introduced a jitter in the interpulse interval based on a random normal distribution of up 
to 5 Hz surrounding the arbitrarily-examined stimulus frequency of 23 Hz (Error! 
eference source not found.A). The resulting 50 mW/mm
2
, 10 ms pulsed stimulus 
produced similar depolarization/hyperpolarization responses to that of the fixed-
frequency pulsed stimulation, as seen in the peristimulus averages generated (Error! 
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eference source not found.B), but notable differences were observed spectrographically 
(Error! Reference source not found.C). First, a broader response was  
 
 
Figure 10: Hippocampal LFP response to alternative, customizable optical stimulation 
patterns in the medial septum.  
(A-C) Varying the frequency of 50 mW/mm
2
, 10ms stimulation pulses ±5 Hz within a normal 
distribution centered on 23 Hz (A) produced a peristimulus average waveform (B) similar to that 
seen with fixed-frequency simulation (Figure 6), but also generated a broader peak in the 
spectrogram (C) with variations in the peak response frequency during the stimulation time. 
Interestingly, this stimulation in the beta frequency range reduced the power at frequencies <10 
Hz. (D-F) Poisson 50mW/mm
2
 10ms pulses generated with a frequency of 23 Hz (D) also 
demonstrated a similar LFP peristimulus average response (E). However, the spectrogram (F) 
revealed a broadband increase in power peaking at the Poisson distribution frequency that did not 
influence <10 Hz power. (G-I) 50 mW/mm
2
, 10 ms pulses were generated in bursts of four pulses 
at 42 Hz, with the burst frequency set to 7 Hz (G). This pattern generated a sinusoidal 
peristimulus waveform (H) similar to that seen with constant 42 Hz stimulation (Figure 6). While 
harmonics of the 7 Hz oscillation were noted (I), the amplitude of these harmonics varied widely, 
most likely due to constructive and destructive interference. (J-L) A continuous sinusoidal 
oscillation in light intensity through the implanted ferrule (J) was also capable of generating a 
LFP response. The peristimulus average of the response was largely sinusoidal (K), and also 
lower in amplitude that that of pulsed stimulation. Power was concentrated at the stimulus 
frequency in the spectrogram (L), with the presence of harmonics much reduced.  
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observed that varied over time within the stimulation epoch. This is reflective of the 
variability introduced to the stimulation signal. Note that a harmonic is also apparent, 
with similar variability as seen in the primary signal. The spectrogram also demonstrates 
an increase in power across frequencies greater than 25 Hz during the stimulation, and a 
concomitant reduction in power at frequencies less than 10 Hz.  
 
3.3.3.2 Poisson distribution 
In our next example experiment, we stimulated the medial septum with a Poisson 
distribution of 10 ms pulses at 50 mW/mm
2
, generated at an average frequency of 23 Hz 
independent of the previous stimuli (Error! Reference source not found.D). A 
imilarly-stereotyped peristimulus average response was observed (Error! Reference 
source not found.E). However, the increase in spectral power was much broader than 
that generated by fixed or jittered-frequency stimulation (Error! Reference source not 
ound.F). A smear of increased power was observed during the stimulation epoch, 
extending from ~15 Hz to 70 Hz, peaking at the stimulation frequency average of ~23 
Hz. Also observed was a reduced impact on low-frequency (<10 Hz) power as compared 
to fixed and jittered stimulation pulses. 
 
3.3.3.3 Cross-frequency stimulation 
Cross-frequency interactions, such as those between theta and gamma frequencies, are 
thought to play an important role in neural processing, such as perception and memory 
(Jensen and Colgin 2007). In order to try and artificially generate a theta-gamma coupled 
state, we stimulated the medial septum at 50 mW/mm
2
 with four 10 ms pulses at 42 Hz 
with the cycle occurring at a frequency of 7 Hz (Error! Reference source not found.G). 
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his produced a highly sinusoidal pattern in the LFP, as demonstrated by the peristimulus 
average (Error! Reference source not found.H) and consistent with what has been 
bserved previously (Figure 6). Spectral analysis demonstrated a complex response 
dominated by power bands at 7 and 42 Hz (Error! Reference source not found.I). 
armonics of the 7 Hz response were visible, but the amplitude varied considerably and in 
a pattern unlike that previously encountered (Figure 7, Figure 8). It is likely that 
constructive and destructive interference between the harmonics of the 7 Hz and 42 Hz 
components of the response are responsible for the particular patterning observed. 
 
3.3.3.4 Continuous sinusoidal 
Continuous optical stimuli, as opposed to pulsed stimuli, can introduce stimulus currents 
that better mimic natural synaptic bombardment (Tchumatchenko et al.). Therefore, we 
also explored stimulating with a continuous 23 Hz sinusoidal signal (Error! Reference 
ource not found.J). The average response was more sinusoidal than fixed frequency 
(Error! Reference source not found.K). As in other stimulation cases, power was 
argely concentrated at the stimulus frequency as well, with a reduced harmonic 
component as compared to the fixed-frequency pulses (Error! Reference source not 
ound.L). Intriguingly, this stimulation pattern seemed to alter the LFP at frequencies 
other than just the stimulation frequency, with stimulation onset correlating with a 





3.3.4 Validation of hippocampal response to pulsatile stimulation patterns in the 
hippocampus 
In our second example experiment, we explored stimulation and recording from the same 
site, namely, the dorsal hippocampus (Figure 5B). NeuroRighter is compatible with a 
wide variety of electrode configurations, as evidenced in our use of the combined 
NeuroNexus array and optical ferrule in this example (Figure 4J). Optically stimulating 
and electrically recording in the same location does possess a significant caveat, in the 
form of optically-induced artifacts on the recording electrodes (Ayling et al. 2009; Han et 
al. 2009; Cardin et al. 2010) that must be separated from the true neurologic signal. This 
has long been a problem with electrical stimulation and recording, where the multi-fold 
difference between the stimulation and recording regimes readily obscures or saturates 
the signal (Wagenaar and Potter 2002; Rolston et al. 2010). The photoelectrochemical 
artifact, or Becquerel effect (Khurram and Seymour 2013), is not of the same magnitude; 
it is typically on the same order as the electrophysiologic signal (Figure 11A). However, 
these artifacts still pose a potential problem – can they be separated from the underlying 
neural signal in order to resolve the LFP and single-unit responses to optical stimulation? 
We first set out to characterize the artifact in vivo, and then to separate the artifact 
from the underlying electrophysiologic signals (Figure 11). Stimulating in non-ChR2-
expressing cortical tissue, we were able to define the stereotypical artifact waveform at 
10, 30, and 50 mW/mm
2
, which appeared in the LFP as charge/discharge 
depolarization/hyperpolarizations at the beginning and end of the stimulus pulses (Figure 
11A, red). We did not note DC offsets as seen by Cardin et al. (Cardin et al. 2010), 
perhaps due to our particular ground and reference configurations. The electrodes also 
possessed an iridium oxide coating, as this had been indicated by NeuroNexus Tech 
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(personal communication) to potentially reduce optically-induced artifacts. Note that as 
the intensity increased, so too did the artifact amplitude, but otherwise the waveform was 
largely stereotyped in appearance. The immediacy with which these artifacts appeared, as 
well as the steps we took to prevent optically-induced artifacts, suggests that they were 
actually a result of direct electrical coupling. Since these were unobserved on the TDT 
microwire arrays and the impedance values between the arrays were similar, we suspect 
that they resulted from the 21mm ribbon cable attaching the electrode shank to the 
Omnetics connector. The cable could be acting as an antenna, picking up the driving 
current to the LED, and amplifying this noise alongside the neurologic signal. 
 
 
Figure 11: Stimulation and recording within the hippocampus.  
The dorsal hippocampus was stimulated with the combined NeuroNexus array and ferrule (shown 




, and 50 mW/mm
2
. Artifacts 
of stimulation (A, red) that were intensity-dependent were noted and characterized in the cortex 
during implantation. The peristimulus average of the raw hippocampal LFP (A, top) is thus a 
combination of a LFP response and stimulation artifact. This makes it difficult to interpret the 
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corresponding spectrogram (A, bottom), as it is unclear whether or not the response is due to the 
artifact or the neurophysiologic activity. We removed the mean artifact from each stimulation 
time point (B), assuming that it would remain consistent between the locations, and suggesting 
the remaining signal was a true neurophysiologic response to stimulation. A single unit (C) 
increased in firing rate during stimulation (D), but returned to basal firing rate in the post-
stimulus epoch. In contrast, (E) shows an artifact from the stimulation signal that resembles a 





In the ChR2-expressing regions of the LFP of the dorsal hippocampus (Figure 
11A, gray), a delayed LFP response to the stimulation was apparent along with the 
artifact, peaking approximately 11 ms after stimulus onset. Note that this LFP waveform 
response was only observed in the ChR2-expressing hippocampus. Similarly to medial 
septal stimulation (Figure 7), these responses generated an increase in LFP power at the 
stimulation frequency (Figure 11A, bottom). However, with the artifact still present in the 
recorded signal, it is unclear whether this increase in power was due to the presence of 
the artifact, or the underlying electrophysiological response. 
In order to remove the artifact, we assumed that the artifact wouldn’t significantly 
change between non-expressing tissue and expressing tissue, in part due to its stereotypy. 
To remove the artifact signal offline, we then subtracted the mean artifact recorded from 
the cortex from the LFP recording in the hippocampus (Figure 11B). As the 
neurophysiologic response was much larger than the artifact, the resulting spectrographic 
analysis remained largely unchanged (Figure 11B, bottom).  
While the artifacts in the LFP were readily identifiable from the underlying 
neurophysiologic signal, the single-unit responses proved difficult to resolve. While 
common median referencing was employed to attempt to improve the signal to noise ratio 
of the action potentials (Rolston et al. 2009), it remained difficult to distinguish true 
single-units from artifacts. This is demonstrated in (Figure 11C-F), wherein a unit 
believed to be real, and a unit believed to be an artifactual response, are presented. The 
first detected unit (Figure 11C-D) had a basal firing rate preceding the stimulus that 
increased during the stimulation epoch in successive trials. The second detected unit 
(Figure 11E-F) also increased its firing rate during the stimulus, and appeared to be 
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largely locked to stimulus onset. However, the latter unit failed to be detected outside of 
the stimulation epoch, and despite the favorable appearance of its waveform, appeared to 
have been consequent to high-pass filtering of the stimulation artifact on this electrode. 
Without an accompanying intracellular waveform, or a tetrode-based identification 
scheme, it remains very difficult to clearly define a unit in this fashion. This is 
particularly a problem if the unit only appears during stimulation, and is locked to the 
stimulation frequency. 
 
3.3.5 Closed-loop stimulation 
We used NeuroRighter for closed-loop stimulation of medial septum in which 
hippocampal theta-rhythm was used as a control signal to trigger the stimulation of the 
medial septum.  The control system was implemented using a dynamic link library (dll) 
based on the NeuroRighter application programming interface (API) (Newman et al. 
2013). The API contains a set of tools for interacting with NeuroRighter’s input and 
output streams. In this framework the dll accesses the NeuroRighter data servers, 
performs computation on the neural data, and then generates and introduces stimulation 
protocols into the stimulation servers, enabling real-time and closed-loop functionality. 
Latency is largely determined by the called hardware and software – NeuroRighter’s 
double-buffered StimSrv output had a response latency of 46.9 ± 3.1,s – but this was 
reducible to 7-9 ms with alternative triggers, stimulation hardware, and less-complex 
outputs (Newman et al. 2013). Our implementation made use of StimSrv, which we 
found to be fast enough for most of our closed-loop requirements, and nicely integrated 
with the existing LFP data stream without significant hardware or software complexity. 
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The LFPs from the 16 channel microelectrode array were sampled by the API and 
analyzed in this fashion to estimate the power spectral density of theta oscillations (6-
10Hz, Figure 12) over time, relative to the total power of the signal in each time window. 
The power spectral density was estimated using the signal processing libraries of the 
Accord.net framework. When the normalized theta power dropped below a defined 
threshold a predefined stimulation profile (50mW/mm
2
, 35Hz, 10ms for 30 seconds) was 
generated and sent to the NeuroRighter stimulation servers. The stimulation parameters 
and threshold can be adjusted in run-time through a graphical user interface. This 
arbitrarily-designed closed-loop system worked quite robustly, generating readily-
identifiable increases in power at 35 Hz following periods of low-theta power relative to 
the total signal (Figure 12, magenta arrow). In this particular case, theta power did appear 
to recover by the end of the stimulus, but more robust testing will be necessary to 





Figure 12: Closed-loop stimulation of the medial septum in response to decreased theta 
power.  
As an example of the closed-loop capabilities of NeuroRighter, theta power (6-10Hz, within 
black dotted lines) was evaluated in a closed-loop dll produced for use with NeuroRighter. 50 
mW/mm
2
, 35sHz, 10 ms stimulation pulses were produced for 30 seconds in response to a 
decrease of power within the theta band below threshold relative to the total power in the time 




NeuroRighter has been demonstrated to be an adept and versatile platform for 
real-time, in vivo awake and behaving experiments with optogenetic neuromodulation 
and electrophysiologic recordings. It is capable of open- and closed-loop optical 
stimulation in a wide variety of user-defined patterns, and provides single-unit and LFP 
outputs, which are easily and readily analyzed. Through our example experiments and 
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analyses we have demonstrated the capabilities of this system, and imply future 
endeavors that are worthy of exploration. 
 As we suspected, the parameters of square-wave optical stimulation in our medial 
septal stimulation experiments had a significant impact on response waveform properties 
(Figure 6). As we are stimulating in the medial septum and recording in the hippocampus, 
the LFP responses we detected were likely the result of post-synaptic potentials generated 
via medial septal axons (Buzsáki et al. 2012). At higher stimulation frequencies the 
response became increasingly sinusoidal and decreased in amplitude. There has long been 
evidence that ChR-2-infected neurons have difficulty following stimulation patterns at 
>40 Hz (Yizhar et al. 2011). A decrease in LFP response amplitude might therefore be 
assumed at frequencies >40 Hz as a result of less reliable spike generation: fewer neurons 
are following the stimulus and generating action potentials, so the signal conducted to the 
hippocampus – manifested in the hippocampal post-synaptic LFP – is reduced. However, 
the stimulation frequencies we explored are within this experimentally-determined 
acceptable window. We hypothesize instead that the pattern of decreasing amplitude with 
increasing stimulation frequency is instead a consequence of the photocycle of ChR2. 
ChR2 is believed to possess a four-stage photocycle consisting of two open states with 
different ion conductances, and two closed states (Berndt et al. 2010). The first open 
state, which is triggered by sudden light intensity changes, results in the non-specific 
conduction of several ionic species. The second open state, which occurs with prolonged 
illumination, follows the first open state and is associated with a decrease in the total 
conductance, in part due to increased selectivity for H
+
 ions, as well as the accumulation 
of channels in nonconducting states. The waveform response properties we observed may 
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then be a result of similar accumulation of ChR2 channels in these non-conducting states, 
whereas low-frequency stimulation is able to more maximally activate a recycled and 
conductive population of light-sensitive ion channels. This hypothesis also provides an 
explanation for the observation that longer pulse widths altered the time-to-peak 
responses with different intensities. With short pulse widths the primary conductive 
mediator would be the first, fast open state. With longer pulse widths the second, slower 
conducting open state could come into play, delaying the time-to-peak with a later 
contribution to the response waveform. Computer modelling of these dynamics could 
provide more quantitative hypotheses that would better reveal the influence of 
stimulation parameters on these responses, as well as greater insight into the ChR2 
channel. 
 Increasingly, alternative stimulation patterns are being explored for use in clinical 
deep brain stimulation therapies (Brocker et al. 2013). Indeed, the regimented frequency-
specificity of our existing therapies and experiments appear quite artificial when 
compared with the natural oscillations within these neural circuits. Alternative 
stimulation patterns that better approximate neurologic signals, such as those presented 
here (Error! Reference source not found.), may prove more effective in eliciting 
ehavioral and experimental outcomes. 
 The artifacts of optical stimulation that we and others have observed (Figure 11), 
while of significantly less magnitude than equivalent electrical stimulation artifacts, do 
obscure and potentially influence the underlying neurophysiologic activity. In our hands 
these artifacts have proven very array-dependent, and others have suggested some 
mechanisms for reducing and removing them (Cardin et al. 2010). As they can prove 
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quite insidious, leading to false detections as single units, robust methods for preventing, 
defining, and removing such artifacts will be necessary to limit improper conclusions. 
 
3.5. CONCLUDING REMARKS 
The NeuroRighter platform provides a low-cost, open-source, real-time solution 
for optogenetic neuromodulation and multielectrode electrophysiology in awake and 
behaving animals. It is readily customizable to a number of applications, including open- 
and closed-loop experimentation with a variety of stimulation patterns, recording 








OPTOGENETIC NEUROMODULATION OF MEDIAL 
SEPTAL GABAERGIC NEURONS AND THE IMPACT ON 
HIPPOCAMPAL OSCILLATORY ACTIVITY IN AWAKE 
AND BEHAVING RATS 
 
4.1. INTRODUCTION 
Substantial evidence implicates the medial septum-diagonal band complex 
(MSDB) in the generation and maintenance of the hippocampal theta rhythm (Stewart 
and Fox 1990; Tóth et al. 1997; Buzsáki 2002). Three genetically-distinct neuron 
subpopulations have been identified within the MSDB – GABAergic, glutamatergic, and 
cholinergic neurons – all of which project to the hippocampus and may play a role in 
modulating hippocampal activity and theta oscillations (Freund and Antal 1988; Sotty et 
al. 2003; Yoder and Pang 2005; Huh et al. 2010; Bell et al. 2013), individually or in a 
coordinated fashion. The GABAergic subpopulation in particular possesses several 
anatomical and electrophysiologic features that suggest it may play a definitive role in 
driving and pacing hippocampal theta. 
Histological investigation of the septohippocampal axis demonstrated that the 
GABAergic MSDB population selectively innervates most of the GABA-containing 
interneurons throughout the hippocampus, establishing basket-like formations around cell 
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bodies and proximal dendrites (Freund and Antal 1988). These synaptic contacts are 
found in all hippocampal layers, but were predominantly observed in the strata oriens and 
radiatum of CA3 and the hilus and granule cell layers of the dentate gyrus. 
 No hippocampal glutamatergic pyramidal cells were found that received multiple 
synaptic inputs from the GABAergic projections (Freund and Antal 1988). Consequently, 
it was hypothesized that activity in MSDB GABAergic neurons would inhibit 
GABAergic interneurons of the hippocampus, effectively disinhibiting the pyramidal 
neurons they in turn synaptically contact. Rhythmic synchronous disinhibition sponsored 
by the medial septum could then generate periods of inhibition and disinhibition, 
manifesting as an oscillatory rhythm. 
Electrophysiological investigations lent support to the hypothesis that the MSDB 
GABAergic neurons were capable of pacing theta oscillations in the hippocampal local 
field potential (LFP). In cleverly prepared septohippocampal slice preparations, Tóth et 
al. stimulated either the medial septal nucleus or at the septal end of the fimbria in the 
presence of muscarinic and excitatory amino acid antagonists, while concurrently 
recording intracellularly from neurons in the CA3 field (Tóth et al. 1997). Single or 
repetitive stimulation of the MSDB reduced the frequency of inhibitory post-synaptic 
potentials (IPSPs) in CA3 pyramidal neurons. In contrast, hippocampal inhibitory 
interneurons experienced IPSPs in response to septal stimulation, in some cases 
abolishing spontaneous firing. Furthermore, Toth et al. determined that rhythmic (5 Hz) 
septal stimulation generated a conserved period of oscillating hippocampal synaptic 
oscillation driving hippocampal LFP. During this period, the authors also noted that 
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despite the lack of increase in pyramidal cell firing frequency, action potentials were 
strongly entrained to the peak of the artificial disinhibitory oscillation.  
Coupled with work from Stewart and Fox that identified a rhythmically bursting 
neuron population in the MSDB (Stewart and Fox 1990), it was hypothesized that the 
GABAergic MSDB neurons in this disinhibitory circuit pace hippocampal theta 
oscillations. However, it was unclear whether this bursting neuron subpopulation was 
indeed composed of the MSDB GABAergic neurons, as the correlation between 
neurochemical identity and electrophysiologic properties had yet to be established. In fact 
it would soon become clear that despite this work an entirely novel population of 
glutamatergic neurons was unrecognized.  
Significant progress towards elucidating these facts was accomplished by Sotty et 
al, in a thorough series of elegant experiments (Sotty et al. 2003). The authors coupled 
whole-cell recordings with single-cell reverse-transcription polymerase chain reaction 
(RT-PCR) to simultaneously characterize both the electrophysiologic and genetic 
characteristics of the MSDB neurons they sampled. They characterized four distinct 
firing populations – slow-firing, burst-firing, fast-firing, and slow/cluster-firing – 
alongside three major neurochemical profiles, and a few multi-neurochemical profiles. 
The choline acetyl-transferase (ChAT) positive cells (cholinergic) were identified as the 
slow-firing neurons, whereas the novel VGLUT-positive neurons (glutamatergic) 
demonstrated a stimulus-dependent slow/cluster firing rate. GAD67 expressing neurons 
(GABAergic), as hypothesized, were found to consist of both burst- and fast-firing 
populations. Despite these findings, it should be noted that sustained rhythmic bursting – 
necessary for the maintenance of an oscillatory rhythm – was not observed in these 
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populations. In addition, several of their genetically-identified neurochemical groups also 
demonstrated cross-reactivity, including VGLUT reactivity. The authors thus 
hypothesized that either the bursting GABAergic neurons or cluster-firing glutamatergic 
neurons were contributing to pacemaker activity in the hippocampus, but could not 
establish a definitive argument for either of them.  
One concern with these investigations is that they were performed in deafferented 
septohippocampal slices, a preparation which might change the firing properties of the 
investigated neurons and the associated physiologic rhythms (Stewart and Fox 1990; 
Williams and Kauer 1997). However, in a similar series of in vivo juxtacellular recording 
experiments in anesthetized rats, Borhegyi et al. used cytoplasmic filling to perform 
immunocytochemical identification (Borhegyi et al. 2004). They identified two distinct 
populations of highly regular, constitutively bursting medial septal GABAergic neurons 
whose activity was correlated to either the peak or trough of the hippocampal theta 
oscillation. Investigating the axonal arborizations revealed the presence of numerous 
collaterals within the medial septum, suggesting that the bursting MSDB GABAergic 
neurons could synchronize the activity of the entire septohippocampal network. 
While these investigations asked whether the GABAergic populations of the 
MSDB were capable of driving hippocampal theta activity, Yoder et al. investigated their 
necessity to the oscillatory rhythm (Yoder and Pang 2005). The authors selectively 
lesioned the MSDB GABAergic and cholinergic neurons chemically and examined the 
impact on hippocampal theta in two states – urethane anesthesia and awake locomotion. 
Urethane anesthesia is associated with theta II, a theta oscillatory rhythm sensitive to 
arrest from the competitive muscarinic antagonist atropine. A second type of 
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hippocampal theta, theta I, co-occurs with theta II during locomotion, and is resistant to 
elimination by atropine (Vanderwolf 1975; Montoya and Sainsbury 1985; Yoder and 
Pang 2005). Intraseptal injections of kainic acid or 192 IgG-saporin were utilized to 
selectively destroy MSDB GABAergic and cholinergic neurons, respectively (Yoder and 
Pang 2005). We should note that they did not assess the impact of either of these 
interventions on the glutamatergic population, which may have been affected. Either of 
these interventions greatly reduced hippocampal theta power under urethane anesthesia, 
suggesting that both populations are each necessary for type II (atropine-sensitive) 
hippocampal theta. Theta during locomotion was less reduced by the same interventions, 
suggesting that contribution to theta during awake behavior may also stem from another 
source. The authors postulated that the source of this input may be glutamatergic 
projections from the entorhinal cortex, and that the reduction in theta power during 
locomotion was due to elimination of intermixed type II theta (Yoder and Pang 2005). 
Combinatorial lesions – including of entorhinal cortex projections – suggested that each 
of these sources was involved in theta I, with the MSDB GABAergic cells – in 
conjunction with the MSDB cholinergic neurons – providing the atropine-sensitive 
component (theta II). 
Additional work correlated disruption of medial septal GABAergic activity with 
alterations to hippocampal theta (Villette et al. 2010). In this study, Villette et al. 
introduced amyloid β into the dorsal hippocampus of rats. They subsequently observed a 
reduction in theta power and detuning of theta oscillations, as well as a significant 
impairment of long term memory. Intriguingly, the alterations to the theta oscillations 
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were found to be in conjunction with a reduction in the rhythmic bursting activity of 
theta-phase locked MSDB GABAergic neurons, but without any accompanying cell loss.  
Most recently, Kaifosh et al. attempted to characterize the synaptic population 
dynamics of MSDB GABAergic projections during awake behavior (Kaifosh et al. 2013), 
an important step as the work by Yoder et al suggests that theta behaves differently under 
anesthesia (Yoder and Pang 2005). Utilizing an AAV-hSynapsin-GCaMP5 injection into 
the medial septum of mice, the authors selectively expressed the Ca
2+
 indicator in the 
MSDB GABAergic population. In the postsynaptic hippocampal interneurons, they then 
expressed tdTomato fluorescent protein for targeting purposes and head-post fixed the 
animal with a chronic imaging window above CA1. This enabled fluorescence signals 
from axonal varicosities to be examined with two-photon microscopy during a treadmill 
task. During running episodes simultaneous extracellular field recordings demonstrated 
increased bouton fluorescence correlating with increased theta power – supporting the 
evidence from slices and anesthetized animals implicating the MSDB GABAergic 
neurons role in hippocampal theta.   
Despite these efforts, the role of the MSDB GABAergic neurons in hippocampal 
theta remains less than clear, particularly in the light of novel glutamatergic cell 
populations. This confusion stems from issues of selectivity in lesioning studies, awake 
vs. anesthetized models, and the effects of electrical stimulation on nervous system 
tissue. To best assess the role of MSDB neuron subpopulations in hippocampal 
oscillatory activity, several experimental aspects are optimal: 1) experimentation in 
awake and behaving subjects 2) genetically and temporally selective excitation of the 
neurochemically defined MSDB GABAergic neurons to investigate the capability of 
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modulating hippocampal theta, and 3) genetically and temporally selective inhibition of 
the MSDB GABAergic neurons to investigate their necessity to hippocampal oscillatory 
theta activity.  
To evaluate the hypothesis that the medial septal GABAergic neuron population 
pace hippocampal theta activity, we investigated optogenetic excitation and inhibition of 
the MSDB GABAergic neurons in unrestrained awake and behaving rats. Optogenetic 
tools provide a powerful methods for genetically and temporally precise manipulation of 
complex heterogeneous nervous system circuitry (Aravanis et al. 2007; Carter et al. 2009; 
Gradinaru et al. 2009; Kravitz et al. 2010; Yizhar et al. 2011; Packer et al. 2012; Wykes 
et al. 2012; Paz et al. 2013). When combined with electrophysiological recordings, 
optogenetic control can provide unprecedented insight into neural connectivity and 
function (Bell et al. 2013), particularly in awake and behaving animals (Gradinaru et al. 




2-3 month old adult male Sprague-Dawley rats (250-300g) were purchased from Charles 
River Laboratories (Wilmington, MA, USA). 2-3 month old adult male Long-Evans rats 
were bred as the non-expressing cage-mates of a Chat-CRE transgenic rat colony. Three 
rats apiece were used in each experimental group. No differences were seen between the 
strains, so the animals were grouped for all analyses. All animals were maintained within 
a 12/12 light/dark cycle vivarium with unlimited access to food and water. This work was 




Each subject underwent two surgical procedures. The first survival surgery 
introduced the viral vector to the medial septum and provided time for expression of the 
optogenetic channel. Rats were anesthetized with 1.5-4% inhaled isoflurane, and a 
craniectomy was made 0.40 mm anterior and 2.00 mm lateral to bregma on the right side 
of the skull. A pulled-glass pipette attached to a stereotactically mounted injector 
(Nanoject; Drummond Scientific Co., Broomall, PA, USA) was used to inject 1.8 µL of 
10
12
 particles/mL AAV5-hSynapsin-hChR2(H134R)-EYFP or AAV5-hSynapsin-
eNpHR3.0-EYFP (UNC Vector Core Services, Chapel Hill, NC, USA). This promoter 
has been described as selectively expressing in the GABAergic neurons of the MSDB 
(Kaifosh et al. 2013). The injection was made at a 20° angle to the dorsal-ventral axis 
(0.40 mm anterior, 2.12 mm lateral at the 20° angle, 5.80 mm ventral to pia along the 
rotated axis) in order to target the medial septum without damaging the medially-located 
central sinus. After 5 minutes for equilibration, the injection was made over 7 minutes 
with the pipette remaining in place an additional 10 minutes post-injection to prevent 
reflux. Once withdrawn, the scalp was stapled closed, ketofen was administered as an 
analgesic (3-5 mg/kg), and the rats were kept in BSL2 housing for 72 hours before 
returning to normal housing.  
 The second survival surgery was performed two weeks later. A second 
craniectomy was made over the right dorsal hippocampus centered at 3.50 mm posterior 
and 2.80 mm lateral to bregma. The dura was incised with a sterile curved scalpel blade. 
In order to record from the dorsal hippocampus 16-channel microwire multielectrode 
arrays (Tucker Davis Technologies (TDT), Alachua, FL., USA; MEA) were constructed 
from sixteen 33 µm diameter tungsten electrodes with polyimide insulation (Figure 4I). 
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The electrodes were arranged in two rows of eight electrodes with 1 mm between rows 
and 175 µm of space between the electrodes within a row. Ground and reference wires 
were separated on the array and routed through two stainless steel wires, which were 
affixed to separate skull screws during the implantation surgery. The two rows were cut 
to different lengths, 4.0 mm and 3.0 mm, to target and record simultaneously from the 
hippocampal CA3 and CA1 regions, respectively, enabling multiunit and local field 
potential recording from the hippocampus distantly from the optical stimulation site in 
the medial septum. The array was positioned at a 50° angle to midline, with the posterior 
end swung laterally, to match the positioning of the hippocampal pyramidal cell layers 
pyramidal cell layers (Rolston et al. 2010). The MEA was lowered while simultaneously 
recording single unit and local field potential (LFP) activity to attain the ideal positioning 
(Rolston et al. 2009). When the electrophysiologic recordings stabilized and the CA1 and 
CA3 layers were identified, the original injection craniectomy was reopened, and a 
calibrated optical fiber ferrule (Figure 4E, H) was implanted at a 20° angle to the dorsal-
ventral axis (0.40 mm anterior, 2.12 mm lateral in the rotated axis). Stimulation was 
performed as the ferrule was implanted, with the resulting recordings immediately 
analyzed spectrographically. Descent was halted when a strong stimulus-response signal 
was observed in the spectrogram, or when the optical ferrule reached a maximum depth 
of 5.50 mm from pia along the rotated axis.  
Once the electrodes and ferrules were in place, the craniectomy was sealed with 
dental acrylic (OrthoJet; Lang Dental; Wheeling IL), securing the array and ferrule in 
place in their respective targets. The rats were administered ketofen (3-5 mg/kg) to 
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minimize pain and returned to normal housing to recover for 3-5 days before optical 
stimulation and recording experiments were performed. 
 
4.2.2 Optical stimulation and electrophysiologic recordings 
Using our adapted NeuroRighter system (CHAPTER III), electrophysiologic recordings 
were sampled at 25 kHz with a 1-9,000 Hz bandwidth. LFPs were isolated online with a 
1-500 Hz 1-pole Butterworth band-pass filter and downsampled to 2000 Hz. Action 
potentials were isolated online (Newman et al. 2013) and sorted using spike-sorting 
Wave_clus scripts and superparamagnetic clustering (Quiroga et al. 2004).  
 To stimulate awake and behaving animals, calibrated ferrules were connected via 
armored patch fiber cables (200 µm diameter, 0.67 NA, Plexon) to the NeuroRighter 
platform. ChR2 animals were stimulated with a 465 nm blue LED module. Square-wave 
stimulation pulses varied between 10, 30, and 50 mW/mm
2
; 7, 11 (theta), 17, 23, 35 
(beta), and 42 (gamma) Hz; and 2, 5, and 10 ms pulse widths. eNpHR3.0 animals were 
inhibited with a 620 nm orange LED module. Square-wave stimulation pulses varied 
between 10, 30, 50, 70, and 90 mW/mm
2
; 7, 11 (theta), 17, 23, 35 (beta), and 42 (gamma) 
Hz; and 2, 5, and 10, 20, and 50 ms pulse widths. Continuous stimulation at 50, 70, and 
90 mW/mm
2
 was also performed. The experimental protocol consisted of repeated one 
minute recordings of 20 seconds of pre-stimulation background, 20 seconds of 
stimulation, and a subsequent 20 seconds of additional post-stimulation background. 
Stimulation protocols were performed in random order and repeated several times over 
multiple recording sessions. This setup was able to stimulate and record LFP and single-
unit responses from awake and behaving animals uninterrupted for several hours and over 
several days. Subjects were introduced into an open-field environment for the duration of 
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the experiments. Data were recorded intraoperatively and for up to four weeks 
postoperatively. 
 
4.2.3 Data analysis 
We isolated recording days where we simultaneously recorded CA1 and CA3 single 
units, and selected those contacts with the highest amplitude and best-isolated single units 
for further analysis. Power spectra, spectrograms, coherence, and coherograms were 
computed from the LFP on these channels using the Chronux suite of analysis tools and 
multitaper analysis (Bokil et al. 2010). For spectrum and coherence calculations, T=1, 
W=5 with 9 Slepian tapers. A Jackknife approach was used to calculate 95% confidence 
intervals for statistical testing purposes. For spectrogram and coherogram analysis a 
moving window size of 4s was stepped in 0.5s increments, T=1, W=4 and 7 Slepian 
tapers. Note that these parameters sacrifice temporal specificity to gain greater resolution 
in frequency. As a result, edge transitions in spectrograms and coherograms will be 
blurred into the pre and post-stimulation epochs. Mean autocorrelation and cross-
correlation between CA1 and CA3 were performed to assess alterations in theta phase 
during the stimulation and non-stimulation epochs, with 95% confidence intervals 
calculated and presented alongside the mean for statistical testing. 
 
4.2.4 Histology 
Histology was performed after experimentation to verify microelectrode recording 
locations and light-sensitive ion channel expression. Rats were deeply anesthetized with 
an overdose of Euthasol (5ml/kg, Virbac, Fort Worth, TX, U.S.A.) injected 
intraperitoneally. They were then transcardially perfused with 0.9% saline followed by 
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4% paraformaldehyde in 0.1M phosphate buffer at pH 7.2. The heads, still containing the 
electrodes and ferrules, were then separated and post-fixed at 4°C overnight. The next 
day the brains were dissected out, removed, and cryoprotected with 30% sucrose at 4°C. 
Frozen transverse (horizontal) sections were made of 50 µm thickness on a sliding 
microtome and collected in 0.1M PBS. Sections were mounted on glass slides and 
mounted with Vectashield mounting medium with DAPI (Burlingame, CA, U.S.A.) for 
visualization of nuclei. Sections were imaged in the NIS-Elements software (Nikon 
Instruments, Inc., Melville, NY, USA) using a Nikon DS-Fil color digital camera on a 




4.3.1 Histologic verification of channel expression 
Injection of AAV5-hSynapsin based viral vectors resulted in robust expression in the 
medial septum (Figure 13, Figure 5A, green). The hSynapsin promoter has demonstrated 
specificity for the GABAergic neurons of the medial septum (Kaifosh et al. 2013). From 
the medial septum, axonal projections to the hippocampus (Figure 13C, Figure 5A, C) 
were visible, coinciding with the passage of the electrodes (Figure 5C, red and white 
arrows) and the hippocampal pyramidal cell layer (Figure 5C, yellow arrow). AAV5-
hSynapsin-eNpHR3.0 expression is not shown because those animals have yet to be 





Figure 13: Robust expression of ChR2-EYFP in the medial septum.  
(A) AAV5-hSynapsin-ChR2-EYFP injection into the medial septum (MS) produced robust 
ChR2-EYFP expression (green). Scale 1 mm. Expression was noted specifically within 







4.3.2 Rhythmic excitation of GABAergic MSDB neurons 
4.3.2.1 Evoked LFP response waveforms to excitation are highly influenced by 
stimulation parameters. 
To address the question of whether GABAergic MSDB neurons can modulate 
hippocampal oscillatory activity, we selectively excited this population with 
hChR2(H134R) in pulse trains of varying width, amplitude, and frequency, and examined 
the resulting hippocampal LFP response. Stimulation produced evoked field potentials in 
both the CA1 and CA3 layers. These evoked potentials were readily visible in the local 
field potential recording (Figure 14A). Averaging the response from each pulse across all 
parameters (peristimulus average) indicated that the evoked potential waveform was 
highly dependent upon stimulation parameters (Figure 14B). Stimulating at lower 
frequencies (7-23 Hz) produced defined evoked potentials which increased in amplitude 
with light intensity and longer pulse-widths. However, at high beta (35 Hz) and low 
gamma (42 Hz) frequencies, the response to stimulation was visibly sinusoidal and no 




Figure 14: CA3 LFP response as a function of stimulus intensity, frequency, and pulse 
width.  
Stimulation of the GABAergic neurons of the medial septum resulted in pronounced evoked 
potentials in the hippocampal LFP. (A) An example CA3 LFP recording during 50 mW/mm
2
, 7 
Hz, 10ms excitation (blue bar). (B) Calculating the peristimulus average (thick line is mean, 
shaded area is standard deviation) response in CA3 across each of the stimulation protocols 
demonstrated that the evoked potential waveform was highly dependent on the stimulation 
parameters. Low-frequency stimulation (7-23 Hz) produced defined waveform peaks, particularly 
at high stimulation intensities and long pulse-widths. At higher frequencies (35-42 Hz), however, 
the response was largely sinusoid and independent of stimulus intensity. Note that at higher 
frequencies the interpulse interval reduces such that each 50ms window features multiple pulse 
responses, which is likely what is driving the sinusoidal response. 
 
3.2.2 Frequency-specific responses to optical excitation in both layers  
Spectral analysis was performed to evaluate the effect of stimulation at theta frequencies 
on hippocampal oscillatory activity. The primary result observed during the stimulation 
epoch was a statistically significant stimulus-frequency specific increase in power 
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relative to the pre-stimulation epoch, as well as harmonics of that stimulation frequency 
(Figure 15). The harmonics necessarily derive from the Fourier decomposition of the 
non-sinusoidal evoked potentials (Figure 8). Also notable was a significant decrease in 
theta power below the stimulation frequency, and a general increase in power at >20 Hz, 
again as compared to the pre-stimulus epoch. The lack of coherence at the stimulation 
frequency is potentially a result of indiscriminate grouping of the subjects. 
 
 
Figure 15: CA1 and CA3 demonstrate stimulation theta frequency-specific increases in 
power with 7 Hz stimulation.  
Stimulation was performed at 50 mW/mm
2
, 7 Hz, and 10 ms, and the pre-stimulus (black), post-
stimulus (red) and stimulus (blue) epochs across all trials were separated and spectrally 
examined for changes in power. 95% confidence intervals were calculated for each epoch using a 
Jackknife approach (dashed lines). Statistically significant (p<0.05) increases in power at the 
stimulus frequency were demonstrated in both the CA1 (top) and CA3 (middle) layers, alongside 
stimulation harmonics. Power at frequencies less than 7 Hz was significantly reduced during 
stimulation, and increased above 20 Hz. No significant difference in power was noted between 
the pre- and post-stimulation epochs. CA1-CA3 coherence at the stimulation frequency (bottom) 




Stimulating the GABAergic neurons at other frequencies also generated a significant 
(p<0.05) stimulus-frequency specific response in the hippocampal LFP (Figure 16). The 
GABAergic neurons of the MSDB, when synchronously and rhythmically activated, 
transmitted the frequency pattern to the hippocampal LFP in all cases. With high beta 
stimulation (35 Hz, Figure 16) a significant decrease in power at theta (~ 7 Hz) was noted 
alongside a general increase in power >15 Hz in CA1, and less so in CA3. Also notable 




Figure 16: Stimulus-frequency specific increases in spectral power with 35 Hz stimulation. 
 Stimulating with 50 mW/mm
2
, 35 Hz, 10 ms pulses also significantly (p<0.05) increased power 
at the stimulus frequency, as well as reduced hippocampal theta power. CA1 demonstrated a 
significant increase in power at frequencies >15 Hz, but CA3 was not as robust in this aspect. 




Examining the spectrogram of the same recordings also demonstrated the consistent 
stimulation-frequency specificity of the LFP response in CA1 and CA3 layers, as well as 
the temporal specificity of the stimulation onset and offset (Figure 17, Figure 18). The 
post-stimulation epoch was not impacted by the stimulation epoch – increase in 
hippocampal oscillatory power at the stimulus frequency was not entrained and ended 
with the stimulus. Decreased spectral power at non-stimulus theta frequencies was 
observed in both stimulation paradigms, and a significant increase in CA1-CA3 
coherence was observed with 35 Hz stimulation. A consistent phase relationship during 
the stimulation epoch was also observed for each stimulation frequency (significant only 
for 35 Hz), suggesting GABAergic MSDB stimulation may lock hippocampal CA1-CA3 






Figure 17: Temporal specificity of the spectrographic and coherence response to 7 Hz 
stimulation.  
Stimulation of MSDB GABAergic neurons with 50 mW/mm
2
, 7 Hz, 10 ms pulses (blue bar) 
consistently increased hippocampal power at the stimulus frequency in both CA1 (A) and CA3 
(B), alongside decreased power <7 Hz. While there was a non-significant (p>0.05) increase in 
coherence amplitude (C) at the stimulation frequency, examination of the angle of the coherence 
(D, black arrow at stimulus frequency) suggests that the responses in CA1 and CA3 was 
locked in a particular phase relationship during stimulation. Note no lasting effects from 
stimulation into the post-stimulation epoch. Blurring of the edges is due to the wide moving 






Figure 18: Temporal specificity of the spectrographic and coherence response to 35 Hz 
stimulation.  
Stimulation of MSDB GABAergic neurons with 50 mW/mm
2
, 35 Hz, 10 ms pulses (blue bar) 
also consistently and robustly increased hippocampal power at the stimulus frequency in both 
CA1 (A) and CA3 (B), as well as decreased theta power. In contrast to 7 Hz stimulation (Figure 
17), there was a significant (p<0.05) increase in coherence amplitude (C) at the stimulation 
frequency. This was accompanied by a very consistent phase relationship (D, black arrow). 
 
 
4.3.2.3 Phase-locking to the theta stimulus pattern 
To examine the impact of MSDB GABAergic stimulation on hippocampal phase more 
thoroughly, we evaluated the autocorrelation of the CA1 and CA3 signals in response to 
theta (7 Hz) stimulation, as well as the cross-correlation between the layers (Figure 19). If 
the oscillation was locked in phase and amplitude throughout the stimulation epoch 
(Figure 19, blue), then we would observe peaks in the correlation at stimulation lag times. 
Both CA1 and CA3 demonstrated significantly (p<0.05) correlated peaks at lags 
corresponding to the stimulus frequency (Figure 19). These peaks were consistent well 
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into the lag in both layers, indicating that LFP phase was locked to the stimulation. The 
CA1-CA3 correlation did suggest (not significant, p>0.05) a stimulation-imposed phase-
relationship between the CA1 and CA3 layers, wherein the correlation peak was shifted 




Figure 19: Auto and cross-correlation properties indicate phase-locking to stimulus pulses.  
Autocorrelation of the CA1 and CA3 LFP-signal demonstrated a consistently significant (p<0.05) 
increase in correlation at the stimulus frequency – as compared to the pre and post-stimulus 
epochs, suggesting that the LFP response was phase-locked to the stimulus pattern. Cross-
correlation between CA1 and CA3 was not significant (p>0.05) at zero lag, but was so at 
successive lag times, suggesting a phase relationship between CA1 and CA3 wherein CA3 






4.3.3 Inhibition of MSDB GABAergic neurons 
Whereas the preceding experiments explored the capability of the MSDB GABAergic 
neurons to modulate and drive hippocampal oscillatory activity, the following work 
utilizes optogenetic inhibition to assess the necessity of MSDB GABAergic neurons for 
hippocampal theta oscillations in the awake animal.  
 
4.3.3.1 Rhythmic 35 Hz inhibition of MSDB GABAergic neurons produces a concurrent 
increase in power at the stimulus frequency.  
Rhythmic 90 mW/mm
2
, 35 Hz, 10 ms inhibition of MSDB GABAergic neurons was 
performed. This pattern produced a statistically significant (p<0.05) increase in 
hippocampal LFP power at 35 Hz in both the CA1 and CA3 layers (Figure 20), with the 
effect more pronounced in CA3. This effect was not nearly as robust as that seen with 
excitation of the MSDB GABAergic neurons (Figure 16), but indicates successful 




Figure 20: Rhythmic inhibition significantly increases power at the inhibition frequency.  
Inhibitory stimulation was performed at 90 mW/mm
2
, 35 Hz, and 10 ms, and the pre-stimulus 
(black), post-stimulus (red) and inhibitory stimulus (orange) epochs across all trials were 
separated and spectrally examined for changes in spectral power. 95% confidence intervals were 
calculated for each epoch using a Jackknife approach (dashed lines). Statistically significant 
(p<0.05) increases in power at 35 Hz were demonstrated in both the CA1 (A,D) and CA3 (B,E) 
layers. Changes at other frequencies were not observed, and no significant difference in power 
was noted between the pre- and post-stimulation epochs. CA1-CA3 coherence at the stimulation 




Figure 21: Constant inhibition of MSDB GABAergic neurons does not alter hippocampal 
oscillatory power.  
Constant inhibition of the MSDB GABAergic neurons for 20 seconds at 90 mW/mm
2
 (orange 
bar) failed to significantly alter hippocampal power at any frequency in either CA1 (A) and CA3 
(B) from the pre-stimulus epoch. Similarly, no alterations between the pre-stimulus and post-
stimulus epochs were seen in the coherogram (C) or the phase coherence (D). Theta power was 
not altered in the awake and behaving animal in either hippocampal layer.  
 
4.3.3.2 Constant 90 mW/mm
2
 inhibition of MSDB GABAergic neurons does not alter 
hippocampal LFP. 
To examine the necessity of MSDB GABAergic neurons for hippocampal oscillatory 
activity, we performed constant 90 mW/mm
2
 inhibition for 20 seconds. Inhibition in this 
fashion did not alter hippocampal spectral power at any frequency (Figure 21 A, B), nor 
coherence between CA1 and CA3 (Figure 21 C, D). It also failed to significantly alter 
phase relationships as assessed by autocorrelation and cross-correlation (Figure 22).  It is 





Figure 22: Constant inhibition of MSDB GABAergic neurons does not significantly alter 
hippocampal phase.  
No significant changes between the pre-stimulus (black), stimulus (orange), and post-stimulus 
(red) epochs was seen during constant 90 mW/mm
2




Rhythmic optogenetic stimulation of the GABAergic MSDB neurons in awake 
rats effectively transmitted the frequency pattern of stimulation to the hippocampal LFP 
across both the CA1 and CA3 layers. This is in agreement with previous work in 
septohippocampal slice preparations (Tóth et al. 1997), and provides additional support 
for the disinhibitory hypothesis. In addition, we determined that this response was not 
dependent upon stimulation frequency – GABAergic stimulation effectively conveyed 
theta, beta, and low gamma patterns to the hippocampal LFP (Figure 14, Figure 17, and 
Figure 18). This might be expected from the disinhibitory circuit MSDB GABAergic 
neurons are acting through, as the structure of the circuit, supported by these results, 
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suggest that there is nothing inherent about the circuit that necessitates its oscillation at 
theta frequencies.  
Our stimulation pattern was additionally associated with a phase-locking effect 
(Figure 19), wherein the hippocampal LFP in both CA1 and CA3 demonstrated 
significantly increased correlation at stimulation lag-points. This implicates a role for 
synchronous firing in the MSDB GABAergic neurons subpopulation in altering 
hippocampal oscillatory phase, which might prove important in theta phase resetting 
(Suthana et al. 2012).  
 The experimental evidence from this study and others suggest that the medial 
septum GABAergic neurons are capable of modulating hippocampal oscillatory activity. 
However, this does not necessarily mean that these neurons are necessary for theta. Work 
from Yoder et al. suggests that the MSDB GABAergic neurons are not majorly involved 
in theta in awake and behaving animals (Yoder and Pang 2005). In fact, their work 
implies that the anesthetized and slice-preparations most commonly used reflect an 
altered non-physiologic state of the septohippocampal axis. 
 Thus to effectively examine the necessity of the MDSB GABAergic neurons in 
hippocampal oscillatory activity, we optogenetically inhibited this population in the 
medial septum and examined the effects on hippocampal LFP. Rhythmic 35 Hz inhibition 
produced a frequency-specific response in the hippocampal LFP (Figure 21) suggesting 
that our intervention effectively modulated MSDB GABAergic neurons. This frequency-
specific response may be due to filtering of fast-firing neurons action potentials, but 
electrophysiologic reports of the medial septum do not indicate the glutamatergic neurons 
firing at a high enough rate for this to be likely (Sotty et al. 2003; Borhegyi et al. 2004; 
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Simon et al. 2006). Instead, we hypothesize that the oscillation was generated from 
rebound bursting in the burst-firing MSDB GABAergic neurons (Sotty et al. 2003). 
Inhibition of the MSDB GABAergic population would be followed by synchronized 
rebound excitation, which would then be transmitted to the hippocampus. 
 In contrast, constant 90 mW/mm
2
 inhibition failed to significantly alter 
hippocampal LFP power, coherence (Figure 21), and phase (Figure 22). Of particular 
note, no changes in hippocampal theta power or phase in response to inhibition were 
observed. This supports the observations by Yoder et al. that theta in awake and behaving 
animals is resistant to lesions of GABAergic neurons in the medial septum (Yoder and 
Pang 2005), and supports the conclusion that the GABAergic population is not necessary 
for hippocampal theta. However, it is unclear how successful our inhibitory paradigm 
was at arresting MS GABAergic activity, and the lack of effects may be a result of an 
inability to completely abolish extant neural activity in this population. 
This does not rule out a modulating or synchronizing role for MSDB GABAergic 
neurons – this subpopulation may be particularly state-dependent. Indeed, the role of 
MSDB-derived theta has well established associations with learning and memory 
(McNaughton et al. 2006; Colom and Garrido-Sanabria 2007; Lipponen et al. 2012). 
Performing these same experiments under a memory behavioral paradigm (e.g. Morris 
water maze) could provide greater insight into MSDB GABAergic function.  
In addition, combinatorial effects cannot be ruled out. Yoder et al. observed that 
combined GABAergic and cholinergic lesions produced a greater decrease in theta power 
than either alone (Yoder and Pang 2005). As septal inactivations and lesions can reduce 
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or abolish theta (Colom and Garrido-Sanabria 2007), there appears to be a role for the 
medial septum in theta.  
In addition, pulsatile stimulation may not best reflect the physiologic activity of 
the MSDB GABAergic neurons. Pulses may overly synchronize activity – note the 
differences at the first theta lag in the LFP autocorrelation between the stimulus and pre- 
and post-stimulation epochs (Figure 19). Instead, stimulating with a continuous sinusoid 
(Error! Reference source not found.) could better reflect the electrophysiologic signal 
hysiologically conveyed from the medial septum to the hippocampus. 
Finally, the demonstrated ability of the GABAergic population to tightly regulate 
phase in the hippocampus suggests that the GABAergic population may be serving to 
amplify a pacemaking signal and coordinate it within the hippocampal circuitry. The 
hippocampus is capable of theta-like oscillations in the deafferented state (Konopacki et 
al. 1987), and it is possible the GABAergic input from the MSDB acts upon extant 
hippocampal oscillatory activity to shape and modulate it. Indeed, stimulation 




Medial septal GABAergic neurons, when synchronously activated 
optogenetically, produce stimulation-frequency specific activity in the hippocampal CA1 
and CA3 local field potential. This enables these neurons to modulate theta oscillations – 
as well as other frequencies – and indicates that the MSDB GABAergic neurons are 
capable of pacing theta, as well as other frequencies. However, inhibition of MSDB 
GABAergic neurons failed to alter hippocampal oscillatory activity at any stimulation 
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frequency, suggesting that the GABAergic neurons of the medial septum do not modulate 





OPTOGENETIC MODULATION OF MEDIAL SEPTAL 
GLUTAMATERGIC NEURONS AND THE IMPACT ON 
HIPPOCAMPAL OSCILLATORY ACTIVITY IN AWAKE 
AND BEHAVING RATS 
 
5.1. INTRODUCTION 
Substantial evidence implicates the medial septum-diagonal band complex 
(MSDB) in the generation and maintenance of the theta rhythm in the hippocampus 
(Stewart and Fox 1990; Tóth et al. 1997; Buzsáki 2002; Huh et al. 2010). Three 
genetically-distinct neuron subpopulations have been identified within the MSDB – 
GABAergic, glutamatergic, and cholinergic neurons – all of which project to the 
hippocampus and may play a role in modulating hippocampal activity and theta 
oscillations (Freund and Antal 1988; Sotty et al. 2003; Yoder and Pang 2005; Huh et al. 
2010; Bell et al. 2013). The glutamatergic neurons of the medial septum have only 
recently been discovered (Lin et al. 2003; Sotty et al. 2003; Wu et al. 2003), but the 
implications for their role in the septohippocampal axis, and in theta modulation, is 
profound. 
Definitive histologic evidence for the existence of the glutamatergic population in 
the MSDB would stem from immunohistochemical investigations for vesicular glutamate 
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transporter-2 (VGLUT2), a neuron-specific marker for the transport of glutamate (Lin et 
al. 2003). Many of the connections these glutamatergic neurons have were local, 
synapsing onto parvalbumin-immunoreactive dendrites as well as parvalbumin-positive 
cell bodies, and appeared to mediate the effects of nicotine on septohippocampal 
GABAergic neurons (Wu et al. 2003). 
The first electrophysiologic investigation of the glutamatergic neuron population 
was performed by Sotty et al. (Sotty et al. 2003). The authors coupled whole-cell 
recordings with single-cell reverse-transcription polymerase chain reaction (RT-PCR) to 
simultaneously characterize both the electrophysiologic and genetic characteristics of the 
MSDB neurons. They described four distinct firing populations – slow-firing, burst-
firing, fast-firing, and slow/cluster-firing – alongside the three major singular 
neurochemical profiles. The choline acetyl-transferase (ChAT) positive cells 
(cholinergic) were identified as the slow-firing neurons, while the GAD67 neurons 
(GABAergic) were found to consist of burst and fast-firing populations. The novel 
VGLUT-positive neurons (glutamatergic) – identified via the sole presence of vGLUT1 
and/or vGLUT2 mRNA – demonstrated a stimulus-dependent slow/cluster firing rate. 
Small depolarizations resulted in the slow-firing activity, while depolarizations of up to -
45 mV (from a baseline of -60 mV) resulted in cluster firing and subthreshold membrane 
oscillations between clusters. This raised the question of whether these neurons – which 
were also thought to project to the hippocampus (Manns et al. 2001) – might be providing 
pacemaker activity to the hippocampal theta rhythm. Their connectivity with the 
parvalbumin neurons of the MSDB (Wu et al. 2003) suggests that they could also drive 
the disinhibitory GABAergic circuitry. 
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More extensive histologic investigation of this population was then performed by 
Colom et al., who estimated a population of approximately 16,000 glutamatergic neurons 
concentrated in the medial septum (Colom et al. 2005). Fluorogold-based retrograde 
tracing of injections from the CA1, CA3, and dentate gyrus demonstrated that MSDB 
glutamatergic neurons send projections to each region, comprising ~23% of the total 
septo-hippocampal projection. This suggests that this population may primarily be 
involved in local circuitry of the medial septum, but this contribution to 
septohippocampal circuitry cannot be discounted. Indeed, the authors hypothesized that 
the glutamatergic population was providing a necessary excitatory background for theta 
rhythm generation onset and maintenance (Colom et al. 2005). Manseau et al. would 
further explore this hypothesis (Manseau et al. 2005), demonstrating that glutamatergic 
neurons within the local MSDB network could generate excitatory inputs to cholinergic 
and GABAergic neurons, and that these glutamatergic neurons were in turn activated by 
muscarinic cholinergic inputs. 
Huh et al. further investigated the electrophysiologic properties of the MSDB 
glutamatergic neuron subpopulation, including their synaptic projections to the 
hippocampus, in septal and septohippocampal slices from transgenic mice expressing 
VGLUT2-driven enhanced green fluorescent protein (eGFP) (Huh et al. 2010). MSDB 
glutamatergic neurons demonstrated a broad range of firing patterns in this study. Cluster 
firing was again uniquely observed in this population, but the largest proportion of the 
subpopulation was fast firing. They also observed burst and slow firing subsets. All three 
of these firing patterns were shared with their GABAergic counterparts, and the fast-
firing glutamatergic neurons were extremely electrophysiologically similar to fast-firing 
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GABAergic neurons. Huh et al. also found that 21% of the fast-firing glutamatergic 
MSDB neurons recorded fired spontaneously at 4-12 Hz, with the remaining 
demonstrating little to no spontaneous firing. In contrast, 75% of fast-firing GABAergic 
neurons demonstrated spontaneous theta-range firing rates. The authors also 
demonstrated that at least a subset of glutamatergic MSDB neurons spontaneously fired 
at theta frequencies in the presence of both excitatory and inhibitory synaptic blockers. 
However, it should be noted that a greater proportion of the GABAergic neurons tested 
under the same conditions demonstrated spontaneous theta firing patterns. 
Huh et al. examined the glutamatergic projections from the medial septum to the 
hippocampus in a septohippocampal slice preparation (Huh et al. 2010). NMDA 
microinfusions into the MSDB directly stimulated the glutamatergic neurons, resulting in 
monosynaptic AMPA receptor-mediated glutamatergic responses in CA3 pyramidal 
neurons. The authors hypothesize – based on the presence of delayed IPSPs with 
electrical fornix stimulation – that the MSDB glutamatergic neurons also acted upon the 
hippocampal GABAergic interneurons. They proposed that the glutamatergic MSDB 
neurons serve to induce fast depolarizations that trigger hippocampal pyramidal cell 
firing, which if synchronous could contribute to theta oscillations. The local and 
projecting nature of these glutamatergic neurons may serve to contribute local excitatory 
drive in both the MSDB and the hippocampus, and coordinate oscillatory activity in the 
septohippocampal axis. 
In order to determine the contribution of MSDB glutamatergic neurons to 
hippocampal oscillatory activity, and evaluate the hypothesis that medial septal 
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glutamatergic neurons drive hippocampal theta activity, we optogenetically excited and 




2-3 month old adult male Sprague-Dawley rats (250-300g) were purchased from Charles 
River Laboratories (Wilmington, MA, USA). 2-3 month old adult male Long-Evans rats 
were bred as the non-expressing cage-mates of a Chat-CRE transgenic rat colony. 
Recordings from four rats were used in the excitation protocol, and three rats were used 
for inhibition. No differences were observed between the animals, and so the strains were 
grouped for all analyses. All animals were maintained within a 12/12 light/dark cycle 
vivarium with unlimited access to food and water. This work was conducted in 
accordance with Emory University’s Institute for Animal Care and Use Committee. 
Each subject underwent two surgical procedures. The first survival surgery 
introduced the viral vector to the medial septum and provided time for expression of the 
optogenetic channel. Rats were anesthetized with 1.5-4% inhaled isoflurane, and a 
craniectomy was made 0.40 mm anterior and 2.00 mm lateral to bregma on the right side 
of the skull. A pulled-glass pipette attached to a stereotactically mounted injector 
(Nanoject; Drummond Scientific Co., Broomall, PA, USA) was used to inject 1.8 µL of 
10
12
 particles/mL AAV2-CaMKIIα-hChR2(H134R)-EYFP (courtesy of Dr. Michael 
Kaplitt) or AAV2-CaMKIIα-eNpHR3.0-EYFP (UNC Vector Core Services, Chapel Hill, 
NC, USA). This promoter has been described as selectively expressing in the 
glutamatergic neurons of the MSDB (Kaifosh et al. 2013). The injection was made at a 
20° angle to the dorsal-ventral axis (0.40 mm anterior, 2.12 mm lateral at the 20° angle, 
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5.80 mm ventral to pia along the rotated axis) in order to target the medial septum 
without damaging the medially-located central sinus. After 5 minutes for equilibration, 
the injection was made over 7 minutes with the pipette remaining in place an additional 
10 minutes post-injection to prevent reflux. Once withdrawn, the scalp was stapled 
closed, ketofen was administered as an analgesic (3-5 mg/kg), and the rats were 
quarantined for 72 hours before returning to normal housing.  
 The second survival surgery was performed two weeks later. A second 
craniectomy was made over the right dorsal hippocampus centered at 3.50 mm posterior 
and 2.80 mm lateral to bregma. The dura was incised with a sterile curved scalpel blade. 
In order to record from the dorsal hippocampus 16-channel microwire multielectrode 
arrays (Tucker Davis Technologies (TDT), Alachua, FL., USA; MEA) were constructed 
from sixteen 33 µm diameter tungsten electrodes with polyimide insulation (Figure 4I). 
The electrodes were arranged in two rows of eight electrodes with 1 mm between rows 
and 175 µm of space between the electrodes within a row. Ground and reference wires 
were separated on the array and routed through two stainless steel wires, which were 
affixed to separate skull screws during the implantation surgery. The two rows were cut 
to different lengths, 4.0 mm and 3.0 mm, to target and record simultaneously from the 
hippocampal CA3 and CA1 regions, respectively, enabling multiunit and local field 
potential recording from the hippocampus distantly from the optical stimulation site in 
the medial septum. The array was positioned at a 50° angle to midline, with the posterior 
end swung laterally, to match the positioning of the hippocampal pyramidal cell layers 
pyramidal cell layers (Rolston et al. 2010). The MEA was lowered while simultaneously 
recording single unit and local field potential (LFP) activity to attain the ideal positioning 
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(Rolston et al. 2009). When the electrophysiologic recordings stabilized and the CA1 and 
CA3 layers were identified, the original injection craniectomy was reopened, and a 
calibrated optical fiber ferrule (Figure 4E, H) was implanted at a 20° angle to the dorsal-
ventral axis (0.40 mm anterior, 2.12 mm lateral in the rotated axis). Stimulation was 
performed as the ferrule was implanted, with the resulting recordings immediately 
analyzed spectrographically. Descent was halted when a strong stimulus-response signal 
was observed in the spectrogram, or when the optical ferrule reached a maximum depth 
of 5.50 mm from pia along the rotated axis.  
Once the electrodes and ferrules were in place, the craniectomy was sealed with 
dental acrylic (OrthoJet; Lang Dental; Wheeling IL), securing the array and ferrule in 
place in their respective targets. The rats were administered ketofen (3-5 mg/kg) to 
minimize pain and returned to normal housing to recover for 3-5 days before optical 
stimulation and recording experiments were performed. 
 
5.2.2 Optical stimulation and electrophysiologic recordings 
Using our adapted NeuroRighter system (CHAPTER III), electrophysiologic recordings 
were sampled at 25 kHz with a 1-9,000 Hz bandwidth. LFPs were isolated online with a 
1-500 Hz 1-pole Butterworth band-pass filter and downsampled to 2000 Hz. Action 
potentials were isolated online (Newman et al. 2013) and sorted using spike-sorting 
Wave_clus scripts and superparamagnetic clustering (Quiroga et al. 2004).  
 To stimulate awake and behaving animals, calibrated ferrules were connected via 
armored patch fiber cables (200 µm diameter, 0.67 NA, Plexon) to the NeuroRighter 
platform. ChR2 animals were stimulated with a 465 nm blue LED module. Square-wave 
stimulation pulses varied between 10, 30, and 50 mW/mm
2
; 7, 11 (theta), 17, 23, 35 
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(beta), and 42 (gamma) Hz; and 2, 5, and 10 ms pulse widths. eNpHR3.0 animals were 
inhibited with a 620 nm orange LED module. Square-wave stimulation pulses varied 
between 10, 30, 50, 70, and 90 mW/mm
2
; 7, 11 (theta), 17, 23, 35 (beta), and 42 (gamma) 
Hz; and 2, 5, and 10, 20, and 50 ms pulse widths. Continuous stimulation at 50, 70, and 
90 mW/mm
2
 was also performed. The experimental protocol consisted of repeated one 
minute recordings of 20 seconds of pre-stimulation background, 20 seconds of 
stimulation, and a subsequent 20 seconds of additional post-stimulation background. 
Stimulation protocols were performed in random order and repeated several times over 
multiple recording sessions. This setup was able to stimulate and record LFP and single-
unit responses from awake and behaving animals uninterrupted for several hours and over 
several days. Subjects were introduced into an open-field environment for the duration of 
the experiments. Data were recorded intraoperatively and for up to four weeks 
postoperatively. 
 
5.2.3 Data analysis 
We isolated recording days where we simultaneously recorded CA1 and CA3 single 
units, and selected those contacts with the highest amplitude and best-looking single units 
for further analysis. Power spectra, spectrograms, coherence, and coherograms were 
computed from the LFP on these channels using the Chronux suite of analysis tools and 
multitaper analysis (Bokil et al. 2010). For spectrum and coherence calculations, T=1, 
W=5 with 9 Slepian tapers. A Jackknife approach was used to calculate 95% confidence 
intervals. For spectrogram and coherogram analysis a moving window size of 4s was 
stepped in 0.5s increments, T=1, W=4 and 7 Slepian tapers. Note that these parameters 
sacrifice temporal specificity to gain greater resolution in frequency. As a result, edge 
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transitions in spectrograms and coherograms will be blurred into the pre and post-
stimulation epochs. Mean autocorrelation and cross-correlation between CA1 and CA3 
were performed to assess alterations in theta phase during the stimulation and non-
stimulation epochs, with 95% confidence intervals calculated and presented alongside the 
mean. 
 
5.2.4 Histology and Immunohistochemistry 
Histology was performed after experimentation to verify microelectrode recording 
locations and light-sensitive ion channel expression. Rats were deeply anesthetized with 
an overdose of Euthasol (5ml/kg, Virbac, Fort Worth, TX, U.S.A.) injected 
intraperitoneally. They were then transcardially perfused with 0.9% saline followed by 
4% paraformaldehyde in 0.1M phosphate buffer at pH 7.2. The heads, still containing the 
electrodes and ferrules, were then separated and post-fixed at 4°C overnight. The next 
day the brains were dissected out, removed, and cryoprotected with 30% sucrose at 4°C. 
Frozen transverse (horizontal) sections were made of 50 µm thickness on a sliding 
microtome and collected in 0.1M PBS.  
To identify the neurochemical identity of the transfected neurons, we performed 
immunofluorescence labelling for vesicular glutamate transporter 1 (vGLUT1), choline 
acetyltransferase (ChAT), and glutamic acid decarboxylase 67 (GAD67). Free-floating 
sections were rinsed in PBS, blocked in either 4% normal donkey serum (NDS, for 
ChAT) or 4% normal goat serum (NGS, for GAD/vGLUT1), and 0.1% Triton-X100 for 
30 min and rinsed in PBS. After PBS rinses, sections were incubated overnight at 4ºC in 
either goat anti-ChAT (1:100, Millipore) in PBS containing 1% NDS, mouse anti-GAD 
(1:1000, Millipore) in PBS containing 1% NGS, or mouse anti-vGLUT1 (1:1000, 
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Millipore) in PBS containing 1% NGS. Sections were rinsed in PBS and incubated in 
Alexa 488-conjugated donkey anti-goat (1:1000, Life Technologies) for ChAT or Alexa 
488-conjugated goat anti-mouse (1:1000, Life Technologies) for GAD and vGLUT1 in 
1% NDS (ChAT) or 1% NGS (GAD, vGLUT1) for 1 hour. All sections were additionally 
counterstained by incubation with 4’6-diamidino-2-phenylindole (DAPI) which labelled 
cell nuclei. Sections were rinsed in PBS and mounted on glass slides with Fluoromount-G 
mounting medium (Southern Biotech) for fluorescence microscopy. Sections were 
imaged in the NIS-Elements software (Nikon Instruments, Inc., Melville, NY, USA) 
using a Nikon DS-Fil color digital camera on a Nikon E400 microscope equipped with 
TRITC, FITC, and DAPI fluorescence cubes. 
  
5.3. RESULTS 
5.3.1 Histologic verification of channel expression 
Injection of AAV2-CaMKIIα based viral vectors produced robust expression in the 
medial septum (Figure 23), with expression limited to the medial septal nucleus (Figure 
23A). Horizontal sections revealed the axonal projections leaving the medial septum 
(Figure 23B). AAV2-CaMKIIα-eNPHR3.0 expression is not shown because those 




Figure 23: Robust expression of ChR2-mCherrry in the medial septum.  
AAV2-CaMKIIα-ChR2-mCherry injection produced robust ChR2-EYFP expression into the 
medial septum (red). Coronal slices (A) demonstrate the localization to the medial septum, while 
individual neurons and projections to the hippocampus were seen in horizontal slices (B). Blue is 
DAPI nuclei stain.  
 
 
 To confirm selective expression of the glutamatergic neurons of the medial 
septum, we performed immunofluorescence labeling for choline acetyltransferase (ChAT, 
Figure 24A), vesicular glutamate transporter 1 (vGLUT1, Figure 24B), and glutamic acid 
decarboxylase 67 (GAD67, Figure 24C). Coexpression of CaMKIIα-ChR2-mcherry 
puncta with identified cholinergic and GABAergic neurons was not observed. vGlut1 





Figure 24: CaMKIIα-ChR2 selectively expressed in glutamatergic neurons of the medial 
septum.  
CaMKIIα-ChR2 expressing neurons (red puncta) failed to colocalize with immunolabelled 
ChAT (A, green) or GAD (C, green) neurons. However, substantial colocalization was seen with 
the immunolabelled vGLUT1 neurons (B, green), suggesting ChR2 was selectively expressed in 




5.3.2 Rhythmic excitation of glutamatergic MSDB neurons 
5.3.2.1 Evoked LFP response waveforms 
To address the hypothesis that glutamatergic MSDB neurons can modulate hippocampal 
oscillatory activity, we selectively excited this population with hChR2(H134R) in pulse 
trains of varying width, amplitude, and frequency and examined the resulting 
hippocampal LFP response. Stimulation generated evoked potentials in both the CA1 and 
CA3 layers. Unlike GABAergic stimulation (Figure 14: CA3 LFP response as a function 
of stimulus intensity, frequency, and pulse width.Figure 14), these evoked potentials were 
not readily visible in the local field potential (Figure 25A). Averaging the response from 
each pulse across all parameters (peristimulus average) indicated that the evoked 
potential waveform was highly dependent upon stimulation parameters (Figure 25B). 
Light intensity was the most important influence, as low intensity stimulation failed to 
produce a recognizable response, and the amplitude of the response was reduced 
compared to the GABAergic response (Figure 14). At high intensities, stimulation 
produced isolated evoked potential waveforms at up to 35 Hz that also increased in 
amplitude with pulse width. At low gamma frequencies (42 Hz), however, the evoked 




Figure 25: CA3 LFP response as a function of stimulus intensity, frequency, and pulse 
width. 
Stimulation of the glutamatergic neurons of the medial septum generated evoked potentials in the 
hippocampal LFP. (A) An example CA3 LFP recording during 50 mW/mm
2
, 7 Hz, 10ms 
excitation (blue bar). (B) Calculating the peristimulus average (thick line is mean, shaded area is 
standard deviation) response in CA3 across each of the stimulation protocols demonstrated that 
the evoked potential waveform was highly dependent on the stimulation parameters. Intensity 
was most important, with low-intensity stimulation barely influencing LFP. Low-frequency 
stimulation (7-35 Hz) produced defined waveform peaks, particularly at long pulse-widths. At 





5.3.2.2 Frequency-specific responses to excitation in both layers 
Spectral analysis was performed to evaluate the impact of stimulation on hippocampal 
oscillatory activity. We observed a statistically significant stimulus-frequency specific 
increase in power during the stimulation epoch relative to the pre-stimulation epoch, as 
well as harmonics of that stimulation frequency, in both of the CA1 and CA3 
hippocampal layers (Figure 26). We also noted significant (p<0.05) reduction in theta 
power at frequencies other than the stimulation frequency. CA1-CA3 coherence 
demonstrated increased coherence at stimulation harmonics as well, but not at the 
stimulation frequency, similarly to that seen with MSDB GABAergic stimulation (Figure 
15). This may also be a result of cross-subject grouping. 
 Stimulating the glutamatergic neurons at other frequencies also produced a 
significant (p<0.05) stimulus-frequency specific response in the hippocampal LFP 
(Figure 27), directly transmitting the stimulation pattern to both layers of the 
hippocampus. With 35 Hz stimulation a slight decrease in power within theta frequencies 





Figure 26: CA1 and CA3 demonstrate stimulation theta frequency-specific increases in 
power with theta stimulation.  
Stimulation was performed at 50 mW/mm
2
, 7 Hz, and 10 ms, and the pre-stimulus (black), post-
stimulus (red) and stimulus (blue) epochs across all trials were separated and spectrally 
examined for changes in power. 95% confidence intervals were calculated for each epoch using a 
Jackknife approach (dashed lines). Statistically significant (p<0.05) increases in power at the 
stimulus frequency were demonstrated in both the CA1 (A) and CA3 (B) layers, alongside 
stimulation harmonics. Theta power at frequencies other than 7 Hz was slightly, yet significantly, 
reduced during stimulation (D,E). No significant difference in power was noted between the pre- 
and post-stimulation epochs. CA1-CA3 coherence at the stimulation frequency (C) demonstrated 




Figure 27: Stimulus-frequency specific increases in spectral power with 35 Hz stimulation. 
 Stimulating with 50 mW/mm
2
, 35 Hz, 10 ms pulses also significantly (p<0.05) increased power 
at the stimulus frequency, as well as significantly reduced hippocampal theta power in both 
layers, although it affected CA3 to a greater extent than CA1. Unlike 7 Hz glutamatergic 
stimulation (Figure 25), 35 Hz resulted in a large increase in CA1-CA3 coherence, and also 
increased coherence at delta frequencies. 
 
 
Spectrograms were calculated to examine the temporal specificity and consistency of the 
response to stimulation (Figure 28, Figure 29). Responses were temporally locked to 
stimulation onset and offset (blue bar) and were consistently represented at the 
stimulation frequency. Reductions in theta power were noted in both cases, with CA1 
theta more influenced by 7 Hz stimulation (Figure 28 A) and CA3 by 35 Hz stimulation 
(Figure 29 B). A statistically significant (p<0.05) increase in CA1-CA3 coherence, along 
with a consistent phase relationship, was noted with 35 Hz stimulation (Figure 29 C, D) 





Figure 28: Temporal specificity of the spectrographic and coherence response to 7 Hz 
stimulation.  
Stimulation of MSDB glutamatergic neurons with 50 mW/mm
2
, 7 Hz, 10 ms pulses (blue bar) 
consistently increased hippocampal power at the stimulus frequency in both CA1 (A) and CA3 
(B), alongside decreased power <7 Hz in CA1. While there was a non-significant (p>0.05) 
increase in coherence amplitude (C) at the stimulation frequency, examination of the angle of the 
coherence (D, black arrow at stimulus frequency) suggests that the responses in CA1 and CA3 
may have maintained a particular phase relationship during stimulation. Note no lasting effects 
from stimulation into the post-stimulation epoch. Blurring of the edges is due to the wide moving 





Figure 29: Temporal specificity of the spectrographic and coherence response to 35 Hz 
stimulation.  
Stimulation of MSDB glutamatergic neurons with 50 mW/mm
2
, 35 Hz, 10 ms pulses (blue bar) 
also consistently and robustly increased hippocampal power at the stimulus frequency in both 
CA1 (A) and CA3 (B), as well as decreased theta power. Notice that this was more pronounced in 
CA3 in higher frequency theta. In contrast to 7 Hz stimulation (Figure 27), there was a significant 
(p<0.05) increase in coherence amplitude (C) at the stimulation frequency. This was accompanied 
by a consistent phase relationship (D, black arrow). 
 
 
5.3.2.3 Phase-locking to the theta stimulus pattern 
To explore the phase relationship within the hippocampal layers, as well as between 
them, we evaluated the autocorrelation of the CA1 and CA3 signals, respectively, in 
response to theta (7 Hz) stimulation, as well as the cross-correlation between the layers 
(Figure 30). If the induced oscillations were locked in phase and amplitude throughout 
the stimulation epoch (Figure 30, blue), then we would observe peaks in the correlation at 
stimulation lag times. Both CA1 and CA3 signals demonstrated significantly (p<0.05) 
correlated peaks at lags corresponding to the stimulus frequency (Figure 30). These peaks 
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were consistent well into the lags, indicating that the hippocampal oscillation remained in 
phase as a result of the stimulus. The CA1-CA3 correlation was not significant from pre-
stimulus, but did suggest a negative correlation between CA1 and CA3 (out of phase) 
with each stimulus. This is in contrast to what was observed with GABAergic stimulation 





Figure 30: Auto and cross-correlation properties indicate phase-locking to stimulus pulses.  
Autocorrelation of the CA1 and CA3 LFP-signal demonstrated a consistently significant (p<0.05) 
increase in correlation at the stimulus frequency – as compared to the pre and post-stimulus 
epochs, suggesting that the LFP response was phase-locked to the stimulus pattern. Cross-
correlation between CA1 and CA3 was not significant (p>0.05), but suggested CA1 and CA3 
were anticorrelated and out of phase with each stimulus. Dark line is the mean. Shaded area is 





5.3.3 Inhibition of MSDB glutamatergic neurons 
Whereas the preceding experiments explored the capability of the MSDB glutamatergic 
neurons to modulate and drive hippocampal oscillatory activity, the following work 
utilizes optogenetic inhibition to demonstrate the necessity of MSDB glutamatergic 
neurons for hippocampal theta oscillations.  
 




, 35 Hz, 10 ms inhibition of MSDB glutamatergic neurons failed 
to generate statistically meaningful responses in either the CA1 or CA3 hippocampal 






Figure 31: Rhythmic inhibition at 35 Hz does not alter hippocampal spectral power. 
 Inhibitory stimulation was performed at 90 mW/mm
2
, 35 Hz, and 10 ms, and the pre-stimulus 
(black), post-stimulus (red) and inhibitory stimulus (orange) epochs across all trials were 
separated and spectrally examined for changes in spectral power. 95% confidence intervals were 
calculated for each epoch using a Jackknife approach (dashed lines). No statistically significant 
changes in power or coherence were noted at any observed frequency. 
 
 
5.3.3.2 Constant 90 mW/mm
2
 inhibition of MSDB glutamatergic neurons does not alter 
hippocampal LFP power, but may impact theta-phase maintenance. 
To examine the necessity of MSDB glutamatergic neurons for awake hippocampal theta 
power, we performed constant 90 mW/mm
2
 inhibition for 20 seconds. Inhibition in this 
fashion did not alter hippocampal spectral power at any frequency (Figure 32A, B), nor 






Figure 32: Constant inhibition of MSDB glutamatergic neurons does not alter hippocampal 
oscillatory power.  
Constant inhibition of the MSDB GABAergic neurons for 20 seconds at 90 mW/mm
2
 (orange 
bar) failed to significantly alter hippocampal power at any frequency in either CA1 (A) and CA3 
(B) from the pre-stimulus epoch. Similarly, no alterations between the pre-stimulus and post-
stimulus epochs were seen in the coherogram (C) or the phase coherence (D). 
 
 
Intriguingly, however, constant 90 mW/mm
2
 inhibition of the MSDB glutamatergic 
neurons did impact theta phase relationships as assessed by auto and cross-correlation 
(Figure 33). Constant inhibition significantly (p<0.05) reduced the maintenance of a 
consistent phase within CA1 and CA3, and between the layers. The initial lag (Figure 33, 
blue arrow), which corresponds to the most proximal cycle, only trended towards 
significance (p>0.05), but successive oscillatory cycles (Figure 33, green arrow) 
demonstrated a more pronounced and statistically significant difference between the pre-
stimulus and stimulus epochs. This indicates that during inhibition theta was not 
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maintaining the same phase relationship with successive cycles as it had during the pre-
stimulus epoch. During constant inhibition of the glutamatergic neurons of the medial 
septum, theta oscillatory phase was not maintained, in contrast to GABAergic (Figure 22) 
and cholinergic (Figure 44) inhibition. This effect continued into the post-stimulus epoch 
as well (red). While it is unclear why this particular effect persisted beyond the stimulus 
epoch, it may be a result of a more profound disturbance in network synchronicity. The 
MSDB and hippocampal network, in response to glutamatergic inhibition, may require 





Figure 33: Constant inhibition may alter consistency of hippocampal phase and phase 
synchrony between CA1 and CA3.  
A non-significant trend (p>0.05) towards a less-correlated signal at the first theta lag (blue 
arrow) was noted in the autocorrelation. The differences became significant (p<0.05) at 
successive lags (green arrow), however, indicating that hippocampal theta phase was not 
maintained as during the pre-stimulus epoch (black trace). CA1-CA3 correlation, and phase 





Rhythmic optogenetic stimulation of glutamatergic MSDB neurons directly transmitted 
the stimulus frequency pattern to both the CA1 and CA3 hippocampal layers, supporting 
anatomical evidence that this population directly innervates both layers (Colom et al. 
2005). It should be noted that this response could have been routed through the MSDB 
GABAergic population (CHAPTER IV) via local circuitry, which in turn would drive the 
hippocampus. However, the pulse-response times between GABAergic and glutamatergic 
stimulation – despite the difference in amplitude – possessed nearly identical delays. 
Were the path truly bisynaptic – as opposed to the monosynaptic GABAergic 
disinhibitory circuit – one would expect a greater delay in transmission, as well as greater 
variability in response time. In addition, cross-correlation analysis between CA1 and 
CA3 in both cases indicated GABAergic stimulation produced a lead-lag response in the 
layers, whereas glutamatergic stimulation produced an anticorrelated (opposing phase) 
relationship. This suggests that the results observed are acting, at least in part, through 
direct projections to the hippocampus. However we cannot rule out local MSDB circuitry 
effects without proper blockade of glutamatergic synaptic input. 
 Our results also suggest that while glutamatergic MSDB neurons were not 
necessary for theta power – which was unaffected by inhibition – they do appear to be 
play a role in maintenance of theta phase. During the stimulus epoch, autocorrelation 
analysis indicated that theta phase was not as consistent on successive cycles, as 
compared to the pre-stimulus epoch, which maintained the same theta phase dynamics 
seen in other interventions (Figure 22).  
This finding supports the hypothesis that glutamatergic MSDB neurons are pacing 
hippocampal theta activity, in that they are coordinating theta so that consistent phase 
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relationships are maintained. The glutamatergic neurons are well positioned to do so, 
synapsing onto the local GABAergic and cholinergic neurons of the medial septum 
(Manseau et al. 2005), as well as in the hippocampus (Colom et al. 2005). More rigorous 
experimentation and analysis is necessary, however, to confirm this effect, as well as to 
explore why this particular effect continued into the post-stimulus epoch. Specific 
examination of this effect during particular behavioral paradigms (locomotion, Morris 
water maze) will provide greater insight into the functional consequences of manipulating 
this neural population. 
 These results also lends support to the growing evidence that MSDB theta 
is a combinatorial effect (Yoder and Pang 2005). Local and projecting glutamatergic 
input in the septohippocampal axis may modulate and synchronize extant theta 
oscillations generated through the MSDB, entorhinal, or intrinsic hippocampal circuits – 
and may be just one of several methods by which this can be accomplished.  
 
5.5. CONCLUSIONS 
Medial septal glutamatergic neurons, when synchronously activated optogenetically, 
produce stimulation-frequency specific activity in both CA1 and CA3 local field 
potential, supporting anatomic evidence that these neurons innervate both layers of the 
hippocampus. Glutamatergic neurons were capable of modulating theta oscillations – as 
well as other frequencies. Intriguingly, inhibition of this population resulted in a failure 
of the hippocampus to maintain a consistent theta phase as compared to the pre-stimulus 
epoch. This effect maintained during the post-stimulus epoch, and is potentially a result 
of temporary network desynchronization. This lends support to the hypothesis that 
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glutamatergic neurons of the medial septum serve to coordinate and pace hippocampal 





OPTOGENETIC MODULATION OF MEDIAL SEPTAL 
CHOLINERGIC NEURONS AND THE IMPACT ON 




Substantial evidence implicates the medial septum-diagonal band complex (MSDB) in 
the generation and maintenance of the theta rhythm in the hippocampus (Stewart and Fox 
1990; Tóth et al. 1997; Buzsáki 2002; Huh et al. 2010). Three genetically-distinct neuron 
subpopulations have been identified within the MSDB – GABAergic, glutamatergic, and 
cholinergic neurons – all of which project to the hippocampus and may play a role in 
modulating hippocampal activity and theta oscillations (Freund and Antal 1988; Sotty et 
al. 2003; Yoder and Pang 2005; Huh et al. 2010; Bell et al. 2013). Cholinergic MSDB 
neurons have long been recognized as an important input to the hippocampus (Lewis et 
al. 1967; Frotscher and Léránth 1985), and implicated as a mediator of theta oscillations 
(Konopacki et al. 1987). 
 Cholinergic afferents from the medial septum contact both pyramidal and 
inhibitory neurons of the hippocampus (Lewis et al. 1967; Frotscher and Léránth 1985), 
and early hypotheses reasoned that they were providing excitatory cholinergic input to 
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hippocampal interneurons in order to pace the theta rhythm (Stewart and Fox 1990). 
However, this hypothesis soon lost favor, as evidence for the GABAergic population 
emerged (Tóth et al. 1997) and excitatory input from the septum was not observed 
(Stewart and Fox 1990). Yet the presence of induced theta activity in hippocampal slices 
via muscarinic agonists suggested that cholinergic inputs still played an important role in 
this oscillatory rhythm (Konopacki et al. 1987).  It has been argued that the theta 
oscillations generated in these reduced preparations did not reflect naturally occurring 
theta (Stewart and Fox 1990; Williams and Kauer 1997). But muscarinic agonists 
delivered to the medial septum in awake animals are able to induce the theta rhythm, 
alongside behaviors associated with theta (Monmaur and Breton 1991). 
 Whereas cholinergic lesions in urethane anesthetized rats abolished theta power, 
lesions in behaving unanesthetized animals of the cholinergic neurons only attenuated it 
(Yoder and Pang 2005). Yoder et al. suggested that the medial septum was consequently 
only important for atropine-sensitive theta (theta II), a component of theta in the awake 
and locomoting animal. Further experiments demonstrated that nicotine recruited the 
newly-discovered MSDB glutamatergic neurons to excite MSDB GABAergic neurons 
(Wu et al. 2003). Cholinergic input might then serve as a sort of gain control – providing 
the necessary background for theta to occur in the septohippocampal axis, but not directly 
pacing its activity. This was also in agreement with electrophysiologic investigations in 
anesthetized and unanesthetized rats of the cholinergic neurons of the medial septum, 
which tended to fire too slowly (~0.3-0.5 Hz) to drive theta oscillations directly (Simon et 
al. 2006), although other work in slice preparations suggested that they may fire in the 
appropriate range (Sotty et al. 2003).  
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 Recently, an elegant series of experiments performed by Karen and Andrew Bell 
et al. used optogenetic methods to control medial septal acetylcholine release in brain 
slices and dissect the muscarinic and nicotinic inputs to the hippocampal CA1 inhibitory 
interneurons (Bell et al. 2011; Bell et al. 2013). They demonstrated that nicotinic input to 
these interneurons produced EPSPs mediated by the activation of α4β2* nicotinic 
receptors (Bell et al. 2011). These EPSPs had slow kinetics of hundreds of milliseconds 
in duration, and were mostly subthreshold for activation, making them favorable for 
integration with other synaptic inputs.  
Muscarinic inputs to CA1 interneurons, however, produced a more heterogeneous 
response – depolarizing, hyperpolarizing, and biphasic (Bell et al. 2013). The authors 
determined that hyperpolarization was mediated by M4 receptors, and required less 
cholinergic presynaptic input as compared to depolarization. Depolarizing responses – 
correlated with higher levels of induced presynaptic activity – were not mediated by M1, 
M4, or M5 receptors, and the role of M2 and M3 receptors was unclear as the necessary 
highly selective drugs are unavailable.  Interestingly, while stimulation alone failed to 
produce action potentials in this population, stimulation during synaptically-induced 
depolarization was able to do so. Biphasic interneurons could furthermore be entrained to 
fire bursts of action potentials with rhythmic flashes of light. This extensive work 
suggests that cholinergic input from the medial septum to the hippocampus can place the 
inhibitory interneurons in a primed state of subthreshold activation. As cholinergic input 
also activates the glutamatergic population of the medial septum, which in turn activates 
the GABAergic disinhibitory network (Wu et al. 2003), cholinergic activity in the MSDB 
may not only prime the hippocampus for rhythmic input, but may also activate the 
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pacemaking and driving functions of the medial septum. Thus cholinergic activity would 
generate excited and inhibited states, with low activity hyperpolarizing hippocampal 
inhibitory interneurons (Bell et al. 2013) thus preventing theta oscillations, and high 
activity supporting it.  
 In order to test the hypothesis that MSDB cholinergic neurons modulate 
hippocampal theta activity, we used optogenetics to selectively excite and inhibit this 
population in awake and behaving animals. Optogenetic tools provide a powerful 
methods for genetically and temporally precise manipulation of complex heterogeneous 
nervous system circuitry (Aravanis et al. 2007; Carter et al. 2009; Gradinaru et al. 2009; 
Kravitz et al. 2010; Yizhar et al. 2011; Packer et al. 2012; Wykes et al. 2012; Paz et al. 
2013). When combined with electrophysiological recordings, optogenetic control can 
provide unprecedented insight into neural connectivity and function (Bell et al. 2013), 




2-3 month old (250-300g) adult male ChAT-CRE Long-Evans rats (Witten et al. 2011) 
were bred from our transgenic rat colony (founder male courtesy of Dr. Karl Deisseroth). 
Six rats were used in the excitation group, and three rats were used in the inhibition 
group. No differences were seen between the animals, and so the recordings were 
grouped for all analyses. All animals were maintained within a 12/12 light/dark cycle 
vivarium with unlimited access to food and water. This work was conducted in 
accordance with Emory University’s Institute for Animal Care and Use Committee. 
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Each subject underwent two surgical procedures. The first survival surgery 
introduced the viral vector to the medial septum and provided time for expression of the 
optogenetic channel. Rats were anesthetized with 1.5-4% inhaled isoflurane, and a 
craniectomy was made 0.40 mm anterior and 2.00 mm lateral to bregma on the right side 
of the skull. A pulled-glass pipette attached to a stereotactically mounted injector 
(Nanoject; Drummond Scientific Co., Broomall, PA, USA) was used to inject 1.8 µL of 
10
12
 particles/mL double-floxed inverted opsin AAV5-EF1a-DIO-hChR2(H134R)-
mCherry or AAV5-EF1a-DIO-eNpHR3.0-EYFP (UNC Vector Core Services, Chapel 
Hill, NC, USA.). This Cre-lox system has demonstrated effectiveness in selectively 
expressing in the cholinergic neurons of the medial septum (Witten et al. 2011). The 
injection was made at a 20° angle to the dorsal-ventral axis (0.40 mm anterior, 2.12 mm 
lateral at the 20° angle, 5.80 mm ventral to pia along the rotated axis) in order to target 
the medial septum without damaging the medially-located central sinus. After 5 minutes 
for equilibration, the injection was made over 7 minutes with the pipette remaining in 
place an additional 10 minutes post-injection to prevent reflux. Once withdrawn, the 
scalp was stapled closed, ketofen was administered as an analgesic (3-5 mg/kg), and the 
rats were quarantined for 72 hours before returning to normal housing.  
 The second survival surgery was performed two weeks later. A second 
craniectomy was made over the right dorsal hippocampus centered at 3.50 mm posterior 
and 2.80 mm lateral to bregma. The dura was incised with a sterile curved scalpel blade. 
In order to record from the dorsal hippocampus 16-channel microwire multielectrode 
arrays (Tucker Davis Technologies (TDT), Alachua, FL., USA; MEA) were constructed 
from sixteen 33 µm diameter tungsten electrodes with polyimide insulation (Figure 4I). 
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The electrodes were arranged in two rows of eight electrodes with 1 mm between rows 
and 175 µm of space between the electrodes within a row. Ground and reference wires 
were separated on the array and routed through two stainless steel wires, which were 
affixed to separate skull screws during the implantation surgery. The two rows were cut 
to different lengths, 4.0 mm and 3.0 mm, to target and record simultaneously from the 
hippocampal CA3 and CA1 regions, respectively, enabling multiunit and local field 
potential recording from the hippocampus distantly from the optical stimulation site in 
the medial septum. The array was positioned at a 50° angle to midline, with the posterior 
end swung laterally, to match the positioning of the hippocampal pyramidal cell layers 
pyramidal cell layers (Rolston et al. 2010). The MEA was lowered while simultaneously 
recording single unit and local field potential (LFP) activity to attain the ideal positioning 
(Rolston et al. 2009). When the electrophysiologic recordings stabilized and the CA1 and 
CA3 layers were identified, the original injection craniectomy was reopened, and a 
calibrated optical fiber ferrule (Figure 4E, H) was implanted at a 20° angle to the dorsal-
ventral axis (0.40 mm anterior, 2.12 mm lateral in the rotated axis). Stimulation was 
performed as the ferrule was implanted, with the resulting recordings immediately 
analyzed spectrographically. Descent was halted when a strong stimulus-response signal 
was observed in the spectrogram, or when the optical ferrule reached a maximum depth 
of 5.50 mm from pia along the rotated axis.  
Once the electrodes and ferrules were in place, the craniectomy was sealed with 
dental acrylic (OrthoJet; Lang Dental; Wheeling IL), securing the array and ferrule in 
place in their respective targets. The rats were administered ketofen (3-5 mg/kg) to 
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minimize pain and returned to normal housing to recover for 3-5 days before optical 
stimulation and recording experiments were performed. 
 
6.2.2 Optical stimulation and electrophysiologic recordings 
Using our adapted NeuroRighter system (CHAPTER III), electrophysiologic recordings 
were sampled at 25 kHz with a 1-9,000 Hz bandwidth. LFPs were isolated online with a 
1-500 Hz 1-pole Butterworth band-pass filter and downsampled to 2000 Hz. Action 
potentials were isolated online (Newman et al. 2013) and sorted using spike-sorting 
Wave_clus scripts and superparamagnetic clustering (Quiroga et al. 2004).  
 To stimulate awake and behaving animals, calibrated ferrules were connected via 
armored patch fiber cables (200 µm diameter, 0.67 NA, Plexon) to the NeuroRighter 
platform. ChR2 animals were stimulated with a 465 nm blue LED module. Square-wave 
stimulation pulses varied between 10, 30, and 50 mW/mm
2
; 7, 11 (theta), 17, 23, 35 
(beta), and 42 (gamma) Hz; and 2, 5, and 10 ms pulse widths. eNpHR3.0 animals were 
inhibited with a 620 nm orange LED module. Square-wave stimulation pulses varied 
between 10, 30, 50, 70, and 90 mW/mm
2
; 7, 11 (theta), 17, 23, 35 (beta), and 42 (gamma) 
Hz; and 2, 5, and 10, 20, and 50 ms pulse widths. Continuous stimulation at 50, 70, and 
90 mW/mm
2
 was also performed. The experimental protocol consisted of repeated one 
minute recordings of 20 seconds of pre-stimulation background, 20 seconds of 
stimulation, and a subsequent 20 seconds of additional post-stimulation background. 
Stimulation protocols were performed in random order and repeated several times over 
multiple recording sessions. This setup was able to stimulate and record LFP and single-
unit responses from awake and behaving animals uninterrupted for several hours and over 
several days. Subjects were introduced into an open-field environment for the duration of 
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the experiments. Data were recorded intraoperatively and for up to four weeks 
postoperatively. 
 
6.2.3 Data analysis 
We isolated recording days where we simultaneously recorded CA1 and CA3 single 
units, and selected those contacts with the highest amplitude and best-looking single units 
for further analysis. Power spectra, spectrograms, coherence, and coherograms were 
computed from the LFP on these channels using the Chronux suite of analysis tools and 
multitaper analysis (Bokil et al. 2010). For spectrum and coherence calculations, T=1, 
W=5 with 9 Slepian tapers. A Jackknife approach was used to calculate 95% confidence 
intervals. For spectrogram and coherogram analysis a moving window size of 4s was 
stepped in 0.5s increments, T=1, W=4 and 7 Slepian tapers. Note that these parameters 
sacrifice temporal specificity to gain greater resolution in frequency. As a result, edge 
transitions in spectrograms and coherograms will be blurred into the pre and post-
stimulation epochs. Mean autocorrelation and cross-correlation between CA1 and CA3 
were performed to assess alterations in theta phase during the stimulation and non-
stimulation epochs, with 95% confidence intervals calculated and presented alongside the 
mean.Single-unit firing rates were assessed using the Chronux locfit density command 
(Bokil et al. 2010). We used a rate density-estimation type family, and smoother with a 
nearest neighbor parameter of 0.2 (20% of the nearest data points were used). In the case 
of single recordings, histograms of the number of spikes detected in 1 second bins were 




6.2.4 Histology and immunohistochemistry 
Histology was performed after experimentation to verify microelectrode recording 
locations and light-sensitive ion channel expression. Rats were deeply anesthetized with 
an overdose of Euthasol (5ml/kg, Virbac, Fort Worth, TX, U.S.A.) injected 
intraperitoneally. They were then transcardially perfused with 0.9% saline followed by 
4% paraformaldehyde in 0.1M phosphate buffer at pH 7.2. The heads, still containing the 
electrodes and ferrules, were then separated and post-fixed at 4°C overnight. The next 
day the brains were dissected out, removed, and cryoprotected with 30% sucrose at 4°C. 
Frozen transverse (horizontal) sections were made of 50 µm thickness on a sliding 
microtome and collected in 0.1M PBS.  
To identify the neurochemical identity of the transfected neurons, we performed 
immunofluorescence labelling choline acetyltransferase (ChAT. Free-floating sections 
were rinsed in PBS, blocked in either 4% normal donkey serum (NDS, for ChAT) and 
0.1% Triton-X100 for 30 min and rinsed in PBS. After PBS rinses, sections were 
incubated overnight at 4ºC in goat anti-ChAT (1:100, Millipore) in PBS containing 1% 
NDS. Sections were rinsed in PBS and incubated in Alexa 488-conjugated donkey anti-
goat (1:1000, Life Technologies) in 1% NDS (ChAT) for 1 hour. All sections were 
additionally counterstained by incubation with 4’6-diamidino-2-phenylindole (DAPI) 
which labelled cell nuclei. Sections were rinsed in PBS and mounted on glass slides with 
Fluoromount-G mounting medium (Southern Biotech) for fluorescence microscopy. 
Sections were imaged in the NIS-Elements software (Nikon Instruments, Inc., Melville, 
NY, USA) using a Nikon DS-Fil color digital camera on a Nikon E400 microscope 





6.3.1 Histologic verification of channel expression 
Injection of AAV5-EF1a-DIO viruses into positively genotyped ChAT-CRE transgenic 
rats produced robust expression in cholinergic neurons of the medial septum (Figure 34). 
Both AAV5-EF1a-DIO-ChR2-mCherry (Figure 34A) and AAV5-EF1a-DIO-eNPHR3.0-
EYFP (Figure 34B) were found to express in the region. ChR2-mCherry expression 
colocalized with cholinergic neurons of the medial septum, supporting cell-type 




Figure 34: Robust and selective expression of ChR2-mCherry in transgenic Chat-CRE 
medial septal cholinergic neurons. 
Expression in the medial septum of AAV5-EF1a-DIO viruses in ChAT-CRE transgenic rats was 
readily observed (A) ChR2-mCherry expressing neurons (red) were observed in the medial 
septum. (B) eNpHR3.0-EYFP (green) expression was also observed post-injection. (C) MSDB 
ChR2 expressing neurons (red) colocalized with immunofluorescently labelled cholinergic 
neurons (ChAT, green). DAPI nuclei stain in blue.  
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6.3.2 Rhythmic excitation of cholinergic MSDB neurons 
6.3.2.1 Rhythmic cholinergic MSDB stimulation fails to alter hippocampal LFP dynamics 
at any stimulation frequency 
To assess the hypothesis that MSDB cholinergic activity modulates hippocampal theta 
activity, we selectively excited the cholinergic MSDB neurons with hChR2(H134R) in 
pulse trains of varying width, amplitude, and frequency, and examined the resultant 
hippocampal LFP response. Unlike GABAergic (Figure 14) and glutamatergic (Figure 
25) stimulation, however, no visible response in the local field potential to any 
stimulation pattern was observed in either layer of the hippocampus. Peristimulus 




Figure 35: Rhythmic 7 Hz cholinergic stimulation fails to alter hippocampal LFP power 
Stimulating with 50 mW/mm2, 7 Hz, 10 ms pulses failed to alter hippocampal power in either 




Figure 36: Rhythmic 7 Hz cholinergic stimulation fails to alter hippocampal LFP power and 
coherence 
Stimulation of MSDB cholinergic neurons with 50 mW/mm2, 7 Hz, 10 ms pulses (blue bar) 
did not alter power at any frequency in either CA1 (A) or CA3 (B), nor did it alter coherence 
amplitude (C) or phase (D).  
 
 
 As cholinergic neurons are thought to be slow firing, we explored whether 
stimulus frequency had an impact on hippocampal LFP. Spectral and coherence analysis 
of 7 Hz (Figure 35, Figure 36) and 35 Hz (Figure 37, Figure 38) stimulation also did not 
reveal any significant differences between the pre-stimulation and stimulation epochs 




Figure 37: Rhythmic 35 Hz cholinergic stimulation fails to alter hippocampal LFP power 
Stimulating with 50 mW/mm
2
, 35 Hz, 10 ms pulse trains failed to alter hippocampal power in 






Figure 38: 35 Hz stimulation of MSDB cholinergic neurons fails to alter hippocampal power 
or coherence 
Stimulation of MSDB cholinergic neurons with 50 mW/mm
2
, 35 Hz, 10 ms pulses (blue bar) did 
not alter power at any frequency in either CA1 (A) or CA3 (B), nor did it alter coherence 
amplitude (C) or phase (D).  
 
 
Similarly, theta phase as assessed by autocorrelation analysis was not altered by 





Figure 39: 7 Hz stimulation does not alter theta phase in CA1 or CA3 
No significant changes in the auto-correlation signal were between the pre-stimulus (black) and 
stimulus (blue) epochs was seen during 50 mW/mm
2
, 7 Hz, 10ms stimulation.  
 
 
6.3.2.2 CA3 Single-unit firing rate changes observed during implantation under 
anesthesia 
During implantation of two animals, we observed single-unit firing rate changes in the 
CA3 layer in response to 50 mW/mm
2
, 35 Hz, 10 ms stimulation of MSDB cholinergic 
neurons in two animals. These firing rate changes were profound and coincided with 
stimulation onset (Figure 40). Some units decreased their firing rate (Figure 40A) 
whereas others increased (Figure 40B). This could occur in the same stimulation session. 
In one case (Figure 40B), firing rate increase was associated with a decrease in power 
>40 Hz in the LFP. This was not seen for decreased firing rates, nor in the awake animal. 
These results suggest that our targeting and stimulation parameters were effective, but 





Figure 40: Single-unit response to stimulation during surgical implantation 
In two animals we noted profound single-unit firing rate changes at the target site during surgery 
and under isoflurane anesthesia. Two example units from the same animal and the same 
stimulation/recording session are illustrated here (A,B). Unit A had a marked decrease in firing 
rate with 50 mW/mm
2
, 35 Hz, 10ms onset (A2) that was unaccompanied by any noticeable 
changes in hippocampal LFP (A3). Unit B, on the other hand, increased its firing rate in response 
to stimulation (B2). Note that there was a decrease in LFP power >40 Hz accompanying this 
firing rate increase. 
 
 
6.3.2.3 Three isolated CA3 and CA1 single units reduced their firing rate in response to 
50 mW/mm
2
, 35 Hz, 10 ms stimulation of cholinergic neurons of the medial septum 
Based on the single-unit results under anesthesia, we examined single-unit firing rate 
changes during stimulation in 50 mW/mm
2
, 35 Hz, 10 ms cholinergic stimulation 
recordings. We isolated 77 putative neurons, most of which did not possess demonstrable 
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changes in firing rate during excitation. However, we identified three neurons – one from 
CA3 and two from CA1 – whose firing rates consistently decreased in response to ChR2 
stimulation in multiple trials (Figure 41), as evidenced by the rate estimation functions 







Figure 41: Three CA1 and CA3 single units reduced their firing rate in response to 50 
mW/mm
2
, 35 Hz, 10 ms stimulation of cholinergic MSDB neurons 
Three neurons – two from CA1 (black, red), one from CA3 (green) responded to stimulation of 
MSDB cholinergic neurons with 50mW/mm
2
, 35 Hz, 10 ms stimulation (blue area) with a 
reduction in firing rate. Dashed lines are 95% confidence intervals, while solid lines are the 
estimated smoothed firing rate. Lighter traces in the same color reflect the single unit waveforms 




6.3.3 Inhibition of MSDB cholinergic neurons 
It’s possible that the lack of response to cholinergic stimulation was due to maximal 
activation of cholinergic activity, wherein additional cholinergic stimulation may not 
significantly alter theta power or hippocampal activity. Thus, we sought to test whether 
optogenetic inhibition of cholinergic MSDB neurons would alter hippocampal theta 




Figure 42: Rhythmic inhibition at 35 Hz does not alter hippocampal spectral power. 
Rhythmic inhibition of the MSDB cholinergic neurons for with 90 mW/mm
2
 (orange bar) failed 
to significantly alter hippocampal power at any frequency in either CA1 (A) and CA3 (B) from 
the pre-stimulus epoch. No significant differences were noted between the pre-stimulus and post-




6.3.3.1 Rhythmic 35 Hz inhibition of MSDB cholinergic neurons did not alter 
hippocampal LFP power or coherence 
We first examined whether rhythmic inhibition could alter hippocampal LFP power or 
coherence. However, rhythmic inhibition at 90 mW/mm
2
, 35 Hz, 10 ms failed to 
demonstrate any alteration to hippocampal spectral power or coherence (Figure 42). 
We then examined constant inhibition of the cholinergic neurons using 
90mW/mm
2
 inhibition. Similarly, however, no alterations were observed in hippocampal 




Figure 43: Constant inhibition of MSDB cholinergic neurons does not alter hippocampal 
oscillatory power 
Constant inhibition of the MSDB cholinergic neurons for 20 seconds at 90 mW/mm
2
 (orange 
bar) failed to significantly alter hippocampal power at any frequency in either CA1 (A) and CA3 
(B) from the pre-stimulus epoch. No significant differences were observed between the pre-




Unlike inhibition of the glutamatergic population (Figure 33), no significant changes in 
theta phase were observed with constant inhibition of the cholinergic MSDB neurons 




Figure 44: Constant inhibition does not alter theta phase in or between CA1 and CA3 
No significant changes in the auto-correlation signal were between the pre-stimulus (black) and 
stimulus (orange) epochs was seen during 90 mW/mm
2
, 20s inhibition.  
 
 
6.3.3.2 No hippocampal single units altered their firing rate in response to optogenetic 
inhibition 
Rhythmic and constant inhibition of the MSDB cholinergic neurons failed to demonstrate 
significant changes in single unit firing rate in detected and isolated CA1 or CA3 





We hypothesized that the cholinergic neurons of the MSDB were serving as a gain 
control for theta, locally increasing the firing rate of glutamatergic and GABAergic 
neurons and priming the hippocampus for input. Stimulating the cholinergic neurons 
would, in theory, promote an excited state that could increase power at theta frequencies, 
whereas inhibiting the cholinergic neurons would reduce theta power. Neither of these 
results was born out in our experiments in awake and behaving transgenic ChAT-CRE 
transgenic rats.  
Neither optogenetic stimulation nor inhibition of the MSDB cholinergic neurons 
in awake animals altered hippocampal local field potential power at theta or other 
frequencies. Under anesthesia during the implantation surgery, two animals demonstrated 
changes in single unit firing rate in response to 50 mW/mm
2
, 35 Hz, 10 ms stimulation 
(Figure 40). We also noted that during the same stimulation protocol in awake animals; 
three neurons reduced their firing rate during the stimulus epoch (Figure 41). No changes 
in firing rate were noted during inhibition of the same population. 
We cannot rule out the possibility that our inhibitory paradigm failed to arrest 
neural activity in the cholinergic neurons of the medial septum. While the parameters we 
chose demonstrated functional effects in hippocampus in response to inhibition of the 
GABAergic (Figure 20) and glutamatergic (Figure 33) populations, no similar response 
or effect was noted in the cholinergic. Optogenetic stimulation and inhibition is partially 
dependent upon the membrane and electrochemical gradient properties of the expressing 
neurons, and it may be that the cholinergic population is more resistant to inhibition, or 
requires a greater transmembrane current, to completely silence. As the expression was 
robust and targeted appropriately (Figure 34), and no significant changes in hardware 
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implantation technique were made, this response is less likely due to a technical error 
particular to these subjects. Further investigation within the medial septum, as well as of 
the single unit recordings from the hippocampus, will be necessary to tease out the 
effectiveness of  MSDB cholinergic inhibition and the interpretation of these results. 
If cholinergic input largely impacts single-unit firing rates in inhibitory 
interneurons, then these results may also reflect poor targeting of our electrode arrays. 
We targeted our contacts to the pyramidal cell layer of the hippocampus. Yet nicotinic 
inputs from the medial septum project to inhibitory interneurons of the stratum 
lacunosum moleculare (Bell et al. 2011), and muscarinic inputs also have pronounced 
impacts on hippocampal interneurons (Bell et al. 2013). Our electrodes may simply be 
sampling from poorly responsive neurons, resulting in a poor signal-to-noise ratio. It is 
also possible that we are not activating a sufficient population of MSDB cholinergic 
neurons to generate a response. Introducing an electrode into the medial septum 
alongside the optical ferrule could provide greater insight into the effectiveness of our 
stimulation and inhibition techniques. These experiments, however suggest that 
cholinergic neurons do not pace or modulate hippocampal theta oscillations in the awake 
animal. 
Behavioral and network state may be highly important. Cholinergic input to the 
deafferented hippocampus is capable of generating theta-like oscillations (Konopacki et 
al. 1987), and perhaps this represents a particular hippocampal state in which cholinergic 
input is most effective. Urethane anesthesia is another case in which cholinergic inputs 
produced a demonstrable effect (Yoder and Pang 2005).  
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Indeed, combinatorial effects may play an important role. Cholinergic input alone 
may not be sufficient to alter septohippocampal dynamics, but instead may require 
concurrent GABAergic or glutamatergic activity to modulate the network. Non-specific 
electrical stimulation – which may be activating all three populations – has been used 
effectively to treat memory dysfunction due to medial septal lesions (McNaughton et al. 
2006), and combinatorial effects of lesioning multiple cell populations have been 
observed (Yoder and Pang 2005). Future experiments will need to explore these 
interactions in well-defined behavioral states to better elucidate MSDB cholinergic 
neuron functionality in the septohippocampal network. 
 
6.5. CONCLUSIONS 
Optogenetic excitation and inhibition of the MSDB cholinergic neurons failed to 
appreciably modulate hippocampal oscillatory power at any frequency, including theta. 
We did observe modulation of single-unit firing rates in rare cases in both anesthetized 








In this thesis, I have described the current state of epilepsy therapy, with particular regard 
to clinical trials in deep brain stimulation. I have also shown how current deep brain 
stimulation therapies are largely empirically derived with regard to targets and 
parameters, and argued that a more mechanistic approach is appropriate. I described our 
motivation for targeting the medial septum, and the importance of the hippocampal theta 
rhythm. I described new technologies, software, and adaptations to NeuroRighter to 
enable concurrent optogenetic neuromodulation and electrophysiology in awake and 
behaving animals, and demonstrated how these technologies and techniques can be used 
in several experimental approaches. I then utilized this system to explore medial septal 
input to the hippocampus. I selectively excited and inhibited each cell population in the 
medial septum with a variety of stimulation patterns, and analyzed the impact on 
hippocampal activity. 
 From these experiments, it appears no medial septal neural population is 
necessary for the presence of the hippocampal theta power, but that at least two are 
capable of modulating it. Synchronous GABAergic and glutamatergic inputs from the 
medial septum to the hippocampus are each capable of pacing and driving hippocampal 
oscillations (Figure 15Figure 26), with the former impacting the network more robustly 
than the latter. While inhibiting the GABAergic neurons did not alter theta or 
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hippocampal activity, inhibiting the glutamatergic neurons impacted the maintenance of 
phase synchrony and consistency in both hippocampal layers (Figure 33), potentially 
desynchronizing theta. Cholinergic inputs to the hippocampus could in a few 
circumstances modulate single unit firing rates, but did not demonstrably affect local 
field potential. 
 Together, this suggests a particular model for the septohippocampal axis and 
theta. Cholinergic neurons of the medial septum serve to prepare or inhibit hippocampal 
interneurons from firing (Bell et al. 2011; Bell et al. 2013), and act locally within the 
medial septum to excite glutamatergic neurons (Wu et al. 2003). These excited 
glutamatergic neurons experience submembrane threshold oscillations sufficient to 
produce fast and cluster-firing spike trains (Sotty et al. 2003; Huh et al. 2010). Some of 
this output projects directly to the hippocampus, while others act locally on MSDB 
GABAergic neurons (Wu et al. 2003). The GABAergic neurons then serve to amplify the 
synchronized glutamatergic pacemaker signal, and transmit it to the hippocampus, where 
it modulates extant theta resonance in the hippocampal circuit to maintain a defined and 
paced phase relationship between neurons within the septohippocampal axis. 
 
7.1. FUTURE EXPERIMENTAL THOUGHTS FOR ELUCIDATING MSDB-
HIPPOCAMPAL INTERACTIONS 
Testing the veracity of this model will require combinatorial approaches. For example, 
this model predicts that inhibition of the GABAergic MSDB neurons with concurrent 
rhythmic excitation of the glutamatergic neurons should reduce the presence of a 
stimulus-frequency specific oscillation in the hippocampus, whereas the opposite 
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experiment should be unaffected. Excitation and inhibition of entorhinal inputs to the 
hippocampus should also prove useful in determining theta’s origins and effects. 
 Coupling these experiments to a memory task will also provide great insight into 
the functional consequences of excitation and inhibition of these medial septal neuron 
subpopulations. One major limitation of this work was the lack of electrophysiologic 
recording performed within the medial septum alongside the hippocampus. This would 
not only provide greater insight into the effectiveness of excitatory and inhibitory inputs, 
it would also provide useful information concerning coherence activity across the entire 
septohippocampal axis, particularly in regards to particular single unit firing patterns. In 
addition, more extensive instrumentation of the hippocampus with tetrode-based 
recordings (Manns et al. 2007) would provide greater insight into spike-field interactions 
and the impact of cholinergic input. Indeed, further assessment of the impact of single 
unit firing rates, firing times, and coherence with local field potential would provide 
useful insight into the role these subpopulations play in normal hippocampal function. 
 
7.2. APPLYING OUR FINDINGS TO AN OPTOGENETIC THERAPY FOR EPILEPSY 
One goal of this research was to identify a viable target for septohippocampal theta 
modulation of hippocampal epilepsy. From the evidence generated, it appears that 
optogenetic stimulation of the GABAergic MSDB neurons is most promising, due to its 
robust impact on hippocampal oscillatory activity (Figure 15). Indeed, if we can identify 
epileptic events we may be able to drive the hippocampus such that the seizure is unable 
to generalize. However, it has been noted that GABAergic neuron population was the 
most vulnerable to cell death as a result of pilocarpine-induced epileptic activity (Garrido 
Sanabria et al. 2006). While I have preliminary evidence that GABAergic stimulation of 
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the medial septum in the tetanus toxin model can successfully modulate hippocampal 
activity, it may not be sufficient in the epileptic animal.  
However, Colom et al. successfully reduced epileptic activity with three disparate 
methods of theta induction – spontaneous, pharmacologic, and sensory (Colom et al. 
2006). Consequently, they hypothesized that it was not the method of theta generation 
that was antiepileptic but instead simply the oscillatory state itself. As the glutamatergic 
population of the medial septum appears to be spared in pilocarpine-induced epileptic 
animals (Garrido Sanabria et al. 2006), modulating the glutamatergic activity (perhaps in 
synergy with the GABAergic) could bypass the injured circuit and restore normal 
function. We are currently preparing the necessary experiments for long-term epileptic 
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